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SUMMARY 
The effects of intravenous (i.v.) anaesthetics on nicotinic acetylcholine receptor 
(nAChR)-mediated transients in intracellular free Ca2+ concentration ([Ca2+]i) and 
currents were investigated in neonatal rat intracardiac neurons using fura-2 photometry 
and patch-clamp recordings. Extensive preliminary tests using fura-2 containing 
solutions in the presence or absence of the anaesthetics were carried out to detect any 
interference of these drugs with the fura-2 fluorescence signal: Using photospectrometry 
and a ratiometric photometry set-up to carry out a series of calibrations of the fura-2 
signal revealed that ratiometric fura-2 recordings can faithfully be carried out in the 
presence of clinically relevant concentrations (clinical EC50) of the i.v. anaesthetics 
studied. In fura-2 loaded neurons, nAChR activation evoked a transient increase in 
[Ca2+]i, which was reversibly inhibited by the clinical EC50 of the i.v. anaesthetic 
thiopental. The EC50 for thiopental inhibition of nAChR induced [Ca2+]i transients was 
28 µM, close to the estimated clinical EC50 of thiopental (25 µM). However, control 
experiments using Ca2+ -channel blockers showed that voltage-gated Ca2+ -channels 
(Cav) are activated by the depolarization following nAChR activation and thus indirectly 
contribute to increases in [Ca2+]i. When fura-2 loaded neurons were voltage-clamped at 
–60 mV to eliminate any contribution of voltage-gated Ca2+ channels, then thiopental 
simultaneously inhibited nAChR-induced increases in [Ca2+]i and peak current 
amplitudes. Thiopental inhibited nAChR-induced peak current amplitudes in dialyzed 
whole cell recordings by ~ 40 % at –120, –80 and –40 mV holding potential suggesting 
that the inhibition is voltage independent. Thiopental did not inhibit caffeine-induced 
[Ca2+]i transients, indicating that an inhibition of Ca2+ release from internal stores via 
ryanodine receptor (RyR) channels is unlikely. The barbiturate pentobarbital and the 
dissociative anaesthetic ketamine used at clinical EC50 concentrations were also shown 
to inhibit nAChR-induced increases in [Ca2+]i. In conclusion, thiopental and other i.v. 
anaesthetics may inhibit nAChR-induced currents and [Ca2+]i transients in intracardiac 
neurons by binding to nAChR and thereby may contribute to changes in heart rate and 
cardiac output under clinical conditions. 
 
Keywords: fura-2, intracardiac neurons, intracellular Ca2+, intravenous anaesthetics, 
ketamine, nicotinic acetylcholine receptor, pentobarbital, ryanodine 
receptor, thiopental.  
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ZUSAMMENFASSUNG 
In dieser Arbeit wurde die Wirkung intravenöser (i.v.) Anästhetika auf intrazelluläre 
Kalziumsignale und Membranströme, die durch die Aktivierung von nikotinergen 
Acetylcholin-Rezeptoren (nAChR) entstehen,  an neonatalen Herzganglienneuronen 
untersucht. Als Untersuchungsmethoden wurden photometrische Messungen mit dem 
Kalziumindikator Fura-2, sowie Patch-Clamp Messungen, teils auch in Kombination, 
eingesetzt. In Voruntersuchungen mit Fura-2 -haltigen Lösungen wurde überprüft, ob 
i.v. Anästhetika mit dem Farbstoff Fura-2 selbst interagieren. Mittels 
Spektrophotometrie sowie einer Serie von Kalibrierungen des Fura-2 Signals am 
Fluoreszenzmikroskop konnte gezeigt werden, dass Fura-2 Messungen in der 
Anwesenheit klinisch relevanter effektiver Konzentrationen (klinische EK50) der 
untersuchten Anästhetika  zuverlässig durchgeführt werden können. In Fura-2 
beladenen Neuronen führte die Aktivierung von nAChR zu einem vorübergehenden 
Anstieg der intrazellulären freien Kalziumkonzentration ([Ca2+]i), welcher durch die 
klinische EK50 von Thiopental reversibel gehemmt werden konnte. Die Erstellung der 
Dosis-Wirkungs-Beziehung von Thiopental auf die Hemmung nikotinerg induzierter 
[Ca2+]i –Transienten ergab eine EK50 von 28 µM, die damit sehr nahe an der klinischen 
EK50 für Thiopental (25 µM) liegt. Weitere Kontrollexperimente unter Verwendung von 
Kalziumkanal-Blockern zeigten jedoch, dass spannungsgesteuerte Kalziumkanäle durch 
die Depolarisation, die durch die Aktivierung der nAChR entsteht, aktiviert werden  und 
somit indirekt zu nikotinerg induzierten Anstiegen der [Ca2+]i mit beitragen. Um diesen 
Beitrag der spannungsgesteuerten Ca2+ -Kanäle zu eliminieren wurden im Rahmen 
simultaner Fura-2 sowie Patch-Clamp Messungen Neurone mit einem Haltepotential 
von –60 mV „geklemmt“. Es ergab sich eine simultane, Thiopental-induzierte 
Hemmung der Amplituden von nikotinerg induzierten [Ca2+]i –Transienten und 
Einwertsströmen. In  („dialyzed“) Patch-Clamp Messungen wurden die Amplituden 
nikotinerg induzierter Einwertsströme bei –120, –80 und –40 mV Haltepotential jeweils 
um ca. 40 % erniedrigt, was auf eine spannungsunabhängige Hemmung hinweist. 
Thiopental hatte keine hemmende Wirkung auf Koffein-induzierte [Ca2+]i -Anstiege, 
was eine Hemmung von Ryanodin-Rezeptoren (RyR) durch Thiopental 
unwahrscheinlich erscheinen lässt. Die klinische EK50 des Barbiturats Pentobarbital 
sowie des dissoziativen Anästhetikums Ketamin hatten ebenfalls hemmende Wirkung 
auf nikotinerg induzierte [Ca2+]i –Transienten. Dies lässt darauf schließen, dass es durch 
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die Wirkung von Thiopental und anderer i.v. Anästhetika am nAChR zu einer 
Hemmung nikotinerg induzierter Ströme sowie intrazellulärer Kalziumsignale in 
Herzganglienneuronen kommen kann, was wiederum zu Veränderungen der 
Herzfrequenz sowie des Herzminutenvolumens, die bei der Verwendung dieser 
Medikamente im Rahmen der Anästhesie zu beobachten sind, mit beitragen kann.  
 
Stichwörter: Fura-2, Herzganglienneurone, intravenöse Anästhetika,  intrazelluläres 
Ca2+, Ketamin, nikotinerger Acetylcholin-Rezeptor, Pentobarbital, 
Ryanodin-Rezeptor, Thiopental.  
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1 INTRODUCTION 
The present study has examined the effects of clinically relevant concentrations of intravenous (i.v.) 
anaesthetics on membrane currents and intracellular calcium signals in rat intracardiac neurons 
following nicotinic acetylcholine receptor (nAChR) activation.  
Clinically, i.v. anaesthetics are well known to affect cardiac parameters such as heart 
rate and cardiac output, and have been shown to alter cardiovascular functions in animal 
studies. On a molecular level, clinically relevant concentrations of i.v. anaesthetics are 
assumed to target a superfamily of ligand-gated-ion channels (LGIC) that includes the 
nAChR channels. 
As intracardiac neurons are known to contribute to the regulation of heart rate and cardiac 
output, and neurotransmission to these neurons is predominantly nicotinic, it was hypothesized 
that i.v. anaesthetics may contribute to the changes in cardiac parameters observed under clinical 
conditions by inhibiting nAChR channels in intracardiac neurons. 
This is a new aspect of heart rate regulation under i.v. anaesthesia, as most studies 
published to date dealing with the effects of i.v. anaesthetics on ion channels have only 
been carried out in expression systems. Yet, to relate studies of anaesthetic effects on ion 
channels in expression systems to physiological function, it is crucial to carry out studies 
in functionally relevant native cells. Thus, the present thesis is one of the first studies 
that examine the effects of clinically relevant anaesthetic concentrations on native neuronal 
receptors in an anatomically relevant tissue.  
Furthermore, most studies to date have focused on electrophysiological effects 
of clinically relevant concentrations of anaesthetics. In contrast, anaesthetic effects on 
neuronal second-messenger systems such as the Ca2+ signalling system have hardly been 
examined - despite the well-known role of Ca2+ ions for various cellular functions, 
including excitability, neurotransmitter release, and gene transcription. 
The present study is based on our previous study (Beker et al., 2003), which has 
shown that nAChR activation in these neurons involves the generation of inward currents 
concurrent with intracellular Ca2+ transients. Furthermore, we have shown that nAChR 
activation is followed by Ca2+ release from intracellular stores through ryanodine receptor 
(RyR) channels. As nAChR activation is likely to depolarize the cell, it can be reasoned 
that voltage-gated Ca2+ channels (Cav) are activated and may also contribute to the observed 
Ca2+ signals. Taken together, these data suggest that nAChR activation may play an 
important role for intracellular Ca2+ signalling in rat intracardiac neurons.  
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Based on these results, it was decided to study the effects of i.v. anaesthetics on 
membrane currents as well as intracellular Ca2+ transients following nAChR activation in 
rat intracardiac neurons. 
 
1.1 Autonomic control of the heart 
The autonomic nervous system (ANS) is a neuronal control system that helps to maintain the 
inner homeostasis of the body. Regarding the cardiovascular system, it contributes to the 
adjustment of the blood circulation to various internal as well as external stimuli such as 
the need to fight or flight, physical work, food digestion etc. This is achieved by 
regulating the resistance of the vessels to blood flow and the cardiac output (CO). The CO is the 
blood volume that the heart pumps in a minute, which is the stroke volume (SV) 
multiplied by the heart rate (HR).  
 
1.1.1 Innervation of cardiac pacemaker centres  
As intracardiac neurons contribute to the autonomic innervation of the heart, this 
chapter begins with a brief overview of the cardiac pacemaker system and subsequently 
describes the traditional concept of the autonomic innervation of the heart. Chapter 1.1.2 then 
focuses on intracardiac neurons and describes recent findings that challenge these 
traditional concepts.  
Neuronal control of CO is obtained through both branches of the ANS by 
innervation of specific target regions within the heart, namely the myocardium and the 
pacemaker- and conductile-system, which is illustrated in figure 1B. The latter can be 
subdivided into three pacemaker centres that are able to generate spontaneous and rhythmic 
action potentials: 
The sinuatrial (SA) node is the primary pacemaker of the heart. It is located in the 
right atria close to the entry point of the vena cava superior. The spontaneously arising 
action potentials in its pacemaker cells initiate a frequency of 60 to 80 beats per minute 
(BPM) in resting human adults. The generated activity spreads through the myocardial 
cells of the atria to the atrioventricular (AV) node as the secondary pacemaker of the heart. It is 
located in the posterior part of the right atria at the interatrial and interventricular 
septum and represents the only excitable spot between the atria and the ventricle. From 
the AV bundle, activation spreads through a specialized conduction system that forms 
the tertiary pacemaker system, which includes the bundle of His, the bundle branches and the 
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Purkinje fibres. The latter innervate the working myocardium of the ventricles (see: Berne 
& Levy, 1998; Thews & Vaupel, 1997; Vander et al., 1987).  
Increased sympathetic activity yields to cardioaugmentation by positive chronotropic, 
dromotropic and inotropic effects, i.e. increases in heart rate, conduction velocity of 
innervation within the heart, and myocardial contractile force, respectively. Increased 
parasympathetic activity yields to cardiodepression by the opposing negative chronotropic, 
dromotropic and inotropic effects: Chronotropic effects are mainly obtained by modulation 
of the SA node. The SA node is targeted by a greater number of parasympathetic than 
sympathetic nerve endings, and parasympathetic tone also appears to outrank sympathetic 
tone on heart rate: This became apparent in experiments where both branches of the autonomic 
system were blocked and heart rate was found to rise from the resting heart rate of typically 
~ 70 BPM up to ~ 100 BPM in humans. Dromotropic effects are mainly obtained by 
modulation of the AV node. Inotropic effects are obtained by modulating the myocardial 
contractile force (Berne & Levy, 1998; Thews & Vaupel, 1997). 
The two branches of the ANS also differ in the more upstream segments of 
their innervation pathways: Sympathetic preganglionic neurons involved in the regulation of 
the heart are located in the intermediolateral columns of the lower cervical and upper 
thoraic segments of the spinal cord. Their relatively short axons synapse with sympathetic 
postganglionic neurons located in nearby paravertebral ganglia of the sympathetic chain and 
the longer axons of the latter project to the heart. Neurotransmission between pre- and 
postganglionic neurons is primarily nicotinic, while neurotransmission between postganglionic neurons 
and the target tissue is mainly noradrenergic.  
Parasympathetic preganglionic “cardiac” neurons are located in the nucleus ambiguous 
and the dorsal motor nucleus of the vagus in the medulla oblongata. Their relatively 
long preganglionic axons join the vagus nerve and synapse with postganglionic parasympathetic 
neurons, i.e. intracardiac neurons that are located in parasympathetic ganglia in the heart. The 
relatively short axons of intracardiac neurons connect with the cardiac target tissues. 
Neurotransmission between pre- and postganglionic neurons is also primarily nicotinic. 
Neurotransmission between postganglionic neurons and the target tissues is mainly 
mediated by type two muscarinic AChR (mAChR; summarized in: Antoni, 1996; Iversen 
et al., 2000; Powley, 1999; Sved, 1999, Vander et al., 1987).  
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Figure 1 illustrates the parasympathetic innervation of the heart.  
 
Figure 1: Parasympathetic innervation of the heart and the cardiac conduction system (adapted 
from Berne & Levy, 1988, p. 346; Saper, 2000, p. 876; Schmidt, 1992, p. 
162) 
A: The brain stem and the vagus nerves (ventral view).  
Cardiac preganglionic parasympathetic fibres originate in the medulla oblongata of the 
brain stem. As part of the 10th cranial nerves (vagus sinister and vagus dexter) they exit the 
medulla bilaterally and project towards the heart. 
B: The cardiac conduction system (ventral view). 
Scheme of the cardiac pacemaker and conduction system. Black arrows indicate the vagus 
nerves that project to postganglionic parasympathetic neurons. The thickness of the arrows 
indicates the differential distribution of vagal nerve endings. The dashed circle indicates the 
location of most postganglionic parasympathetic neurons. The splitting of the left bundle 
branch into the anterior and posterior division is not shown. See text for further details.  
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1.1.2 Mammalian intracardiac neurons 
Traditionally, it is believed that intracardiac (ganglion) neurons or intrinsic cardiac (ganglion) 
neurons are basically efferent postganglionic parasympathetic neurons. The latter are thought to be 
the sole cell population within cardiac ganglia that act as mere (cholinergic) relay stations for 
vagal input to the heart. Indeed, there is little doubt, that a majority of intracardiac neurons 
display cholinergic properties, including the capability for ACh synthesis (Leger et al., 1999; 
Mawe et al., 1996). Furthermore physiological and pharmacological studies have shown that a 
majority of intracardiac neurons do respond to nicotinic stimulation (or inhibition thereof), 
supporting the idea of a nicotinic neurotransmission (see e.g. Adams & Nutter, 1992; 
Bibevski et al., 2000; Cuevas & Adams, 1994; Fieber & Adams, 1991a; Hogg et al., 1999; 
Nutter & Adams, 1995; Poth et al., 1997). In addition, Bibevski et al. (2000) have shown 
that local perfusion of cardiac ganglia with specific blockers of nicotinic transmission 
leads to the increases in heart rate in vivo. This data directly links nicotinic 
neurotransmission to in vivo responses in heart rate discussed in the previous chapter. 
Revisions of the simplistic “relay concept” for intracardiac neurons have in particular 
been proposed by Armour and co-workers (reviewed in Armour, 1999) and are 
illustrated in figure 2:  
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Figure 2: Autonomic innervation of the heart. A controversial view (adapted from Armour, 
1999, p. 42) 
 Schematic representation of neurons and their interconnections suggested being involved in the regulation of 
the heart.  
According to this working model of Armour, and based on anatomical and functional 
evidence, neurons of extrinsic cardiac ganglia not only include neurons of the paravertebral 
ganglia of the sympathetic chain, but also neurons of the middle and superior cervical 
ganglia, as well as the mediastinal ganglia.  
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This model is related to two major points: Firstly, intracardiac ganglions are 
likely to contain a more heterogeneous cell population: In addition to a substantial population 
of efferent postganglionic parasympathetic neurons, cardiac ganglia may also include at least 
small populations of local circuit neurons, afferent neurons and efferent postganglionic sympathetic 
neurons. The presence of efferent sympathetic neurons in intracardiac neurons is supported 
by in vivo and in situ experiments, which have shown that a subgroup of intracardiac 
neurons can elicit cardioaugmentation and thus exerts typical sympathetic function (Armour & 
Hopkins, 1990a; Butler et al., 1990; Huang et al., 1993; Yuan et al., 1993). 
Immunohistochemical studies have further identified tyrosine hydroxylase (TH), i.e. an enzyme 
that is required for norepinephrine synthesis, in groups of mammalian intracardiac 
neurons, indicating that these neurons may be of adrenergic phenotype in that they are able 
to produce catecholamines (Moravec & Moravec, 1989; Slavikova et al., 1993), but other 
studies have failed to so (Baluk & Gabella, 1990; Leger et al., 1999). Leger and co-
workers, e.g. acknowledge that cardioaugmentation can occur following activation of 
intracardiac neurons, but they point out that intracardiac neurons that lack the enzymes 
to produce biogenic amines have been shown to accumulate biogenic amines: Intracardiac 
neurons may thus be able to accumulate and release, but not produce, catecholamines. Non-
neural cells like intensely fluorescent (SIF) cells that are present in intracardiac ganglia may 
release catecholamines and thus contribute to cardioaugmentation. Furthermore, 
neurotransmission to and from intracardiac neurons may not solely be a function of 
ACh- (and possibly catecholamine-) release, but may be mediated by other endogenous 
chemical agents that can either act as neurotransmitters or neuromodulators and may be co-
released together with ACh: Immunohistochemical studies have detected the presence of 
several neuropeptides such as vasoactive intestinal polypeptide (VIP), neuropeptide Y 
(NPY), somatostatin, substance P and dynorphin in intracardiac neurons or nerve fibres 
in the heart, with different expression patterns for subpopulations of intracardiac neurons. 
This suggests a neurochemical complexity despite the common cholinergic phenotype of 
most intracardiac neurons (Steele et al., 1996). This view is supported by physiological 
studies that have shown that endogenous chemical agents like neuropeptides can modulate nicotinic 
signals in intracardiac neurons, and other endogenous chemical agents such as 
adenosine triphosphate (ATP), or enkephalines have been shown to elicit or modulate non-
cholinergic physiological mechanisms, indicating a functional complexity of intracardiac neurons 
(Cuevas & Adams, 2000; Fieber & Adams, 1991b; Liu & Adams, 2001; Liu et al., 2000a, 
2000b; Smith & Adams, 1999).  
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Secondly, in contrast to the “relay station” concept, various types of intracardiac 
neurons seem to form a local intracardiac network. This network appears to exert local control 
of parasympathetic, sympathetic and afferent information to and from the heart 
(Armour, 1999).  
While immunohistochemical methods in atrial preparations have identified the 
somata of intracardiac neurons in the subepicardium throughout the atria, they are concentrated 
in the interatrial septum, close to the origins of the two caval veins and the pulmonary vein 
ostia. The total number of intracardiac neurons has been reported to be some 1500 per atria. 
Individual ganglia can differ significantly in size, ranging from less than five to more 
than 100 neurons per ganglia. Interestingly, not all of the atrial intracardiac neurons 
seem to be ganglionic: While 85 - 95 % of intracardiac neurons derived from the atria of 
adult guinea pigs are part of ganglia (ganglionic neurons), the remaining 5 – 15 % are 
isolated (individual neurons). The cell size of the great majority of neurons in these guinea 
pig preparations are relatively large, ranging from 15 to 40 µm in diameter, but a 
substantial amount of smaller cells have also consistently been detected (Horackova et 
al., 1999; Leger et al., 1999; Seabrook et al., 1990). The cell types of atrial intracardiac 
neurons are mainly uni- or bi-polar (Xu & Adams, 1992a), but multipolar neurons have 
been detected, too, further supporting the idea of a heterogeneous population of 
intracardiac neurons (Horackova et al., 1999). 
Intracardiac neuronal somata have also been detected in ventricular preparations in a 
number of mammalian species, including rats and humans. Most studies, however, seem 
to agree in that the density and the extent of intracardiac ganglia within the ventricles is 
lower than within the atria (Armour & Hopkins, 1990b; Armour et al., 1997; Moravec & 
Moravec, 1989; Pauza et al., 2000; Yuan et al., 1993).  
The target tissues of atrial intracardiac neurons mostly lie within the atria, those of 
ventricular neurons within the ventricles (Butler et al., 1990). Major target tissues of atrial 
intracardiac neurons are the atrial musculature, and especially the SA node, the AV node, 
the valves as well as other ganglia (Seabrook et al., 1990; Steele et al., 1996).  
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1.2 General Anaesthetics 
In 1948, Morton and co-workers successfully used diethyl ether to carry out the first 
general anaesthesia in public (Mutschler et al., 2001). Since these adventurous 
beginnings, general anaesthetic procedures have become widely employed and generally 
safe: In France, e.g., ~ 13.5 % of the whole population undergoes anaesthesia every 
year, and ~ 77 % of theses anaesthetic procedures involve general anaesthesia (Clergue 
et al. 1999). Furthermore, less than one death that is directly attributable to anaesthesia 
occurs per 200,000 procedures (Urban & Bleckwenn, 2002).  
Yet there is still need for improvement, as the use of general anaesthetics can involve 
severe side effects. This becomes apparent in descriptions of the general anaesthesia: While 
no generally accepted definition of general anaesthesia seems to exist, there is 
consensus, that the clinical effect(s) of anaesthesia can involve several components, some of 
which are desired, while others are undesired (side-effects) as illustrated in figure 3: The 
desired effects include amnesia, analgesia, unconsciousness and muscle relaxation. Undesired effect 
can range from shivering, emesis (=vomiting), and excitation/convulsions to most importantly 
for the present thesis: cardiovascular instability.  
 
Figure 3: Components of general anaesthesia (based on Urban & Bleckwenn, 2002, p. 3) 
 Desired (+) and undesired (-) components of general anaesthesia.  
Analgesia is part of two categories of the above scheme and for that reason has been put in 
brackets: Assuming that pain involves a conscious perception of noxious stimuli, 
unconsciousness may involve analgesia (= the absence of pain). Therefore, analgesia is part 
of unconsciousness in this scheme. In contrast, analgesia does not necessarily require 
unconsciousness, which is why analgesia itself comprises a separate category. 
Cardiovascular instability has been printed in bold to indicate its importance in the context 
of the present thesis.  
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There are some drugs such as ether or chloroform that, if solely applied, can (more 
or less) generate all the components of general anaesthesia and are therefore called 
general anaesthetics. In clinical application, however, the aim is not to use a single 
compound that generates the whole spectrum of general anaesthesia but rather use a 
combination of drugs to allow for a fine-tuning of individual components of general anaesthesia 
(Urban & Bleckwenn, 2002). Typically 3 different types of drugs are being used: While opioids 
are used to obtain analgesia and muscle relaxants to achieve muscle relaxation, general 
anaesthetics are used to achieve unconsciousness and amnesia (Urban & Bleckwenn, 2002).  
Our detailed knowledge concerning clinical effects and side effects of general 
anaesthetics is in marked contrast to our lack of understanding of the cellular and 
molecular mechanisms on which these mechanisms are based. Such knowledge has only 
begun to emerge within the last couple of years (Krasowski & Harrison, 1999; Urban & 
Bleckwenn, 2002; Yamakura et al., 2001) and it is the aim of the present thesis to 
contribute to this process: By examining the effects of i.v. anaesthetics on intracardiac 
neurons it may yield to a better understanding of the cardiovascular side effects of these 
drugs. The following chapter gives an overview of the family of general anaesthetics. 
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1.2.1 Molecular diversity 
General anaesthetics are a chemically very heterogeneous group that includes a number 
of volatile anaesthetics, anaesthetic gases, intravenous (i.v.) anaesthetics as well as alcohols as 
illustrated in figure 4 for a selection of these drugs.   
 
 
Figure 4: Chemical structures of general anaesthetics (from Krasowski & Harrison, 1999, p. 
1279; adapted by M. Weber) 
 General anaesthetics can (somewhat indiscriminately) be subdivided into: volatile anaesthetics, anaesthetic 
gases, intravenous anaesthetics and alcohols.  
 The anaesthetics used in the present thesis are printed in bold. 
 
Interestingly, some of these drugs do not exist as salts, bases and acids and were 
originally called non-specific anaesthetics (Urban & Bleckwenn, 2002). The i.v. anaesthetics of 
the present study, i.e. thiopental, pentobarbital and ketamine, however, exist as salts and 
bases, and have pKa values ranging from 7.5 to 8.11 (see appendix A.2), indicating that 
at physiological pH values, one substantial fraction of the molecules is likely to exist in the 
dissociated state, while a second fraction is likely to exist in the non-dissociated state.  
Further complexity arises as several of these anaesthetics, including thiopental, 
pentobarbital and ketamine, exist as stereoisomers (or optical isomers, or enantiomers), i.e. 
variants of molecules of identical molecular and structural formula, but with different 
spatial configuration due to the presence of an asymmetric carbon atom. As a result, the 
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two variants exist in spatial configurations that are mirror images of each other, which 
cannot be rotated to completely overlay each other (see e.g. Franks & Lieb, 1994; Graf 
& Martin, 1998).  The great majority of the commercially available isomeric anaesthetics 
actually are (1:1) racemic mixtures of the enantiomers, meaning that (both) enantiomers are 
present in the compound in the same quantities. Pure enantiomers can be derived from 
racemic mixtures, e.g. using high-performance liquid chromatography techniques (see 
e.g. Tomlin et al., 1999). Different enantiomers sometimes have varying anaesthetic 
potencies, which make them interesting for clinical use, as the sole application of the 
enantiomer with the higher anaesthetic potency allows for lower drug concentrations. 
However, due to the high costs of their purification, enantiomers are not yet widely used 
for anaesthetic procedures (Graf & Martin, 1998).  
 
1.2.2 In vivo effects of thiopental, pentobarbital, and ketamine 
The present thesis has focused on racemic mixtures of the barbiturates thiopental (also 
called thiopentone, thiobarbital and pentothal) and pentobarbital (also called 
pentobarbitone or nembutal), as well as the dissociative anaesthetic ketamine. All of them are 
considered to be general anaesthetics, even though none of them can be properly used 
for general anaesthesia in the absence of additional drugs: The barbiturates are hypnotics, 
but lack analgesic properties, ketamine does have analgesic properties, but it has to be used together 
with benzodiazepines to avoid negative psychological reactions. 
  Like all barbiturates, thiopental is a derivate of barbituric acid (Larsen, 2002). It is a 
popular anaesthesia-inducing hypnotic drug that leads to a rapid loss of consciousness, typically 
within fractions of a minute following the start of its i.v. administration. Figure 5 
illustrates the thiopental distribution in body tissues following a typical, single i.v. bolus 
application at the beginning of the anaesthetic procedure. 
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Figure 5: Distribution and redistribution of thiopental in human body tissues (adopted from 
Büch & Büch, 2001, p. 291, based on Price et al., 1960, p. 21) 
 Estimation of thiopental concentrations in body tissues following a single i.v. injection of thiopental. 
The model describes the (re-) distribution of thiopental in the body of human adults and 
has been confirmed by the extraction of samples. It assumes four compartments that that 
are connected via a circulatory pump. The compartments correspond to different tissues 
with different masses, blood and lymph flow rates and concentration ratios for thiopental 
(tissue/blood).  The central blood volume is the 1st compartment. The 2nd compartment 
includes the CNS, the heart, the kidneys and the liver, which have been pooled together 
due to similar perfusion rates and thiopental affinities. The 3rd and 4th compartment in 
essence are the musculature and the fatty tissue, respectively. Further assumptions include 
an instant thiopental mixture with the 1st compartment, an immediate distribution to the 
tissues, a constant tissue blood flow and an equilibrium state between any tissue and the 
blood that leaves this tissue. Excretion or metabolic mechanisms are not considered for 
the limited time period examined. 
  
 A rapid thiopental accumulation occurs in the CNS and other vessels-rich organs, 
such as the heart, lungs, liver and kidneys, reaching a peak value ~ 1 min following its 
bolus. The rapidity of this process is due to the high lipophilicity of thiopental, which also 
facilitates the penetration of the blood-brain barrier. The decline of the thiopental 
concentration in these strongly perfused tissues is also very fast: Thiopental 
concentrations typically reach sub-narcotic levels in the CNS (so that the patient regains 
consciousness) within less than ten minutes. This rapid decline is due to a redistribution of 
thiopental into tissues with lower blood circulation, in particular the musculature, and not 
due to its metabolic breakdown, as the half-life T1/2β of thiopental in the blood plasma has 
been determined as longer than ten hours (see Evers & Crowder, 2001). The thiopental 
concentration within the musculature increases somewhat more slowly, reaching peak 
values after about half an hour. Its subsequent decline is mostly due to another 
redistribution into the fatty tissue (Büch & Büch, 2001, according to Price et al., 1960).   
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Thiopental readily binds to plasma proteins: While ~ 85 % of thiopental in the 
plasma (total thiopental) is bound to proteins (protein-bound thiopental), only ~ 15 % is 
present as free, unbound thiopental (free thiopental; Burch & Stanski, 1983). This 
characteristic has to be taken into account for the calculation of clinically relevant 
concentrations of thiopental for in vitro experiments (see chapter 1.2.3). See appendix 
A.2 for further data on thiopental. 
Pentobarbital also is a barbiturate with hypnotic properties, but nowadays it is no 
more used in humans. It is nonetheless a very interesting anaesthetic compound, as it is 
an active metabolite of thiopental in the human body that is obtained by oxidative desulfuration 
in a fraction of the thiopental molecules present (Büch & Büch, 2001; Chan et al., 1985; 
Charney et al., 2001). This metabolic transformation thus leads to a prolonged presence 
of hypnotics in the human body in particular, as pentobarbital is a longer-acting barbiturate 
(Evers & Crowder, 2001). Its half-life T1/2β in the blood plasma has been determined as 
~ 30 hours (Fichtl, 2001; Wellhöner, 1988).  
Pentobarbital is several folds less lipophilic than thiopental (Raaflaub, 1970), in line 
with the general tendency of oxybarbiturates to be less lipophilic than the corresponding 
thiobarbiturates. Its reduced lipophilicity is likely to account for an increased duration of 
action and latency to onset of activity, a prolonged metabolic degradation and a reduced 
hypnotic potency (Charney et al., 2001). The metabolites of pentobarbital themselves are 
not hypnotic (see e.g. Büch & Büch, 2001).  
Pentobarbital also binds to plasma proteins, but to a smaller degree than thiopental. 
Franks and Lieb (1994; based on Ehrnebo & Odar-Cederlöf, 1977) report that ~ 61% 
of the total pentobarbital concentration in blood plasma is bound to proteins.  
Ketamine differs from the barbiturates in several respects: Chemically, ketamine is a 
derivate of phencyclidine, which causes strong psychotomimetic activity (Larsen, 2002; White 
et al., 1982). The unusual anaesthetic state caused by ketamine already became apparent with 
the first use of ketamine in man:  
 
The unusual analgesic and aesthetic action of this drug with sympathomimetic 
properties, and cerebral dissociative actions, makes it imperative that a new 
terminology be developed for drugs of this type. It is suggested that the 
state produced by this drug be called “dissociative” anaesthesia (from Adams 
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& Werner, 1997, p. 1026; based on Domino et al., 1965; italicisation 
added by M. Weber).  
 
Dissociative anaesthesia describes a cataleptic state that involves amnesia, analgesia and 
only a superficial loss of consciousness during which patients typically have their eyes open 
and often display involuntary movements of their limbs, but do not respond to 
commands despite their mostly intact, spontaneous respiration (see e.g. Adams & 
Werner, 1977; Evers & Crowder, 2001; Trevor & Miller, 2001).   
Ketamine is extremely lipophilic, with a 5-10 times better lipid solubility than 
thiopental (Büch & Büch, 2001). It rapidly penetrates the CNS (and other strongly 
perfused tissues such as the heart (see above) and has a rapid onset of activity: Loss of 
consciousness also occurs within fractions of a minute following a typical i.v. bolus 
application. Ketamine also redistributes from the strongly perfused to less perfused tissues. 
A difference between ketamine and thiopental, however, is that its metabolic breakdown 
and to some extent urinary and biliary excretion plays a greater role during the initial 
decay of its concentration (Trevor & Miller, 2001): Its half-life T1/2β in the blood plasma is 
~ 3 hours and thus considerably shorter than that of thiopental and pentobarbital. 
Furthermore, only ~ 12 % of the total ketamine concentration in the blood plasma are 
bound to protein (Evers & Crowder, 2001; see also appendix A.2).  
Table 1 illustrates further effects of thiopental and ketamine.  
 
Drug  CBF CMRO2 ICP MAP HR CO RespR VE 
Thiopental – – – – – – – – – – + – – – – 
Ketamine ++ +/– ++ + ++ + +/– +/– 
 
Table 1: Major clinical effects of the i.v. anaesthetics thiopental and ketamine (adopted from 
Evers & Crowder, 2001, p. 348) 
 Thiopental differs from ketamine with respect to its profile of effects and side effects. 
The table shows typical effects of a single bolus application in humans.  
Legend:  CBF cerebral blood flow; CMRO2 cerebral metabolic rate for oxygen; ICP intracranial 
pressure; MAP mean arterial pressure; HR heart rate; CO cardiac output; RespR 
respiratory rate; VE minute ventilation.  
Symbols:  – – – large decrease; – – moderate decrease; – slight decrease;  
+++ large increase;  ++ moderate increase;  + slight increase;  
+/– no significant change. 
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More data on thiopental, pentobarbital and ketamine is gathered in 
appendix A.2. Their effects on the cardiovascular system are discussed in the following 
chapter. 
 
1.2.2.1 Cardiovascular effects 
Clearly, general anaesthetics are basically in use because of their main effects on the 
CNS. However, following their CNS effects, the most crucial clinical side effects of 
anaesthetics are those on the cardiovascular system (Graf et al., 1995; Graf & Martin, 1998). 
In his paper on thiopental and ketamine Horwitz (1977, p. 44) already points out that: 
“Potentially deleterious cardiovascular responses have been associated with virtually all drugs capable of 
general anaesthesia”.  
However, due to the large number of organ systems and parameters that are 
involved in the regulation of the cardiovascular system, it would go beyond the scope of 
this thesis to discuss the possible i.v. anaesthetic modulation of all of these parameters 
and their interplay (for introductory reviews see: Fragen &Avram (2000); Reves et al. 
1999, 2000). Therefore, only key parameters, with a focus on chronotropic effects, will be 
discussed in the following sections.  
Lieb and Mulinos using amytal have already reported a barbiturate-induced decrease 
in blood pressure in 1929. Since then, this finding has been confirmed for other 
barbiturates such as thiopental or pentobarbital in many studies over several decades in 
animals, healthy humans and in humans with chronic heart disease (see e.g. Aono et al., 
2001; Manders & Vatner, 1976; Morrison et al, 1950; Naguib et al., 2003; Peiss & 
Manning, 1964; Price et al., 1952; Reiz et al, 1981; Scheffer et al., 1993; Seltzer et al., 
1980; Sonntag et al., 1975). 
Barbiturates are well known for their negative inotropic effect, which is attributed to a 
direct effect on the myocardium (Azari & Cork, 1993; Frankl & Poole-Wilson, 1981; 
Gelissen et al., 1996; Kissin et al., 1983; Komai & Rusy, 1984; Manders & Vatner, 1976; 
Park & Lynch, 1992).  
A barbiturate-induced increase in heart rate has also been reported in a great 
number of studies, also in animals, healthy humans and humans with coronary heart 
disease (see e.g. Aono et al., 2001; Blake & Korner, 1981; Bristow et al., 1969; 
Christensen et al., 1982; Filner & Karliner, 1976; Manders & Vatner, 1976; Milocco et 
al., 1985; Morrison et al, 1950; Price et al., 1952; Reiz et al, 1981; Scheffer et al., 1993; 
Seltzer et al., 1980; Sonntag et al., 1975; Tarabadkar et al, 1980; Van Citters et al., 1964).  
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The origin of this effect, however, has been controversially discussed. Most 
studies seem to agree that an indirect effect plays a role, i.e. the baroreceptor reflex contributes 
– at least in part - to the observed positive chronotropic effect in the presence of the 
anaesthetic (Bristow et al., 1969; Filner & Karliner, 1976; Manders & Vatner, 1976; Reiz 
et al., 1981): Moderate increases in heart rate may serve as a compensatory mechanism to 
maintain cardiac output, given that blood pressure (and contractile force) is reduced 
following the application of barbiturates (see above).  
In addition, a direct effect, i.e. a barbiturate effect on cardiac pacemaker centres and/or 
neurons that are involved in the regulation of the heart rate, is very likely to play a role. In 
particular, direct barbiturate effects on sympathetic and/or parasympathetic neurons that are 
involved in the regulation of the heartbeat e.g. would provide plausible alternative 
explanations.  
Firstly, and most importantly in the context of the present study, a suppression of 
parasympathetic cardiac neurons could explain the observed positive chronotropic effect. 
Indeed, the pioneering studies of Lieb and Mulinos (1929), and Shafer et al. (1929), 
using amytal, have already demonstrated a barbiturate-induced suppression of the vagal 
innervation of the heart. Later experiments by Blake and Korner (1981), Halliwill and 
Billman (1992) and Murthy et al. (1982) using rabbits or dogs have demonstrated 
barbiturate-induced suppression of vagal tone, which was accompanied by increases in heart rate. 
Experiments in man by Scheffer and co-workers (1993), using sophisticated beat-to-beat 
analysis of cardiovascular signals in man, similarly suggest a barbiturate-induced suppression 
of vagal tone on the heart.  
Secondly, as pointed out by Bristow et al. (1969), increased (neural) sympathetic 
activity or increased catecholamine levels in the blood flow could similarly explain the observed 
increases in heart rate. However, experimental evidence rather suggests a suppression of 
sympathetic nervous activity (Shimokawa et al., 1998; Skovsted et al., 1970) and a reduction 
of general sympathetic outflow from the CNS in the presence of barbiturates (Aono et al., 
2001). The data of Scheffer et al. (1993) also supports a thiopental-induced inhibition of 
sympathetic outflow in addition to the already mentioned suppression of vagal tone. 
Taken together, experimental evidence rather suggests a barbiturate-induced suppression of 
both parasympathetic and sympathetic nervous activity.  
Such a condition in which both, the parasympathetic and sympathetic branch of the 
ANS are similarly down-regulated, with very few exceptions, typically leads to an increase in 
heart rate in a wide range of mammals, including humans, due to the greater importance 
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of the vagal tone on heart rate under conditions of rest. These findings have been an 
accepted part in physiology textbooks for several years (see e.g. Berne & Levy, 1998; 
Thews & Vaupel, 1997), and they have recently been confirmed using state of the art 
electrocardiography (ECG) analysing techniques (Després et al., 2002; Just et al., 2000). 
Furthermore, the effect of parasympathetic tone on heart rate has even been shown to 
persist during conditions of heavy exercise in dogs (O’Leary et al., 1997). In sum, there 
is substantial evidence that barbiturates yield a positive chronotropic effect, which is partly due to the 
vagolytic properties of these drugs.  
While cardiovascular side effects of anaesthetics are basically undesired, they 
may not be too dramatic in healthy subjects. Increases in heart rate, however, can 
represent a particularly adverse type of side effect in patients with an unstable 
cardiovascular system, e.g. in patients with cardiovascular disease, as it can increase 
myocardial oxygen demand. The latter depends on several factors besides heart rate, 
including wall tension and myocardial contractility (Reiz et al., 1981). Under certain 
experimental conditions, including an experimentally controlled heart rate, barbiturates 
have thus been shown to reduce myocardial oxygen demand (Manders et al., 1976; Reiz 
et al., 1981). The crux of the matter, however, is that increased heart rate is related to 
increased myocardial work and can lead to increased myocardial oxygen demand (Sonntag et al., 
1975, Tarabadkar et al., 1980). A dramatic consequence of general anaesthesia that is 
likely to be linked to this effect has been demonstrated by Jugdutt and co-workers 
(1986) who found that dogs that were exposed to thiopental during acute myocardial 
infarction had higher heart rates and subsequently greater infarct sizes than control dogs not 
exposed to thiopental. A second group of dogs were not exposed to thiopental, and 
heart rates were artificially paced and set to a frequency comparable to that of the 
thiopental group during acute myocardial infarction. Here, infarcts were also larger than 
that of the control group – but comparable to that of the thiopental group.  
Ketamine’s uniqueness within the group of the general anaesthetics is also due to 
its cardiostimulatory and sympathomimetic properties, which – in healthy subjects - typically 
induce increases in blood pressure, heart rate and cardiac output. These effects have also been 
demonstrated over several decades in a wide range of studies in animals, healthy humans 
and humans with coronary heart disease (see e.g. Akine et al, 2001; Bålfors et al., 1983; 
Blake & Korner, 1981; Doenicke et al., 1992; Domino et al., 1965; Horwitz, 1977; Idvall 
et al., 1979; Inoue & Arndt, 1982; Ivankovich et al., 1974; Johnstone, 1976; Nishimura 
et al., 1973; Savege et al., 1976; Schwartz & Horwitz, 1975; Stanley, 1973; Traber et al., 
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1968; Virtue et al., 1967). Yet, the origins of these sympathomimetic ketamine effects 
remain somewhat enigmatic. 
Interestingly, ketamine does not appear to exert its positive inotropic effects via 
the myocardium itself, as the majority of in vitro studies have demonstrated a direct negative 
inotropic effect (see e.g. Diaz et al., 1976; Dowdy & Kaya, 1968; Pagel et al., 1992; Valicenti 
et al., 1973). Under in vivo conditions, however, this effect is likely to be masked by the 
cardiostimulatory effects of ketamine. It has been suggested that the negative inotropic 
effect of ketamine may only become apparent in the absence of adrenergic transmission (see 
e.g. Horwitz, 1977; Pagel et al., 1992), e.g. in vivo following the depletion of 
catecholamine stores, which may also have contributed to the decrease in cardiac 
performance observed in severely ill patients following ketamine application (Waxman 
et al., 1980).  
There is very little doubt, that the sympathomimetic and cardiostimulatory properties of 
ketamine are in part centrally mediated. In their classical study, Ivankovich et al. (1974) were 
able to show that administration of ketamine through an artery catheter directly into the 
CNS was followed by increases in heart rate, blood pressure and cardiac output before 
the drug could have possibly reached the myocardium and other peripheral targets 
through the blood stream. 
It appears to be equally clear that the sympathomimetic and cardiostimulatory 
effects of ketamine are partly related to catecholamines. One catecholamine effect is 
systemic, i.e. a ketamine-induced intravasal catecholamine release, which leads to a rise in 
plasma catecholamine levels. Interestingly, administration of tranquillisers such as diazepam or 
midazolam, or the neuroleptic droperidol has been shown to attenuate both, the rise in plasma 
catecholamines as well as the cardiostimulatory effects of ketamine (Bålfors et al., 1983; 
Doenicke et al., 1992; Virtue et al., 1967; Zsigmond, 1974; Zsigmond et al., 1974). A 
second effect seems to take place locally in the periphery and involves a cocaine-like action of 
ketamine, i.e. an inhibition of the norepinephrine uptake into postganglionic, sympathetic neurons 
that project towards the heart and vessels (Byrne et al., 1979; Hill et al., 1978; Miletich et 
al. 1973; Nedergaard, 1973; Salt et al., 1979). These results, however, have been 
challenged by other studies where a cocaine-like response could only be elicited at very 
high ketamine concentrations (see e.g. Clanachan & McGrath, 1976; Liao et al., 1979). 
These sympathomimetic characteristics are ketamine-specific and differ from those of other 
anaesthetics, including the barbiturates.  
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Yet, ketamine and the barbiturates do have strikingly similar effects on 
parasympathetic efferent neurons, suggesting that the positive chronotropic effect of 
ketamine may in part be due its vagolytic properties: Inoue and Arndt (1982) have 
demonstrated a ketamine-induced suppression of vagal tone, which was accompanied by 
increases in heart rate. In a later study, Inoue and König (1988) were able to show that the 
peripheral vagal transmission inside the heart was suppressed when ketamine was locally applied 
into the pericardium. Interestingly, ketamine altered heart rate responses not only to 
electrical stimulation of the vagus nerve, but also to local application of acetylcholine 
right into the pericardium, suggesting that cholinergic transmission is suppressed by 
ketamine. Furthermore, support for an inhibition of cholinergic transmission by 
ketamine in cardiac parasympathetic neurons comes from a recent study by Irnaten et al. 
(2002): They were able to show that the response of preganglionic cardiac 
parasympathetic neurons located in the nucleus ambiguus of the brain stem to nicotinic 
innervation was inhibited by ketamine, suggesting an inhibition of nicotinic transmission 
in particular.  
In sum, despite distinct effects on central, systemic and sympathetic targets, 
ketamine and the barbiturates may exert similar, i.e. inhibitory effects on efferent 
parasympathetic neurons and intracardiac neurons in particular, thereby contributing to the 
observed positive chronotropic effect of these drugs.  
Therefore, as neurotransmission in intracardiac ganglia (i) is mainly mediated by 
nicotinic innervation (see chapter 1.1) and (ii) appears to be inhibited by barbiturates 
and ketamine (see above), it was interesting to see, if the response of intracardiac 
neurons to nAChR activation was inhibited by these drugs. Further support for the 
plausibility of this idea comes from studies showing that nAChR are very sensitive to 
general anaesthetic and thus may represent one of their molecular targets, as described 
in chapter 1.2.4. 
 
1.2.3 Relating molecular effects to in vivo effects 
The molecular mechanisms of anaesthetics are typically examined in in vitro experiments. In order 
to put these molecular anaesthetic effects into a meaningful relation to their clinical, i.e. in vivo 
effect Krasowski and Harrison (1999, p. 1283) have specified four  
[p]harmacological criteria that a candidate receptor must meet to be 
considered as a reasonable general anaesthetic target […]: 
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1. The general anaesthetic must alter the function of the receptor at 
clinically relevant concentrations.  
2. The receptor must be expressed in the appropriate anatomical locations to 
mediate the specific behavioural effects of the anaesthetic.  
3. If an anaesthetic molecule shows stereoselective effects in vivo, these 
should be mirrored by the in vitro actions at the receptor.  
4. The hydrophobicity of a compound within a homologous series of 
anaesthetics should correlate with the in vivo anaesthetic potency and that at 
the target receptor (italicisation added by M. Weber). 
 
The presence of an effect at a clinically relevant anaesthetic concentration 
certainly represents the most important criteria; in particular as high concentrations of 
general anaesthetics can affect a huge amount of molecular targets (see e.g. Franks & 
Lieb, 1998) that may be unrelated to any effect or side effect that occurs during a 
general anaesthetic procedure. Clinically relevant anaesthetic concentrations for in vitro 
experiments (including the present study) at physiological pH values are typically based on 
experimentally determined in vivo (total) plasma concentrations during an anaesthetic procedure 
and are subsequently corrected for protein binding (see chapter 1.2.2). For thiopental, Franks 
and Lieb (1994) have estimated a clinically relevant, effective, free aqueous 
concentration (clinical EC50) of 25 µM. This estimation is based on a total thiopental 
plasma concentration of 40 µg/ml (Becker, 1978) at which 50 % of patients do not 
respond to a stimulus of about the painfulness of a surgical incision. The molecular 
weight of thiopental (FW = 241.33) and a value for protein binding of 85 % (Burch & 
Stanski, 1983) is furthermore taken into account. In a comparable procedure, Franks 
and Lieb (1994) have estimated a clinical EC50 of ~50µM for pentobarbital. For 
ketamine, Krasowski and Harrison (1999) have reported a clinical EC50 of ~10 µM. This 
value roughly corresponds to the stable ketamine plasma concentration of 9.3 µM that 
has been observed in humans during the maintenance of ketamine anaesthesia (Idvall et 
al., 1979), as the protein binding value of ketamine does not play a mayor role (see 
chapter 1.2.2; appendix A.2). 
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 Anaesthetic effects on a molecular target can only yield to certain physiological 
and clinical effects, if the target molecules are present and functional in a sufficient 
amount in an anatomical location that mediates this effect. The great majority of studies 
published to date have tried to comply with this criterion by referring to the presence of 
the target molecule, e.g. a membrane receptor, in a relevant anatomical location, while 
the anaesthetic effect on the receptor type is examined in an expression system. Thus, 
the actual physiological and pharmacological effects are merely studied in Xenopus 
oocytes or in mammalian expression systems, but not in the anatomically relevant target 
cells that have been reported to express this receptor. This concerns almost all of the 
studies that have examined clinically relevant concentrations of barbiturates and 
ketamine on neuronal nAChR (see e.g. Andoh et al, 1997; Coates & Flood, 2001; Coates 
et al., 2001; Downie et al., 2000; Flood & Krasowski, 2000; Flood & Role, 1998; Furuya 
et al., 1999; Kamiya et al., 2001; Sasaki et al., 2000; Tassonyi et al., 2002; Yamakura et al., 
2000b). This is a drawback because recombinant nAChR channels expressed in Xenopus 
oocytes and mammalian cell lines are not necessarily functionally similar to native 
nAChR channels in (ganglionic) neurons (Lewis et al, 1997; Sivilotti et al., 1997). A 
particular setback of nAChR expressed in Xenopus oocytes is that “desensitization kinetics 
are often more than an order of magnitude slower for the same receptor expressed in the oocyte compared 
to other cell systems” (Quick & Lester, 2002, p. 461). This is crucial, as anaesthetics may 
partly act by altering the desensitization characteristics (see chapter 1.4.3) of the nAChR 
channel. Furthermore, the effects of anaesthetics on the electrophysiological properties 
of ligand-gated ion channels in native neurons have been shown to differ from those in 
expression systems, as demonstrated for GABAA channels in the absence of the (native) 
channel modulating GABA-receptor-associated protein (P. W. Gage, Australian 
National University, Canberra, Australia; personal communication). Therefore, to relate 
studies of anaesthetic effects on ion channels in expression systems to physiological 
function, it is crucial to carry out studies for the range of clinically relevant 
concentrations in functionally relevant native cells. This present thesis is one of the first 
studies that support this approach by examining clinically relevant anaesthetic 
concentrations on native neuronal receptors in an anatomically relevant tissue.  
The criteria of stereoselectivity allows to make a distinction between molecular 
targets that are merely sensitive to general anaesthetics and those that are sensitive and 
actually contribute to the general anaesthetic effect: As the S(–) isomers of thiopental 
and pentobarbital are about two times as potent as the R(+) isomers in their ability to 
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abolish the righting reflex (Christensen & Lee, 1973; Haley & Gidley, 1970; 1976), any 
plausible molecular target should thus display the same stereoselectivity pattern in in vitro 
experiments or be ruled out as a molecular target for the main effect of these general 
anaesthetics. However, as in vivo stereoselectivity data is not available for the 
cardiovascular side effects of these barbiturates, the use of the stereoselectivity criteria in 
in vitro studies is of limited use. For ketamine, the S(+) isomer is roughly three times more 
potent as the R(–) isomer in abolishing the righting reflex (Marietta et al., 1977; White et 
al., 1980, 1985). Three studies have included attempts to compare the cardiovascular 
effects of ketamine enantiomers and the racemate in humans, but their results are 
controversial: Pfenninger et al (1994) and White et al. (1980) showed that patients 
receiving the S(+) isomer displayed smaller rises in heart rate than those receiving the 
racemate. Yet, in a later study of the same group, White et al. (1985) were not able to 
replicate this finding. The present thesis has thus focused on the racemic mixtures of 
anaesthetics.  
The hydrophobicity criterion is based on the so-called Meyer-Overton correlation, 
saying that the anaesthetic potency of (non-specific) anaesthetics is positively correlated to their 
lipid solubility (Urban & Bleckwenn, 2002). The classical examples that support this rule 
are the n-alcohols. Yet, the problem is that exceptions to the Meyer-Overton hypothesis, 
i.e. drugs with different anaesthetic potencies than to be expected from their lipid 
solubility do exist. Examples for this rule are nonanaesthetics or nonimmobilizers, i.e. highly 
lipid soluble drugs without an anaesthetic potency (see e.g. Koblin et al., 1994; 
Krasowski & Harrison, 1999). The existence of such drugs limit the use of the 
correlational criteria, but they are nonetheless helpful as their main molecular targets can be 
ruled out as mediators of the anaesthetic effect (Franks & Lieb, 1998).  
 
1.2.4 Molecular effects of thiopental, pentobarbital, and ketamine 
The Meyer-Overton correlation has also lead to the believe that the lipid portions of neuronal 
membranes are the major molecular target sites of general anaesthetics. This believe had to be 
abandoned for several reasons: (i) Several exceptions to the Meyer-Overton hypothesis 
were discovered (see chapter 1.2.3 on nonanaesthetics). Stereoselectivity also threatens this 
hypothesis as enantiomers can differ substantially in their in vivo potency despite their 
common lipid solubility, i.e. identical abilities to disrupt the lipid bilayer of membranes 
(Krasowski & Harrison, 1999). (ii) Clinically relevant concentrations of several 
anaesthetics have been shown to inhibit the soluble enzyme firefly luciferase in the absence 
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of any membrane lipids, suggesting that proteins may alternatively represent important 
general anaesthetic targets (Franks & Lieb, 1984).  
Nowadays, a large body of evidence supports the view that membrane proteins, and 
a number of ligand-gated ion channels (LGIC) in particular, are the prime molecular targets of 
general anaesthetics. This does not necessarily contradict the Meyer-Overton hypothesis, as not 
only membrane lipids, but also ion channels do have lipophilic sections, such as their 
membrane-spanning segments, as illustrated in figure 14 and 15 in chapter 1.4.3. Not all 
LGIC are similarly susceptible to general anaesthetics: Clinically relevant concentrations of 
general anaesthetics have been shown to target glutamate receptor channels and a superfamily 
of fast-acting LGIC including nicotinic ACh-, GABAA-, glycine-, and 5-HT3- receptor 
channels (reviewed in: Franks & Lieb, 1994, 1998; Krasowski & Harrison, 1999; 
Yamakura et al., 2001). The phylogenetic tree of this superfamily of channels is 
illustrated in figure 6. 
 
Figure 6: The anaesthetic-sensitive superfamily of fast-acting, ligand-gated ion channels (adapted 
from Franks & Lieb, 1998, p. 5) 
 Phylogenetic tree of the evolutionary history of the channel subunits. 
The distance between the subunits indicate the similarity of their DNA base sequence, 
with shorter distances for greater DNA homologies. The dashed rectangle indicates the 
relative subunits for the present thesis.  
Symbols: Receptor type:  ACh nicotinic acetylcholine receptor; 5-HT3 serotonin receptor; 
GABA GABAA receptor; Gly glycine receptor. 
Subunit type:  α, β, γ, δ, ε, ρ  
Subscript letters:  m muscle; n neuronal; i invertebrate. 
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Interestingly, clinically relevant concentrations of general anaesthetics have been 
shown to potentiate the inhibitory GABAA and glycine receptor-mediated (whole-cell) currents, but 
inhibit the excitatory glutamate, 5-HT3 and nACh receptor-mediated (whole-cell) currents (see 
Franks & Lieb, 1994, 1998; Krasowski & Harrison, 1999; Yamakura et al., 2001). 
Even though all of these receptors types have been shown to be sensitive to 
clinically relevant concentrations of general anaesthetics, not all of them appear to be 
important for the generation of the general anaesthetic state. The prime molecular target for the 
generation of general anaesthesia seems to be the GABAA receptor channel for at least two 
reasons: Firstly, in vitro experiments with clinically relevant concentrations of several 
volatile and intravenous anaesthetics have displayed a similar stereoselectivity pattern (see 
chapter 1.2.3) on the GABAA receptor channel than in vivo (Dickinson et al., 2000; Hall 
et al., 1994; Tomlin et al., 1998; 1999). Furthermore, the GABAA receptor channel has also 
been shown to be sensitive to clinically relevant concentrations of basically all volatile and 
intravenous anaesthetics with the exception of ketamine (Yamakura et al., 2001). This is the 
second point: Ketamine’s failure to potentiate GABAA receptor responses is crucial as it 
may be related to the unique dissociative type of anaesthesia caused by ketamine (see chapter 
1.2.2; Flood & Krasowski, 2000). The main effect of ketamine appears to be the inhibition 
of NMDA receptor channels (Lodge et al., 1982; Anis et al., 1983), which mirrors its 
stereoselectivity pattern for the loss of the righting reflex (see chapter 1.2.3; Zeilhofer, 
1992).  
Ketamine’s stereoselectivity pattern on nAChR is controversial: An inhibition in 
line with its in vivo stereoselectivity has been detected by Lodge et al. (1982), but not by 
Sasaki et al. (2000). Yet, ketamine’s effects on the nAChR channel may nonetheless play 
a role in generating some aspects of its anaesthesia, as pointed out by Flood and 
Krasowski (2000; p. 1424): “The inhibition of nAChRs by general anaesthetics may mediate 
analgesia, as well as inattentiveness and delirium”.  
The general anaesthetic effect caused by the barbiturates is also unlikely to be primarily 
due to an action on the nAChR.  Downie and co-workers (2000) have clearly demonstrated 
that clinically relevant concentrations of thiopental inhibit neuronal nAChR channels of 
the CNS, but with a stereoselectivity pattern that is not compatible with that observed in 
vivo (see chapter 1.2.3). On page 782 they conclude: “[A]lthough thiopental inhibition of 
nAChR does not actually produce anaesthesia, the fact that these receptors can be very sensitive to 
anaesthetizing concentrations of this intravenous agent suggests that they may be involved in the 
generation of anaesthetic side effects”.  
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This may include the generation of cardiovascular effects and their (nicotinic-mediated) 
neuronal regulation in particular, given that basically all of the neuronal nAChR channel 
subtypes tested to date, including the highly Ca2+ permeable α7 homomer, are sensitive to 
clinically relevant concentrations of the barbiturates and ketamine, with somewhat varying 
subunit specificities (Andoh et al, 1997; Coates & Flood, 2001; Coates et al., 2001; 
Downie et al., 2000; Flood & Krasowski, 2000; Flood & Role, 1998; Furuya et al., 1999; 
Kamiya et al., 2001; Sasaki et al., 2000; Tassonyi et al., 2002; Yamakura et al., 2000b; see 
chapter 1.4.3 for details on nAChR subunits). 
Even though the inhibition of neuronal nAChR channels by clinically relevant 
concentrations of these drugs has now firmly been established, the detailed mechanism of 
the inhibition have not yet been fully resolved. Speaking generally and in terms of kinetics, this 
inhibition can be due to decreases in agonist affinity, open gating rate, or increases in desensitization 
(Dilger, 2002). However, detailed kinetic studies on i.v. anaesthetic actions on the 
neuronal nAChR are very scarce at present and have mainly been carried out by a single 
research group (see below). 
Most of the data on neuronal nAChR for the barbiturates and ketamine supports a non-
competitive inhibiting mechanism. Yet, a competitive inhibition was observed with thiopental 
for human neuronal α7 homomers expressed in Xenopus oocytes and with ketamine for 
high concentrations of nicotine for the sympathetic ganglionic nAChR-type of PC12 
cells (Andoh et al., 1997; Coates et al., 2000; Coates & Flood, 2001; Furuya et al., 1999; 
Yamakura et al., 2000b). Ketamine may also exert a use-dependent inhibition, i.e. increasing 
current inhibition with repetitive ACH applications, as was demonstrated for α4β2 and 
α4β4 heteromers in some (Coates & Flood, 2001; Flood & Krasowski, 2000), but not 
all studies (Yamakura et al., 2000b). A use-dependent block of neuronal nAChR 
channels by barbiturates has not been reported to date.  
Whole-cell recordings with the barbiturate thiopental have demonstrated a voltage-
independent inhibition of nAChR activation-induced currents, i.e. the percentage of the 
current inhibition in the presence of thiopental was independent of the holding potential 
from–30 mV to –70 mV. Yet, only the α7 homomer and the sympathetic ganglionic-
type nAChR have been examined to date (Andoh et al., 1997; Coates et al., 2001). The 
ketamine inhibition of these receptor types and α4β4 heteromers was similarly voltage-
independent (Coates & Flood, 2001; Flood & Krasowski, 2000; Furuya et al., 1999), but 
a voltage-dependent effect was demonstrated for α3β4 and α4β2 heteromers (Coates & 
Flood, 2001; Yamakura et al., 2000b).  
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Single channel recordings of neuronal nAChR currents in the presence of 
barbiturates and ketamine are also lacking. Studies on the muscle-type nAChR have shown 
that clinically relevant concentrations of the barbiturates and ketamine shorten the mean 
open time of the channel, while the amplitudes of the single currents remain unaffected (Gage et al., 
1985; Jacobson et al., 1991; Wachtel et al., 1988; Wachtel & Wegrzynowicz, 1992). 
Also for the muscle-type nAChR, it has been shown that barbiturates and ketamine 
are able to interact with both, open and closed states of the channel, but strongly prefer an 
interaction with the open state (de Armendi et al, 1993; Dilger et al., 1997; Downie et al., 
2000; Scheller et al., 1996). For the neuronal nAChR, the data is less clear: A preferential 
interaction with the open channel state is not supported by the data of Downie et al. 
(2000) for the neuronal, CNS-type α4β2 nAChR. However, this study contradicts 
detailed kinetic analyses of nAChR-induced currents in sympathetic ganglionic neurons by 
Andoh and co-workers. Their data suggests an accelerated current decay in the presence of 
the anaesthetics, which is likely to be due to an open channel block and/or an enhancement of 
receptor desensitization (Andoh et al. 1997, Furuya et al., 1999, Sasaki et al., 2000).  
Relatively little is known about actual barbiturate and ketamine binding sites on the 
nAChR. One study has detected barbiturate-sensitive, but not barbiturate-binding sites 
on the neuronal nAChR: Yamakura et al. (2000a) have shown that single point mutations 
near the middle of the 2nd transmembrane segment (M2) of the α4β2 (at α4-Val254 and β2-Val253) 
and α4β4 (at α4-Val254 and β4-Phe255) nAChR significantly alters the channel sensitivity to 
pentobarbital, but not for ketamine, when valine (Val) residues were replaced with 
phenylalanine (Phe) residues or vice versa. For the closed, i.e. the resting or desensitized 
states of the muscle-type nAChR, possible binding sites have been identified. As illustrated in 
figure 7, Arias et al. (2001) suggest that pentobarbital is located within the channel pore, in close 
proximity to the narrow crevice of the channel that is presumed to be composed of a 
highly conserved leucine ring (Unwin, 2000). Ketamine appears to bind to a different 
site within the channel pore, which is located more towards the extracellular end of the 
pore. Yet, an alternative ketamine-binding site at the intracellular side of the narrow 
crevice cannot be excluded, either (Arias et al., 2002).  
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Figure 7: Model of the complexion of pentobarbital with the pore-lining M2 segments of the 
(muscle-type) nAChR in the closed (resting) state (adapted from Arias et al., 2001, 
p. 504) 
Blue: Pore-lining 2nd transmembrane segments (M2). 
Red: Residues at position 13 of M2. 
Yellow: Residues at position 9 of M2. 
Orange:  Pyrimidine ring of pentobarbital. 
Green: 1-methylbutyl group of the 5’ chain of pentobarbital. 
A: Lateral view of the channel pore complexes together with pentobarbital.  
The pentobarbital molecule is located between the residues 9 and 13 of the M2 segment, at 
the narrow crevice of the channel. The scheme on the right hand side illustrates that 
ketamine is likely to have a different location inside the channel pore, presumably between 
position 13 and 20 or alternatively beyond position 9 more towards the cytoplasm (see 
Arias et al., 2002). Only three of the five M2 segments are shown.  
Top: extracellular end (c-terminal) of M2, bottom: cytoplasmic end (n-terminal) of M2.  
B: Cross-sectional view of the channel pore complexes together with pentobarbital. 
Viewed from the cytoplasmic end. 
A
B
ketamine
(ketamine)
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As Ca2+ homeostasis is crucial for the regulation of various neuronal functions 
(see chapter 1.3), it is of interest to find out if anaesthetics alter intracellular Ca2+ 
signalling. This is a central part of the present thesis and a research question mostly 
neglected by the mainly electrophysiological approach of other groups. The relevance of 
this research question became apparent with studies demonstrating the high Ca2+ 
permeability of nAChR in rat intracardiac neurons and the finding that nAChR 
activation is followed by CICR from ryanodine-sensitive stores (see chapters 1.3.3 and 
1.4.3). The importance of this (highly Ca2+ permeable) nAChR for the 
neurotransmission in intracardiac ganglia (see chapter 1.1) and its likely sensitivity to i.v. 
anaesthetics as suggested by studies from expression systems (see above) have further 
indicated that Ca2+ signals following nAChR activation may be significantly altered by 
general anaesthetics. Voltage-dependent Ca2+ channels represent another player of the 
neuronal Ca2+ signalling system and could also contribute to some of the Ca2+ signals 
studied in the present thesis (see chapter 1.3.3), but they are unlikely to play a direct role 
in the mediation of the anaesthetic effect or side effect, given that these channels, with 
few exceptions, are relatively insensitive to clinically relevant concentrations of general anaesthetics 
(reviewed in Franks & Lieb, 1994). Furthermore, little is known about the effects of i.v. 
anaesthetics on intracellular Ca2+ release channels in neurons. The data from other cell types 
is controversial and effects appear to vary with tissue type. For example, in rat papillary 
muscles, experimental evidence suggests that thiopental inhibits ryanodine-induced Ca2+ 
release from the sarcoplasmic reticulum (SR; Komai and Rusy, 1994), whereas in rat 
smooth aortic muscle, thiopental has been shown to induce Ca2+ release from the SR 
(Mousa et al., 2000). Studies from our lab on skeletal muscle preparations have 
demonstrated that (high) concentrations of general anaesthetics can enhance Ca2+ 
release from the SR (Kunst et al., 1999, 2000).  
The present study investigates the effect of i.v. anaesthetics on parasympathetic 
intracardiac neurons. Given that modulation of nAChR in autonomic neurons may 
contribute to cardiovascular side effects of i.v. anaesthetics, it was of interest to 
determine if these drugs affect nAChR-activated membrane currents and cytoplasmic 
Ca2+ levels in rat intracardiac neurons.  
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1.3 Neuronal CA2+ -homeostasis 
Intracellular Ca2+ signalling is mostly based on (brief) pulses of Ca2+, i.e. transient increases 
of the intracellular, cytosolic free Ca2+ ion concentration [Ca2+]i. This seemingly simple 
Ca2+ signalling principle is known to regulate a diversity of (Ca2+ -dependent) cellular processes 
in mammalian cells, including excitability, exocytosis, contraction, metabolism, 
transcription, fertilization and proliferation. Ca2+ -dependent cellular targets or effectors 
include Ca2+ -binding proteins (e.g. calmodulin or troponin C), Ca2+ -sensitive enzymes (e.g. 
Ca2+/calmodulin-dependent protein kinase, protein kinase C or adenylate cyclase), 
transcription factors (e.g. CREB-binding proteins) and Ca2+ -dependent ion channels (e.g. Ca2+ -
activated potassium channels; reviewed in Berridge, 1998; Berridge et al. 2000, 2003). 
Yet, Ca2+ signals, in particular excessive increases of [Ca2+]i, have also been implied in cell 
death, including apoptosis and necrosis. The major self-destructive mechanisms that are 
triggered include activation of catabolic enzymes, generation of free radicals, and impairment of 
cellular structures and functions of organelles, in particular the mitochondria (see e.g. Berridge et 
al., 1998; Ferrari et al., 2002).  
The key players of the complex Ca2+ signalling system are the cell membrane and 
the membranes of organelles, in particular the endoplasmic reticulum (ER), as the equivalent to 
the sarcoplasmic reticulum (SR) of muscle cells, and the mitochondria. These organelles 
play an active role in the maintenance of the Ca2+ homeostasis of cells by acting as Ca2+ 
storage facilities that either take-up or release Ca2+ (see e.g. Berridge et al., 2003). The 
nucleus is affected by cytosolic Ca2+ signals, but does not seem to play a major role in the 
generation of cytosolic Ca2+ signals (reviewed in Bootman et al., 2000). Figure 8 gives an 
overview of the major Ca2+ signalling components.  
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Figure 8: Major components of the Ca2+ signalling system (based on Hille, 2001; p. 271, 
adapted by M. Weber) 
 Important receptors and transporters for the Ca2+ signalling of various cell types illustrated in one cell.  
The figure illustrates Ca2+ signalling components with a focus on Ca2+ permeable channels 
and transporters. The question mark besides the mitochondrial uniporter indicates that the 
corresponding molecule has not yet been identified and that RyR could alternatively carry 
out Ca2+ uptake in mitochondria. The thick, black arrow indicates metabotropic pathways 
such as IP3 –mediated induction of Ca2+ release from the ER. All membrane potentials are 
measured against the extracellular fluid. Second-messenger-operated channels that are 
present in the cell membrane of specific cell types include the CNG, SOC, TRP and VR 
(see Hille, 2001; Bakowski & Parekh, 2002; Putney, 2003).  
Legend:  A/K AMPA/kainate receptor; ATP adenosine triphosphate; Cav voltage-dependent Ca2+ 
channel; CNG cyclic nucleotide gated channel; ER endoplasmic reticulum; IP3R inositol-
1,4,5-trisphosphate receptor; MCU mitochondrial Ca2+ uniporter; MR metabotropic 
receptor; nAChR nicotinic acetylcholine receptor; NCX Na+/Ca2+ exchanger; NMDAR 
N-methyl-D-aspartate receptor; PMCA plasma membrane Ca2+ -ATPase; ROC receptor-
operated channel; RyR ryanodine receptor; SERCA pump sarco(endo)plasmic reticulum 
Ca2+ -ATPase pump; SOC store-operated channel; TRP transient receptor potential 
channel; VDAC voltage-dependent anion channel; VR vanilloid receptor.   
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1.3.1 Concentration gradients for Ca2+ ions 
Ca2+ signals take advantage of electrochemical gradients for Ca2+ ions across the cell 
membrane, and the membranes of the ER and the mitochondria: The extracellular free 
Ca2+ ion concentration is in the low millimolar range (~ 1-2 mM). The free Ca2+ ion concentration 
in the cytosol ([Ca2+]i) of a resting mammalian cell is extremely low, typically about 100 nM, 
with a range from about 30 to 200 nM (see e.g. Armstrong et al., 2002; Hille, 2001). The 
concentration gradient for free Ca2+ ions between the exterior of the cell and the cytosol 
is thus ~ 10000:1. The resulting theoretical equilibrium potential for Ca2+ ions can be 
estimated using the Nernst equation: 
 
Eion = (R * T)/(zion * F) * ln([ion]o/[ion]i)    (1) 
 
where R is the gas constant, T the absolute temperature, z the charge of the ion, F 
Faraday’s constant, [ion]a the free ion concentration outside of the cell and [ion]i the free 
ion concentration inside the cytosol. For calcium ions (z = +2), a temperature of 37 °C 
(= 310.15 °K), and the values of the constants R (= 8.3145 V * C * mol-1 * K-1) and F 
(= 96485 C * mol-1), equation (1) can be written as:  
 
ECa = 0.0133634 V * ln([Ca]o/[Ca]i)     (2) 
 
Assuming an extracellular free Ca2+ concentration of 1 mM to 2.5 mM (the latter 
was used in the present thesis), and a [Ca2+]i of ~ 100 nM, then the equilibrium potential 
for Ca2+ ions is in the range of about +123 to +135 mV (see e.g. Hille, 2001; for 
formulas and constants).  
A high concentration gradient for free Ca2+ ions also exists between the ER and 
the cytosol. The free Ca2+ ion concentration in the ER has been difficult to assess and 
varies somewhat depending on the measurement technique, but most studies have 
detected values in the range of several hundred µM (Alvarez & Montero, 2002; Meldolesi 
& Pozzan, 1998). While it is clear that Ca2+ ions in resting cells are driven from the 
SR/ER into the cytosol, the exact quantification of the driving force is speculative, as 
little is known about the electrochemical potentials across the SR/ER membrane (Fink 
& Veigel, 1996).  
The free Ca2+ ion concentration in the mitochondrial matrix of resting cells is in the 
range of that in the cytosol [Ca2+]i (~ 100 nM), but there is a considerable driving force 
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for Ca2+ ions into the mitochondrial matrix due to the negative membrane potential 
across the inner mitochondrial membrane (IMM; up to –180 mV against the cytosol; 
Brini, 2003), as illustrated in figure 8. 
 
1.3.2 The dynamics of Ca2+ signalling 
Berridge et al.(2000, 2003) describe the onset of the cytosolic Ca2+ -signal as an “on-reaction”, 
its termination as an “off-reaction” as illustrated in figure 9:  
 
Figure 9: The “on-“ and “off-reactions” of the Ca2+ signalling system and the initiated responses 
(from Berridge et al., 2003; p. 518) 
 Figure summarizing the steps from the initiation of the Ca2+ signal and the activation of the physiological 
response to the termination of the Ca2+ signal.  
During “on reactions” a stimuli acts on receptors and initiates either a Ca2+ influx into the 
cytosol through Ca2+ permeable channels of the cell membrane or a Ca2+ release from the 
ER/SR through RyR or IP3R channels. Most of the Ca2+ ions readily bind to Ca2+ buffers, 
but a small fraction binds to effectors (see beginning of chapter 1.3 for examples) to 
initiate cellular processes. This can require Ca2+ signalling to last from the microsecond up 
to the hours range. During “off reactions”, Ca2+ separates from buffers and effectors and 
is removed from the cytosol and transported into the ER/SR, and the extracellular fluid 
through exchangers and ATP -driven pumps for Ca2+. Mitochondria provide temporary 
Ca2+ storage by an initial, rapid Ca2+ uptake and a subsequent, slow release into the cytosol.  
Legend:  ER/SR endoplasmic/sarcoplasmic reticulum; Ins(1,4,5)P3R inositol-1,4,5-triphosphate 
receptor; NCX Na+/Ca2+ exchanger; PMCA plasma-membrane Ca2+ -ATPase; R receptor; 
RyR ryanodine receptor; SERCA sarco(endo)plasmic reticulum Ca2+ -ATPase.  
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Interestingly, Ca2+ signalling can occur within very different time frames, ranging 
from several microseconds for exocytosis to several hours, e.g. for cell proliferation (see 
e.g. Berridge et al., 2003). When Ca2+ signalling is required over long periods of time 
long lasting rises of [Ca2+]i can be avoided using [Ca2+]i oscillations, i.e. repetitive, but 
brief rises in [Ca2+]i (see e.g. Berridge et al., 1998).  
The spatial aspects of Ca2+ signalling are similarly diverse, ranging from local, 
subcellular to “global” Ca2+ signals that affect the entire cell (reviewed in Berridge, 1997; 
Berridge et al., 2000). The present study has examined global, spike-like events, i.e. Ca2+ 
transients that almost instantly affect the entire cytosol where the fura-2 fluorescence 
signals that correspond to the Ca2+ signal, typically last less than a minute (see chapter 3).  
The onset of the Ca2+ signal is basically due to an influx of Ca2+ ions across the 
cell membrane through Ca2+ -permeable ion channels, or to a Ca2+ release from intracellular 
stores, mainly the ER or SR, through the Ca2+ permeable inositol-1,4,5-trisphosphate receptor 
(Ins(1,4,5)P3R; IP3R) and ryanodine receptor (RyR) channels. Interestingly, mitochondria are 
rather unlikely to contribute to the onset of the Ca2+ signal, as Ca2+ ions are basically driven from 
the cytosol into the mitochondrial matrix due to the electrochemical gradient for Ca2+ 
ions across the IMM (see chapter 1.3.1).  
The activation of the intracellular Ca2+ release channels is mediated through second 
messengers. Two newly discovered intracellular Ca2+ release pathways are the nicotinic acid 
adenine dinucleotide phosphate (NAADP) and the sphingolipid-derived messenger 
pathways. These pathways are independent of the traditional intracellular Ca2+ release 
mechanisms through RyR and IP3R channels (Berridge et al., 2003).  
IP3R channels are tetrameric channels of identical or different subunits. Three 
different subunits types have been identified (Taylor & Laude, 2002). Ca2+ release from 
intracellular stores through IP3R channels is accomplished through a G-protein-mediated, 
phospholipase C (PLC) -dependent metabotropic pathway that leads to the generation of the freely 
diffusible second messenger IP3 (see e.g. Aidley et al., 1998). IP3 subsequently diffuses through 
the cytoplasm and binds to IP3 receptors located in the membrane of the SR or ER 
where it evokes a Ca2+ release through the IP3R channel given that a moderate [Ca2+]i of 
~ 100-300 nM is present (see e.g. Ehrlich et al., 1994). A PLC –dependent, and thus 
most likely IP3 -mediated, Ca2+ release from intracellular stores has been demonstrated 
in rat intracardiac neurons following activation of metabotropic, purinergic receptors 
(P2YR; Liu et al., 2000b), as well as muscarinic AChR (mAChR; Beker et al., 2003). The 
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major steps of the suggested mAChR-induced Ca2+ mobilizing pathway are illustrated in 
figure 10 in chapter 1.3.3. 
The other major group of intracellular Ca2+ release channels are the ryanodine 
receptor channels (RyR), which are discussed in more detail in chapter 1.4.1. RyR channels 
are important for the Ca2+ signalling system, as the Ca2+ acts as agonist on RyR channels to 
induce calcium-induced calcium-release (CICR), where Ca2+ release from the ER/SR through 
RyR channels is activated by increases in [Ca2+]i. CICR thus acts as an amplifier of Ca2+ 
signals. Our study  (Beker et al, 2003) has also demonstrated the presence of CICR 
following nAChR activation in rat intracardiac neurons, as illustrated in figure 10.   
 Ca2+ permeable channels of the plasma membrane are the other major contributor to the 
onset of Ca2+ signals. Some Ca2+ permeable channels such as the second-messenger-operated 
channels (SMOC) of the plasma membrane are mainly present in specific cell types such as 
sensory neurons (see e.g. Hille, 2001; Bakowski & Parek, 2002; Putney, 2003). Figure 8 
also illustrates the major SMOC. 
Ca2+ -permeable channels that are present in most excitable cells are receptor-
operated channels (ROC) and voltage-operated Ca2+ channels (Cav). Voltage-operated Ca2+ -
channels are discussed in more detail in chapter 1.4.2. Very Ca2+ -permeable ROC of the 
plasma membrane include the N-methyl-D-aspartate receptor (NMDAR) channels (Mayer & 
Westbrook, 1987), the purinergic P2X receptor channels and the nAChR channels (Rogers & 
Dani, 1995). Interestingly, these channel families are distinct with respect to their 
presumed evolutionary history, amino acid sequences and architecture (see e.g. Aidley, 
1998; Hille, 2001).  
Using patch-clamp whole cell recordings in combination with fura-2 
measurements, Rogers and Dani (1995) have determined the fractional Ca2+ current, i.e. the 
percentage of the inward current that is carried by Ca2+ ions, through NMDAR channels. 
Using hippocampal neurons, a holding potential of –50 mV and a Mg2+ -free 
extracellular recording solution, it was determined as 12.4 %. Glutamate receptors are 
very common in the CNS, but are hardly present in the peripheral nervous system (PNS; 
e.g. Hille, 2001; Kemp & McKernan, 2002). While no study to date has demonstrated 
glutamate receptor-induced currents in rat intracardiac neurons, their presence in these 
cells cannot be totally excluded, given that polymerase chain reaction (PCR) and 
immunohistochemistry techniques suggests the presence of NMDAR and non-
NMDAR subtypes also in cardiac ganglia (Gill et al., 1998). 
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The study of Gill and Dani (1995; see above) has determined the fractional Ca2+ 
current through P2X receptors (P2XR) channels in sympathetic neurons as 6.5 % under 
the experimental conditions outlined above. Fieber and Adams (1991b) have 
demonstrated the presence of functional Ca2+ permeable P2XR channels in rat 
intracardiac neurons. The neuronal nAChR channel, which is also very permeable to Ca2+ -
ions, is discussed in more detail in chapter 1.4.3. 
The offset of the [Ca2+]i signals is due to a system of ATP-driven Ca2+ pumps, 
exchangers, and (possibly) uniporters that together with certain proteins remove free Ca2+ 
ions from the cytosol (see e.g. Berridge et al., 2000, 2003): 
ATP-driven Ca2+ pumps include the plasma-membrane Ca2+ -ATPases (PMCA) and 
their relatives, the sarco(endo)plasmic reticulum Ca2+ -ATPase (SERCA) of the SR/ER 
membrane. These pumps are thought to transport Ca2+ ions out of the cytosol by 
allowing two Ca2+ ions to bind to cytosolic binding sites of the unphosphorylated pump. 
Subsequent binding and hydrolysis of ATP yields a conformational change of the pump 
that enables the access and the release of Ca2+ ions to the extracellular fluid in the case 
of the PMCA, or the lumen of the SR/ER in the case of the SERCA pumps, 
respectively (see e.g. Armstrong et al, 2002; Wuytack et al., 2002).  
Mitochondria can also accumulate substantial amounts of Ca2+ ions in their 
interior compartment.  The mitochondrial Ca2+ uptake system mostly is a low Ca2+ 
affinity mechanism, i.e. its activation requires large (local or global) rises of [Ca2+]i 
(typically > 1 µM). Ca2+ ions are thought to pass the outer mitochondrial membrane 
(OMM) fairly freely through the large pores of the voltage-dependent anion channel (VDAC; 
porin), and subsequently enter the mitochondrial matrix according to their 
electrochemical gradient through Ca2+ uniporters located in the inner mitochondrial 
membrane (IMM; see chapter 1.3.1; Brini, 2003; Hajnóczky et al., 2002). Newer data 
suggests that RyR, which have been shown to be present in the IMM (Beutner et al., 
2001), may alternatively be responsible for the mitochondrial Ca2+ uptake in excitable 
cells (Hajnóczky et al., 2002). The relatively rapid uptake of Ca2+ ions from the cytosol 
into the mitochondrial matrix is followed by a slow release back into the cytosol, which is 
mainly achieved by a Na+/Ca2+ exchanger (NCX) supported by a H+/Ca2+ exchanger. The 
“permeability transition pores”, which are permeable to Ca2+ ions and small molecules may 
also be involved in the mitochondrial Ca2+ -uptake and -release under certain 
(pathological) conditions (Babcock & Hille, 1998; Brini, 2003). Na+/Ca2+ exchangers are 
also present in the plasma membrane of many cell types, as illustrated in figure 8 and 9. 
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Binding of Ca2+ ions to membrane surfaces and proteins inside the cell is another very 
important factor that contributes to the low resting [Ca2+]i. The great majority of Ca2+ 
ions inside the cell are actually bound to membrane surfaces and proteins. The total Ca2+ 
concentration inside the cytosol e.g. is in the range of 1-2 mM (see e.g. Armstrong et al., 
2002). Mammalian cells possess a selection of Ca2+ binding proteins with different 
kinetic properties, including relatively fast Ca2+ binding proteins such as calbindin D-28 
and calretinin, or slower ones such as parvalbumin (see e.g. Berridge et al., 2003). 
Endogenous buffer capacities have been shown to vary between different types of 
neurons (Palecek et al., 1999), probably due to variations in the intracellular 
concentration of their Ca2+ binding proteins. I am not aware of any study that has 
assessed the effects of the intracellular Ca2+ binding capacity of rat intracardiac neurons.  
The following chapter describes the cholinergic Ca2+ signalling system in rat 
intracardiac neurons. 
 
1.3.3 Cholinergic Ca2+ signalling in rat intracardiac neurons 
Given that acetylcholine is the major neurotransmitter in rat intracardiac neurons (see 
chapter 1.1) and likely to evoke Ca2+ signals through activation of mAChR (see chapter 
1.3.2) and the highly Ca2+ -permeable nAChR channel (see chapter 1.4.3), it can be 
reasoned that activation of cholinergic receptors may represent a particular important 
mechanism for the activation of Ca2+ signals in these cells. We have therefore examined 
the cholinergic Ca2+ signalling mechanisms in rat intracardiac neurons in more detail 
(Beker et al., 2003): It was shown that activation of both, mAChR and nAChR leads to a 
single, global intracellular rise in [Ca2+]i following each agonist application: 
Selective mAChR activation was achieved by applying ACh in the presence of 
mecamylamine to block nAChR channels. The resulting Ca2+ transient persisted in Ca2+ 
-free extracellular recording solution, but was abolished in the presence of U-713122, a 
PLC inhibitor. These data suggest that mAChR activation leads to an increase in [Ca2+]i 
that is due to a PLC –dependent, and most likely IP3 -mediated Ca2+ release from 
intracellular stores, as illustrated in the middle of figure 10.  
  
38
 
Figure 10: Model of the Ca2+ mobilizing pathways following cholinergic receptor activation in rat 
intracardiac neurons (from Beker et al., 2003, p. 1962; adapted by M. Weber) 
 The model summarizes the major steps likely to be involved in the generation of Ca2+ signals following 
cholinergic receptor activation.  
Selective activation of nAChR induces Ca2+ influx through nAChR channels and a 
subsequent calcium-induced calcium release (CICR) from ryanodine-sensitive intracellular 
stores (Beker et al., 2003). In addition, nAChR –induced inward currents are likely to 
depolarize the cell membrane and activate voltage-operated channels including Ca2+ 
channels and initiate Ca2+ influx through these channels, which may similarly trigger CICR. 
Selective activation of mAChR induces Ca2+ release from intracellular stores through a 
PLC –dependent second-messenger pathway that is likely to generate IP3 (Beker et al., 
2003). The voltage-gated Ca2+ channel is illustrated with two auxiliary subunits (see chapter 
1.4.2 for details of the receptor structure). Ca2+ pumps and transporters are not shown.  
Legend:  ACh acetylcholine; Cav voltage-operated Ca2+ channel; DAG diacylglycerol; ER 
endoplasmic reticulum; G G-protein; IP3(R) inositol-1,4,5-trisphosphate (receptor); 
mAChR muscarinic acetylcholine receptor; nAChR nicotinic acetylcholine receptor; PIP2 
phosphatidylinositol-4,5-biphosphate; PLC phospholipase C; RyR ryanodine receptor.  
 
In contrast, nAChR activation was achieved by applying ACh in the presence of 
atropine, a mAChR antagonist. [Ca2+]i transients following nAChR activation depended 
on the presence of Ca2+ in the extracellular recording solution and Ca2+ -influx 
following nAChR activation induced CICR. The observed CICR was ryanodine-
sensitive; suggesting that Ca2+ release from the ER through RyR channels amplifies the 
nAChR –induced Ca2+ transient as illustrated in figure 10. 
 Rathouz and Berg (1994) have demonstrated activation of voltage-gated Ca2+ channels 
following nAChR activation for chick ciliary ganglion neurons. It can be reasoned that the 
nAChR -induced depolarization of rat intracardiac neurons is similarly likely to activate voltage-
operated Ca2+ channels, when cells are not clamped close to their resting membrane 
potential using the voltage-clamp technique (see chapter 1.5.3). The recruitment of 
voltage-operated Ca2+ channels is also likely to be intensified by a concurrent activation of 
Mitochondria
mAChR
Na
Ca Ca
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voltage-activated sodium channels. Influx of Ca2+ through voltage-operated Ca2+ channels is 
thus likely to contribute to the nAChR -induced [Ca2+]i transient in unclamped cells.  
The three receptor channel types, namely the nAChR, RyR and the voltage-gated 
Ca2+ channel, that are likely to be involved in the nicotinic Ca2+ signalling system are 
discussed in the following chapters in more detail.  
 
1.4 Ion channels 
The present chapter describes ion channels that are likely to play a crucial role in the 
Ca2+ signalling following nAChR activation, with a focus on nAChR. Voltage-gated 
Ca2+ channels and RyR channels are discussed more briefly. 
1.4.1 Ryanodine receptor channels 
Ryanodine receptor (RyR) channels are well known for their role in excitation-contraction 
coupling in muscle cells, but they have also been shown to mediate Ca2+ release from the 
endoplasmic reticulum (ER) of non-muscle cells, including neurons (see e.g. McPherson & 
Campbell, 1993b).  
RyR are homotetramers of extremely large (~ 560 kDa) subunits that are 
sometimes associated with smaller immunophilins molecules (~ 12kDa; Sharma et al., 
1998, 2000). Each of the main subunits contains a very large N-terminal domain (~ 4000 
amino acids), where the ligand binding sites and regulatory sites are mostly located. The 
C-terminal domain (~ 1000 amino acids) corresponds to the pore containing 
transmembrane assembly with its four transmembrane segments (M1 to M4; Rossi & Sorrentino, 
2002). The main part of the RyR is located on the cytoplasmic site of the SR/ER 
membrane, as illustrated in figure 11A.  
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 Figure 11: Surface reconstructions of RyR channels (based on Hille, 2001, p. 273; Sharma et 
al., 1998, p. 18432; adapted by M. Weber) 
A: Illustration of a RyR1 reconstruction together with the SR/ER membrane.  
The picture shows a side view of a 3-D reconstruction of a completely assembled 
tetrameric RyR1 channel in its location in the SR/ER membrane. The major part of the 
receptor extends into the cytosol. The channel reconstruction is based on cryo-electron 
microscopy. 
B: Comparison of the surface structure of reconstructed models of the RyR1 and RyR2.   
These surface structure images are also based on cryo-electron microscopy. The upper row 
shows a reconstruction of a RyR1 tetramer from different perspectives, the lower row that 
of a RyR2 tetramer. The pictures on the left side show the surfaces of the receptors that 
face the cytoplasm, the middle pictures those that face the SR/ER, and the pictures on the 
right show a side view. The arrows point towards differences between the RyR1 and RyR2, 
and the numbers on the upper subunit refer to 10 putative structural domains. TA denotes 
the transmembrane assembly. 
 
10 nm
10 nm
cytoplasm
ER/SR lumen
A
B
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The family of mammalian RyR includes three subtypes with a high average amino 
acid homology of about 70 % (Fill & Copello, 2002; Rossi & Sorrentino, 2002, Sharma 
et al., 1998, 2000). The RyR1 and the RyR have been called skeletal-type and cardiac-type, 
respectively, for their predominance in these muscle tissues, and the RyR3 brain-type due 
to its presence in the brain. Yet, each receptor type is expressed in a wide range of tissues. All three 
RyR types are present in neurons of the brain (Fill & Copello, 2002; McPherson & 
Campbell, 1993a; Sharma et al., 2000), and the “cardiac type” is the most predominant 
isoform in the brain (Berridge, 1998, McPherson & Campbell, 1993a).  
RyR channels are fairly permeable to Ca2+ ions, with selectivity for divalent ions over 
monovalent ions of approximately 5:1. They have extremely large single channel currents in 
the range of 30 to 130 pS (see Hille, 2001). These properties ensure that large (local) rises of 
[Ca2+]i can occur following activation of (single) RyR. Furthermore, Ca2+ ions act as 
agonists on RyR: RyR activate upon physiological rises of [Ca2+]i from resting [Ca2+]i, but are 
inactive at low nanomolar and (unphysiologically) high, i.e. millimolar [Ca2+]i (see e.g. 
Berridge et al., 2003; Ehrlich et al., 1994). These channel properties contribute to calcium-
induced-calcium-release (CICR), i.e. the phenomenon that (local) rises in [Ca2+]i can activate 
Ca2+ release from nearby RyR that “sense” these rises in [Ca2+]i. 
The RyR1 is functionally different from the other RyR isoforms in that it uses 
the dihydropyridine receptor (DHPR; see chapter 1.4.2) as a voltage sensor for the 
depolarization of the cell membrane e.g. during excitation-contraction coupling in 
skeletal muscle: Following membrane depolarization, the DHPR initiates Ca2+ -release 
through RyR1 channels of the SR via a direct physical link with RyR1, most likely via a 
protein-protein interaction. A major influx of Ca2+ ions across the cell membrane does 
not occur. Not all RyR1 channels are coupled to DHPR. These “uncoupled RyR1 
channels” can be recruited through CICR where Ca2+ release from neighbouring, 
“coupled RyR1 channels”, initiates a Ca2+ release from “uncoupled RyR1 channels”. In 
contrast, activation of RyR2 or RyR3 is independent of any physical link between the DHPR 
and RyR2 and is only achieved by CICR: A Ca2+ flux across the cell membrane through 
Ca2+ permeable channels, in particular voltage-gated Ca2+ channels (Cav), activates RyR 
channels to allow for a Ca2+ release from the SR/ER (Fill & Copello, 2002). 
RyR are also activated by a number of other agonists, including adenine nucleotides, 
caffeine, and ryanodine. Ryanodine, however, is a difficult agonist to work with, given that 
low concentrations of ryanodine lock the RyR in a low conducting state, while channel 
inhibition occurs at high concentrations. The most commonly used pharmacological 
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activator of RyR is caffeine, which easily penetrates the cell membrane. It is thought to act by 
enhancing the Ca2+ sensitivity of the RyR, thereby enabling Ca2+ release from the SR/ER at 
resting [Ca2+]i (Ehrlich et al., 1994; Fill & Copello, 2002; Herrmann-Frank et al., 1999; 
McPherson & Campbell, 1993b). Yet, RyR activation can be modulated by a number of 
intrinsic and extrinsic chemical agents (reviewed in Berridge et al., 2003), possibly 
including various anaesthetics. An interesting example of an intrinsic modulator of 
SR/ER Ca2+-release S100A1, an intracellular Ca2+ binding protein of the EF-hand type: 
We (Most et al., 2003b) have shown that caffeine-induced Ca2+ release from intracellular 
stores in skeletal muscle is enhanced by S100A1, an intracellular Ca2+ binding protein of 
the EF-hand type. Interestingly, S100A1 has also been shown to enhance Ca2+ release 
from the SR in cardiac muscle through an interaction with the RyR2 (Most et al., 2003a). 
Due to the predominance of the RyR2 in neurons (see above), it can be speculated that 
S100A1 could also play a role in the mediation of Ca2+ release from neuronal ER. With 
respect to extrinsic modulators, other studies from our lab have shown that (high) 
concentrations of general anaesthetics can also modulate Ca2+ release from the SR in 
skeletal muscle (see chapter 1.4.2). Caffeine has also been used in the present study as a 
pharmacological means to activate RyR channels and to examine anaesthetic effects on 
RyR channels. 
This approach is related to experiments by Smith and Adams (1999) and Beker 
et al. (2003) in which caffeine and ryanodine were used to demonstrate that functional 
RyR channels are present in rat intracardiac neurons, as activation of RyR by caffeine induced 
[Ca2+]i transients that could be inhibited by high concentrations of ryanodine. Yet, no 
study to date has examined the distribution of RyR subtypes in rat intracardiac neurons. 
 
1.4.2 Voltage-gated Ca2+ channels 
Voltage-gated Ca2+ channels (Cav) are part of a superfamily of voltage-gated channels that includes 
the voltage-gated potassium and sodium channel families. Cav are present in virtually all 
excitable cell types and under physiological conditions mainly allow for a Ca2+ influx 
following membrane depolarization. They are blocked by a number of divalent cations 
including Cd2+, Co2+, Mn2+, Ni2+ and Mg2+, but are permeable for some other, physiologically 
relatively unimportant divalent ions, including Ba2+ or Sr2+. Cav are marginally permeable to 
monovalent ions, but with extremely low permeability ratios in relation to that for Ca2+ 
ions (PX/PCa ~ 1:1000; summarized in Hille, 2001).  
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The key component of all functional Cav is the α1 subunit (~ 190 kDa), which 
includes the channel pore, the voltage sensor, the gating mechanism and the most important 
regulatory sites. Most Cav additionally include one or several auxiliary subunits labelled α2, 
β, γ and δ (Catterall, 2000; Ertel et al., 2000; Hille, 2001). Figure 12 illustrates a trans-
membrane-folding model of the α1 subunit of a Cav with an intracellular, auxiliary β subunit. 
The Cav1.2 shown here is expressed in cardiac muscle and a very similar form of this 
channel type is expressed in neurons (Catterall et al., 2000; Ertel et al., 2000). 
 
Figure 12: Transmembrane-folding scheme of a voltage-gated Ca2+ channel (based on Catterall, 
2000, p. 527, adapted by M. Weber) 
 Model illustrating the α1 and β subunit of a cardiac-type Cav1.2 channel. 
The α1 subunit of Cav consists of four domains with six transmembrane segments each. 
The aggregation of the 4 domains forms the channel pore. The 4th transmembrane 
segments of the domains in essence represent the voltage sensor. The β subunit 
contributes to the modulation of the channel behaviour. Both subunits contain sites that 
are phosphorylated by protein kinases. Presumed α-helices are drawn as cylinders. 
Legend:  α1, β subunits of the channel; C c-terminal; N n-terminal; P phosphorylation sites; I to IV 
are channel domains; 1 to 6 are transmembrane segments; + voltage sensors of the 4th 
transmembrane segments.  
 
 The α1 subunits of Cav consist of an alignment of four domains that form the 
channel pore. Each domain consists of six transmembrane segments (S1 to S6). The S4 
segments of the domains are thought to correspond to the voltage-sensor, which 
undergoes a conformational change and initiates channel opening following membrane 
depolarization (Catterall, 2000). 
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 The family of voltage-gated Ca2+ channels is very heterogeneous with respect to 
their evolutionary history, electrophysiological and pharmacological properties, as illustrated in 
figure 13:  
 
Figure 13: The voltage-gated calcium channel family (based on Ertel et al., 2000, p. 533; 
Catterall, 2000, p. 524; Hille, 2001, p. 117; adapted by M. Weber) 
 Comparison of the amino acid sequences reveals three subfamilies of voltage-gated calcium channels. 
Analysis of the amino acid sequences of α1 subunits has led to the identification of 10 
family members (Cav1.1 to Cav3.3) of the voltage-gated calcium channel family, which can 
be grouped into three subfamilies labelled Cav1 to Cav3. Individual family members have 
distinct electrophysiological and pharmacological properties (see text). 
Legend:  Cav voltage-activated calcium channel; DHP dihydropyridines, HVA high-voltage activated 
(Cav); LVA low-voltage activated (Cav); L, N, P/Q, T and R refer to Cav subtypes 
according to a phenomenological nomenclature; Cav 1.1 to 3.3 refer to Cav subtypes 
according to a clone nomenclature; ω-agatx IVA ω-agatoxin IVA; ω-ctx GVIA ω-
conotoxin GVIA.  
 
 Early electrophysiological experiments have revealed the existence of two major 
groups of Cav that were called high-voltage activated (HVA) and low-voltage activated (LVA) 
calcium channels. LVA Cav have a relatively low activation threshold, i.e. they only require a 
relatively minor depolarization for channel opening. Activation of LVA Cav is followed 
by a brief (single-channel) current that is terminated by a fast, and voltage-dependent 
inactivation mechanism. LVA Cav are also called T-type Ca2+ channels to describe the tiny 
conductance and transient single-channel current. They were originally discovered in 
cardiac muscle (Nilius et al., 1985), and later in neurons (Nowycky et al., 1985). In 
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contrast, the activation of HVA Cav requires a large depolarization of the cell 
membrane. These channels often lack a fast inactivation mechanism and can still be 
recorded when cells are held at depolarized membrane potentials. HVA Cav were 
originally called L-type Ca2+ channels to describe their large conductance and long-lasting 
single-channel currents. They are sensitive to dihydropyridines such as nifedipine or 
BayK8644 and are therefore called dihydropyridine receptor (DHPR) channels (Hille, 2001; 
Moreno Davila, 1999; Nilius et al., 1985). Dihydropyridine receptors are typically 
present in muscle cells, with a tissue specific subtype distribution, but at least two of the 
four subtypes are also present in neurons (see Catterall, 2000; Nowycky et al., 1985). 
 Further studies in neurons have revealed the presence of HVA Ca2+ channels that 
are insensitive to dihydropyridines, and with single-channel current characteristics in between 
those of the L- and T-type. These Cav types were originally called N-type Ca2+ channels 
to denote their presence in neurons (Nowycky et al., 1985), but were later subdivided 
into a new N-type category and the P/Q-, and “R” –type categories due to distinct 
pharmacological properties: N-type Cav are irreversibly blocked by low concentrations of ω-
conotoxin GVIA, and P/Q –types are sensitive to ω-agatoxin IVA. The “R”-type accounts 
for the residual current that is neither sensitive to ω-conotoxin GVIA nor ω-agatoxin 
IVA (see figure 13 for an overview). Aside from these pharmacological differences, 
however, these channel types are functionally very similar (Hille, 2001; Moreno Davila, 
1999). 
 The electrophysiological and pharmacological properties of Cav currents in rat intracardiac 
neurons were examined in detail by Xu and Adams (1992b): Inhibition of the voltage-
dependent whole-cell Ca2+ currents by Cd2+ had a half-maximal inhibition of 3.6 µM, 
and total current inhibition occurred at 100 µM. About 70 % of the voltage-dependent 
Ca2+ current was inhibited by a 300 nanomolar, i.e. maximally effective, concentration 
of ω-conotoxin GVIA, suggesting the predominance of N-type Ca2+ channels in rat intracardiac 
neurons. 50 % of the residual current could be inhibited by very high concentrations the 
dihydropyridine nifedipine, suggesting the additional presence of L-type Ca2+ channels. The 
demonstration of a ω-conotoxin GVIA and dihydropyridine –insensitive current further 
suggests the presence of at least a third type of Cav in these cells. The I-V curve of the 
currents manifested the dominance of HVA Ca2+ channels, given that a large depolarization 
to about – 20 mV was required to initiate channel opening and that currents were 
maximal at about + 20 mV.  
  
46
1.4.3 nAChR channels 
nAChR channels are cation-permeable ion channels that mediate fast synaptic transmission. 
Activation of the nAChR under physiological conditions allows for an influx of cations 
that is accompanied by a transient membrane depolarization (see e.g. Aidley, 1998; Hille, 
2001).  
nAChR channels, with both their muscle and neuronal receptor type, are part of 
a superfamily of fast-acting ligand-gated ion channels described in chapter 1.2.4. The 
phylogenetic tree of this superfamily is also illustrated in figure 6 of chapter 1.2.4.  
Mostly based on studies of the muscle-type nAChR channel from the electric ray 
Torpedo (see e.g. Aidley, 1998), these channels are thought to have a large pentameric 
structure of ~ 290 kDa (Miyazawa et al., 1999) in which the five subunits enclose the common 
ion pore (see figure 15). Based on biochemical studies, mutation experiments, and 
hydropathy plots, it is suggested that each subunit has a very large extracellular n-
terminal domain, four membrane-crossing segments (M1 to M4), with a large cytoplasmic loop 
between M3 and M4 and a short extracellular c-terminal domain (Ortells & Lunt, 1995; 
Unwin, 2000). Figure 14 shows a hydropathy plot of a nAChR α-subunit. 
 
Figure 14: Hydropathy indices of an α -subunit of the (muscle-type) nAChR (adopted from 
Nicholls et al., 2001, p. 50, based on Schofield et al., 1987, p. 223) 
 Hydropathy indices are used to identify likely membrane-crossing segments of membrane receptors. 
Calculating a „moving sum“ from hydropathy values of subsequent amino acids of the 
amino acid sequence derives the hydropathy index. Positive values correspond to lipophilic 
regions, negative values to hydrophilic regions. Brown regions indicate the signal sequence, 
blue regions the presumed transmembrane regions M1 to M4.  
  
Hydropathy plots have contributed to models of the likely receptor structure as 
illustrated in figure 15. 
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Figure 15: Presumed membrane topology of the nAChR (from Kandel & Siegelbaum, 2000, 
p. 200) 
A: Model of the membrane topology of an individual subunit.  
The model is based on hydropathy plots, biochemical studies, and mutation experiments.  
B: Model of the membrane topology of a nAChR with its five subunits.   
The model assumes an assembly of the five subunits around a central, common 
hydrophilic pore. The five M2 regions are the presumed pore lining segments (see text).  
 
The membrane-spanning M2 regions mainly represent the pore forming 
segments of the ion channel (Leonard et al., 1988), but small fraction of the M1 segment 
also seem to contribute to the pore lining (Wilson & Karlin, 1998, 2001). The exact 
location of the channel gate is still fairly unclear: Cryo-electron microscopic data of 
Unwin (1995) suggests a location of the gate at a narrow kink that is formed by split α-
helices of the pore lining M2-segents that extend into the channel pore at about the 
middle of the bilayer. In contrast, newer biochemical data indicates a location of the gate 
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more towards the cytoplasmic side of the channel (Wilson & Karlin, 1998). Cryo-
electron microscopy has made it possible resolve more functionally relevant details of 
the channel structure, as illustrated in figure 16: (i) The cytoplasmic channel wall 
contains transverse tunnels that may act as (pre) -selectivity filter for ions in the vicinity of 
the channel pore. (ii) The extracellular channel wall contains tunnels that represent access 
pathways for the ACh molecules to their binding sites, as they connect the ACh binding sites 
with the adjacent water-filled space enclosed by the extracellular segments of the 
channel. The α subunit is thought to include the entire ACh binding site, but residues of 
neighbouring “non-α subunits”, namely the γ and δ subunits, are likely to contribute to the 
guiding of ACh into its binding sites (Miyazawa et al., 1999; Unwin, 2000). 
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Figure 16: Current model of the (muscle-type) nAChR (based on Miyazawa et al., 1999, 
p. 180; Unwin, 2000, p. 1820; Hille, 2001, plate 4; adapted by M. Weber) 
A: Schematic illustration of the newly discovered tunnels of the nAChR.  
High resolution cryo-electron microscopy has revealed the presence of (i) access routes for 
ACh molecules to their binding sites in the extracellular wall of the α subunits and (ii) 
transverse tunnels in the cytoplasmic wall that may act as (pre-) selectivity filter for ions to 
the channel pore. Rapsyn molecules are likely to be linked to the cytoplasmic channel end 
are not shown. Ca2+ is printed in brackets due to the low Ca2+ permeability of the muscle-
type, but the high Ca2+ permeability of the neuronal-type nAChR. 
B: Reconstruction model of the (muscle-type) nAChR channel based on cryo-electron microscopy.   
The entire receptor is ~ 160 Å long. The γ subunit is likely to lie directly in between the 
two α subunits, the δ subunit anticlockwise of the left α subunit, and the β subunit 
clockwise of the right α subunit. Asterisks indicate the putative binding sites for ACh in 
the extracellular channel wall. The upper arrow indicates the putative gate of the closed 
pore, and the lower arrow the constricting part of the open pore.  
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 The fully assembled fetal (or extrajunctional) muscle-type nAChR channel is a 
heteropentamer that closely resembles the nAChR of the electric ray Torpedo: It includes 
two α subunits and three non-α subunits, namely one β, γ and δ subunit each (α2βγδ). 
The adult (or junctional) muscle-type nAChR channel has a somewhat different structure 
(α2βεδ) that contains one ε subunit instead of the γ subunit (Dilger, 2002; Hille, 2001; 
Waxham, 1999). The highly conserved muscle type α and β subunits have been denoted 
α1 and β1, respectively, to avoid confusion with newly discovered nAChR subunits in 
neurons (McGehee, 1999, Role & Berg, 1996). Muscle-type nAChR channels are sensitive to 
α- bungarotoxin, and have a relatively low Ca2+ permeability (Le Novère et al., 2002), as 
illustrated in figure 17: 
 
Figure 17: The phylogeny of nAChR subunits (based on Le Novère et al., 2002, p. 448) 
 Phylogenetic differences of nAChR subunits are related to different properties of the assembled channels. 
The length of each horizontal tree branch corresponds to the approximated time between 
the divergence of individual subunits and their “subunit ancestors”. Phylogenetic 
differences are related to particular channel properties e.g. the α-bungarotoxin sensitivity 
or the Ca2+ permeability of the channels. The drawings on the right hand side indicate 
subunit compositions of assembled channels with the presumed ACh binding sites drawn 
as black dots. 
Legend:  α1 to α10, β1 to β4, γ, δ and ε are nAChR subunits;  α-Bgt α-bungarotoxin; + sensitive; – 
insensitive; MYA million years; pCa/pNa relative Ca2+/Na+ permeability of the channel; 
• presumed ACh binding sites.  
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Neuronal nAChR channels are also pentameric pore-forming membrane proteins, but they 
are more diverse than the muscle type, given that they are assembled from a pool of 
nine α (α2-α10) and three β (or “non-α”) subunits (β2-β4; Elgoyhen et al., 2001; Le 
Novère et al., 2002; McGehee, 1999). The neuronal-type α subunits are homologous to 
the muscle-type α1 subunit and (with the possible exception of the α5 subunit) include 
the key residues that form the ACh binding site. The nomenclature for the neuronal-type β 
subunits is unfortunate, given that they are rather distinct from the muscle-type β1 subunit (Le 
Novère et al., 2002; McGehee, 1999). Furthermore, neuronal-type nAChR can form 
functional homopentamers: “α9 and α10 form homopentamers by themselves and heteropentamers 
together. Similarly, α7 and α8 make up homopentamers on themselves and heteropentamers together. 
α2-α6 and β2-β4 are included in a range of complex heteropentamers […]” (Le Novère et al., 
2002, p. 448), in particular heteromers that are assembled from combinations of α and β 
subunits (McGehee, 1999). Interestingly, currents through homomeric nAChR can be blocked by 
nanomolar concentrations of α-bungarotoxin, while currents through nAChR channels of 
the various α/β combinations cannot (Elgoyhen et al., 2001; McGehee, 1999).  
Interestingly, the Ca2+ permeability of neuronal nAChR is several folds higher than that 
of the muscle type (Costa et al., 1994; Vernino et al., 1992; 1994). It is thus not surprising, 
that the “fractional Ca2+ current” (see chapter 1.3.2) through neuronal nAChR channels is 
very high, ranging from 4.7 % in rat sympathetic neurons to 11.7 % in expression 
systems for the α7 nAChR channel, when cells are clamped at potentials from –50 to –
70 mV (Fucile et al., 2003; Rogers & Dani, 1995; Rogers et al., 1997). Several studies 
have confirmed the particularly high Ca2+ permeability of the α7-homomeric channel 
(see e.g. Castro & Albuquerque, 1995; Seguela et al., 1993). This channel property may 
be physiologically significant, in particular as the α7-homomeric channel, unlike the 
NMDA receptor channel, allows for its substantial Ca2+ influx from resting membrane 
potentials without prior and strong depolarization (Couturier et al., 1990; Role & Berg, 
1996). Substantial Ca2+ fluxes through neuronal nAChR channels have not only been 
demonstrated with electrophysiological techniques, but also using intracellular Ca2+ 
fluorescent indicators (see e.g. Fucile et al., 2003; Rathouz & Berg, 1994; Rogers & 
Dani, 1995; Rogers et al., 1997; Vernino, 1994). The latter is important as they 
demonstrate that activation of neuronal nAChR can lead to intracellular Ca2+ signals. 
Taken together, these results indicate that neuronal nAChR are likely to represent an 
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important player in the generation of intracellular Ca2+ signals (Rathouz et al., 1997). The Ca2+ 
permeability of some neuronal nAChR channels is indicated in figure 17. 
 The pharmacological profiles to various agonists as well as antagonists (Chavez-
Noriega et al., 1997; Le Novère et al., 2002; McGehee, 1999; Michelmore et al., 2002) as 
well as the desensitization characteristics of neuronal nAChR channels have been shown to 
vary between nAChR channels of different subunit compositions (Le Novère et al., 2002; Quick et 
al., 2002).  
Such differences are interesting, as nAChR channels expressed in the CNS differ 
from those expressed in the peripheral nervous system: Prominent subunit gene products in the 
CNS are the β2 and in particular the α4, but hardly the α3 subunit. In contrast, the α3, but 
not the α4 subunit is very prominent in the PNS (McGehee, 1999; Role & Berg, 1996).  
In rat intracardiac neurons, the α3-subunit and either the β2 or β4-subunits mainly 
contribute to the nAChRs, but there is evidence suggesting that α7 homomeric channels may 
also be present, given that gene products for α7 subunits are present in about half the cells 
studied, and nAChR-induced whole-cell currents were partly blocked by the homomeric 
nAChR channel blocker α-bungarotoxin (see above; Bibevski et al., 2000; Cuevas & 
Berg, 1998; Hogg et al., 1999; Poth et al., 1997).  
Adams and co-workers have determined the permeability of the nAChR channel 
for various ions (X) in relation to that for sodium ions (PX/PNa) in rat intracardiac 
neurons: (i) The channel is hardly permeable to anions, with a relative permeability for 
chloride ions PCl/PNa ≤ 0.05 (Fieber & Adams, 1991a). (ii) The channel is only weakly 
selective among the alkali metals: The relative permeability (PX/PNa) for Cs+ and K+ were 
determined as 1.27 and 1.23, respectively. (iii) The selectivity among the divalent cations is 
similarly weak, with relative permeabilities (PX/PNa) for Mg2+, and Ca2+ of 1.1 and 0.65, 
respectively (Nutter & Adams, 1995). Fieber and Adams (1991a) have determined an 
even higher PCa/PNa of 0.93. The Ca2+ permeability of the nAChR channel in rat intracardiac 
neurons is thus approximately four to six folds higher than that of the cholinergic skeletal 
muscle endplate channel (Adams et al., 1980).  
The fundamental electrophysiological properties of nAChR –induced whole-cell 
currents in rat intracardiac neurons have been examined by Fieber and Adams (1991a): 
Application of ACh using a focal pressure application system (see chapter 2.5) on 
voltage-clamped neurons held at negative holding potentials and exposed to PSS was 
followed by the onset of an inward-current within milliseconds. The activated current 
lasted for several seconds. The current-voltage (I-V) relation curve of nAChR -induced 
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currents displayed a strong inward rectification with a reversal potential of about – 3 mV, 
when the patch-pipette contained a Cs+ -based solution to block K+ currents. The 
inward rectification of the channel did not depend on the presence of Cs+ ions, but was 
also observed when Cs+ was replaced by K+ as the main cation in the pipette solution.  
In sum, in rat intracardiac neurons, activation of the nAChR under physiological 
conditions, allows for an influx of mainly Na2+ and Ca2+ ions that is accompanied by a 
transient membrane depolarization and a substantial increase in cytoplasmic Ca2+ levels which may be 
further amplified by CICR from ryanodine sensitive stores (Beker et al., 2003) and possibly also 
voltage-gated Ca2+ channels. 
The view presented so far was too simplistic in that it has neglected the presence 
of subconducting, as well as desensitized channel states (see e.g. Aidley, 1998; Hille, 2001). 
While subconducting states are basically demonstrated in single channel recordings, 
desensitization can easily be observed in whole-cell recordings. In the case of the 
nAChR, desensitization corresponds to (partial) inactivation of the channel following prolonged 
or repeated exposure to agonists such as ACh (Ochoa et al., 1989). The (onset of) 
desensitization can on occur on several time scales (Feltz & Trautmann, 1982; Sakmann 
et al., 1980) and it can be modulated by endogenous and exogenous chemical agents 
(possibly including anaesthetics, see chapter 1.2.4), as well as covalent modifications of 
the channel structure (Ochoa et al., 1989). The time course of the recovery process from 
desensitization can similarly occur on several time scales, ranging from seconds to minutes 
following removal of ACh (Hille, 2001). As desensitization affects the size of the 
physiological response, e.g. the current or [Ca2+]i response following nAChR activation, 
it is crucial to avoid, minimize or control the extent of any desensitization in the experiment. It 
should e.g. be ensured that: (i) Agonists are only briefly applied. (ii) Higher than 
necessary agonist concentrations are avoided. (iii) Agonist application is followed by a 
thorough washout of the perfusion chamber. (iv) The time intervals in between 
subsequent agonist applications are sufficiently long, or at least (v) kept constant for 
both, the experimental and control condition. These points have also been taken into 
account during the experiments of the present thesis (see chapter 2.5). 
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1.5 Measurement techniques 
The present thesis has focused on cell physiological techniques, i.e. ratiometric Ca2+ fluorescence 
measurements and patch-clamp recordings in rat intracardiac neurons. Photospectrometry 
recordings supplemented these studies as an independent means of artefact control for 
the Ca2+ fluorescence measurements. 
 
1.5.1 Spectrophotometry 
Spectrophotometry can be used to measure the absorption spectra of solutions. In the present 
thesis, this technique was used to assess, whether cadmium heavy metal ions or 
(lipophilic) i.v. anaesthetics that are present in the solutions (see chapter 3.1) interfere 
with the absorption characteristics of the Ca2+ indicator fura-2. This was done as a 
means of artefact assessment, as various chemical agents, including heavy metal ions and 
lipophilic compounds, have previously been shown to interfere with the absorption 
properties of fura-2 and other fluorescent probes (Grynkiewicz et al., 1985; Marchi et 
al., 2000; Roe et al., 1990; Usai et al., 1999).  
The basic idea of spectrophotometry is to illuminate a sample with monochromatic 
light and measure the amount of the transmitted light, i.e. the light that passes through the 
sample. By relating the amount of the transmitted light in the presence of the sample to 
that transmitted during a blank reading in the absence of the sample, it is possible to 
calculate the amount of light that was absorbed by the sample. Monochromatic light is 
typically generated by letting the light of one (or several) light sources pass through 
several optical elements onto an optical grating, which generates a diffraction pattern of light 
that involves a range of different wavelengths. The wavelength of the generated light 
depends on its angle in relation to the grating (see e.g. Vogel, 1997). By positioning a so 
called exit slit at a certain angle in relation to the grating, it is thus possible to shield all 
but a single wavelength from passing through the exit slit and the sample located behind 
the slit. By changing the orientation of the grading, varying wavelengths can alternatively 
be passed through a fixed exist slit and an entire absorption spectrum of a sample can be 
determined. After the exit slit, the light passes series of mirrors, the sample itself and it 
is finally detected by a photodiode detector (see e.g.: http://www.beckmancoulter.com; or: 
Operating instructions, DU Series 600 Spectrophotometer, Beckman Instruments, Inc., 
Fullerton, CA, USA). A scheme of the photospectrometer that was used in the present 
thesis is presented in figure 21 in chapter 2.2.  
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1.5.2 Fura-2 fluorescence recordings 
Fluorescence is an attribute of certain chemical compounds called fluorophores. It is a very 
brief form of luminescence, which Lankowicz (1983, p. 1) describes as “the emission of 
photons from electronically excited states”. The fluorescence lifetime, during which a fluorescence 
compound is in an excited state, typically lasts about 10-8 seconds. This excited state is 
caused by absorption of light, i.e. an input of energy for the subsequent fluorescence 
emission as well as other forms of “energy disposal”. “Energy disposal” other than 
fluorescence emission is the reason for the so called stokes shift (see e.g. Vogel, 1997), i.e. 
the phenomenon that fluorescence excitation occurs at lower wavelengths (i.e. higher 
energy) than fluorescence emission (see figure 18 for fura-2). Using specific wavelength 
filters or dichroic mirrors, stokes shift can be used to ensure that only the emitted light, 
but not the excitation light, reaches the detection unit of a fluorescence microscope.  
The development of fluorescence microscopic techniques together with highly 
Ca2+ sensitive fluorescent dyes have enabled the study of intracellular Ca2+ signals in 
intact, living cells at a high spatial and temporal resolution. Roger Y. Tsien and co-
workers have undertaken the key steps towards modern intracellular Ca2+ indicators, by 
developing highly Ca2+ -sensitive (fluorescent) buffers with a high selectivity against magnesium ions 
and protons (Tsien, 1980). Furthermore, membrane permeable Ca2+ dyes that can be loaded into 
cells without disrupting the cell membrane were developed: These dyes were based on the 
previously developed polar Ca2+ dyes to which esterifying groups were added to mask their 
polar groups. Once inside the cell, de-esterification by endogenous esterases takes place, 
thereby trapping the polar dye molecules inside the cell (Tsien, 1981). Finally, dual-
wavelength ratiometric dyes were developed (Grynkiewicz et al., 1985). Before that, only 
single-wavelength intensity modulating dyes that – upon binding to Ca2+ - merely change the 
intensity of their excitation and emission spectra were available. This is different with the 
two types of dual-wavelength dyes developed by Tsien and co-workers, namely the dual-emission 
and dual-excitation dyes (Grynkiewicz et al., 1985): Upon binding to Ca2+, dual emission 
dyes such as indo-1 display marked shifts of their emission spectra, while dual excitation 
dyes such as fura-2 shift their excitation spectra, (summarized in Kao, 1994). Figure 18 
illustrates how different Ca2+ concentrations affect the excitation and emission spectra 
of fura-2: The intensity of the emitted light (at 510 nm) from fura-2 containing solutions 
increases with increasing free Ca2+ concentrations when excited with 340 nm (F340), but 
decreases when excited with 380 nm (F380). This effect is used advantageously during 
ratiometric fura-2 recordings, as the excitation of the sample is switched rapidly between 340 
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nm and 380 nm. Each F340 recording is then put into relation to its subsequent F380 
recording by calculating the ratio F340/F380 (R(F340/F380)) and an established calibration 
procedure (see chapter 2.3; Grynkiewicz et al., 1985) relates each R(F340/F380) value to a 
corresponding free Ca2+ concentration. The great advantage of the ratiometric 
technique over the single-wavelength approach to approximate [Ca2+]i is the relative 
independence of R(F340/F380) from mere fluorescence intensities and changes thereof. This procedure 
is based on the idea that changes in fluorescence intensities that are unrelated to changes in [Ca2+]i 
are likely to affect F340 and F380 in a similar manner, but the creation of the ratio 
R(F340/F380) eliminates this (unwanted) effect. In cells loaded with fluorescent Ca2+ 
indicators, changes of emitted fluorescence intensities that are unrelated to changes in 
[Ca2+]i include loss of dye by bleaching or leakage, varying cell thickness and changing 
illumination intensities (see e.g. Grynkiewicz et al., 1985; Kao, 1994). Yet, the ratiometric 
principle is only applicable under the assumption that the [Ca2+]i remains basically 
unchanged within one recording cycle including one illumination at 340 nm and one at 380 nm. 
This assumption only holds true if switches between recordings at 340 nm and 380 nm 
illumination can be executed very rapidly, typically in the low millisecond range. Figure 
18 shows the excitation and emission spectra of Ca2+ -free and -saturated solutions. 
Figure 18: Excitation and emission spectra of Ca2+ -free and Ca2+ -saturated fura-2 calibration 
solutions (adopted from Molecular Probes, Inc., http://www.probes.com) 
 Wavelength shift for fura-2 excitation spectra but not for its emission spectra.  
For excitation spectra recordings (the curves on the left), light was collected at 510 nm. 
For emission spectra recordings (the curves on the right), excitation was at 340 nm only. 
Vertical bars indicate the full width at half maximum (FWHM) of the excitation or 
emission light obtained by typical excitation or emission filters in fura-2 experiments (for 
filter spectra see e.g. Omega Optical, Inc., http://www.omegafilters.com). 
Legend:  (a) Ca2+ -saturated fura-2 calibration solutions; (b) Ca2+ -free fura-2 calibration solutions 
(see chapter 2.5; Grynkiewicz, 1985).  
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From figure 18, it becomes apparent that the peaks of the emission spectra of Ca2+ 
bound and Ca2+ free fura-2 fall within a very narrow range of each other. Furthermore, 
the 510 nm emission filters used in fura-2 experiments typically have a greater FWHM 
than the excitation filters, as more photons can be collected when broader filters are 
used. The 510 nm bandpass filter can even be totally omitted under some circumstances 
to collect photons emitted from an even wider range of the emission spectra, given that 
a dichroic mirror properly separates between the excitation and emission spectra. 
 
1.5.3 Patch-clamp recordings 
The patch-clamp technique became famous as an electrophysiological method that 
allows direct measurements of single channel currents. Yet, the famous publication of 
Neher, Sakmann and co-workers (Hamill et al., 1981) has not just provided detailed 
information on single-channel recording, but has already specified a whole-cell recording 
configuration. The process of establishing this traditional whole cell recording 
configuration is illustrated in figure 19A: After a tight seal between the patch pipette and 
the cell membrane has been established, (electrical) access to the cytosol is obtained by 
breaking through the membrane patch with a brief pulse of suction.  
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Figure 19: Scheme of the procedures that lead to the whole-cell recording configurations of the patch-
clamp technique (based on Hamill et al., 1981, p. 93; Horn & Marty, 1988; Rae 
et al., 1991). 
 The cell-attached configuration, i.e. a tight seal between the pipette and the cell membrane 
is required before any of the whole-cell recording configurations can be established. 
A: The traditional (“dialysed-patch”) whole-cell recording configuration 
Mechanical rupture of the patch provides electrical access to the cell interior and the 
cytosol is dialyzed with the pipette solution.  
B: The “perforated-patch” whole-cell recording configuration 
The tip of the patch pipette is filled with antibiotic-free solution to allow the establishment 
of a proper cell-attached configuration, as the antibiotic otherwise interferes with the seal 
formation. Due to diffusion, the antibiotics (illustrated as red spots) that were back-filled 
into the pipette, eventually reach the tip of the pipette where they form pores into the 
membrane patch enclosed by the pipette. As the pores are selective for small cations, 
electrical access to the cell interior is established while the macromolecular composition of 
the cytosol remains mostly undisturbed. 
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Whole cell patch-clamping offers several advantages in comparison with the 
traditional technique of inserting two microelectrodes into the cell: (i) Leak currents, 
which are a consequence of inserting a microelectrode into the cell, can be neglected. (ii) 
The seal between the pipette and the cell membrane can be in the range of several GΩ 
(the so-called giga-seal) thereby enabling recordings at a much lower level of noise. (iii) The 
standard form of whole-cell patch-clamping (the so-called dialysed-patch recording) involves 
the dialysis of the cytosol with the solution of the patch pipette. As the volume of the 
solution inside the patch-electrode is several orders of magnitude larger than that of the 
cell volume, the composition of the electrode solution basically dictates the composition 
of the intracellular milieu after completion of the dialysis, thereby providing a well-
known intracellular solution (Marty & Neher, 1995; Numberger & Draguhn, 1996). 
However, dialysis of the cell interior also involves a washout of diffusible cytosolic 
components, including second-messengers such as cyclic adenosine monophosphate 
(cAMP) or IP3, and any cellular process that depends on diffusible intracellular 
compounds will eventually be disturbed. This may explain the rundown of some 
physiological responses following the establishment of the dialysed patch configuration 
(Numberger & Draguhn, 1996). Depending on the experimental question at hand, this 
can either be an advantage or a disadvantage.  
To avoid dialysis of the cytosol, the “perforated patch” whole-cell recording configuration 
has been developed by Horn and Marty (1988) and further improved by Rae et al. 
(1991). In perforated patch-recordings, electrical access to the interior of the cell is 
established with the help of pore-forming antibiotics such as nystatin (Horn & Marty, 1988) 
or amphotericin B (Rae et al., 1991). When solely applied from one side of the cell 
membrane, these antibiotics form pores that are selective for small cations such as Na+ 
or K+ ions (Numberger & Draguhn, 1996). Furthermore, the pores do not allow 
passage of divalent ions or uncharged molecules with a molecular weight above 
~ 200 Da, which means that macromolecules cannot cross the cell membrane. Taken 
together, these properties leave the composition of the cytosol relatively undisturbed 
(Horn & Marty, 1988). Rae et al. (1991) have proposed a simple procedure obtain the 
perforated-patch configuration: The patch pipette is “tip-filled” with an antibiotic free 
solution and back-filled with the antibiotic-containing solution. The initial lack of 
antibiotics in the tip of the pipette allows establishing a tight seal of a proper cell 
attached configuration. Due to diffusion, the antibiotics eventually reach the tip of the 
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pipette and the cell membrane and form pores into the membrane patch as illustrated in 
figure 19B. 
The patch-(voltage-)clamp technique is an advanced form of the voltage-clamp technique.  
Voltage-clamping in general make it possible to hold (= “clamp”) the membrane potential of 
cells at a desired value and simultaneously record currents across the cell membrane. 
The resulting control over the membrane potential has greatly facilitated the study of 
ion channels in cells, as it provides a possibility to specifically eliminate – or activate – 
the contribution of voltage-gated ion channels to the membrane currents in excitable 
cells. This greatly reduces the complexity of the physiological events studied. Hille 
(2001, p.34-35) describes the traditional two-electrode voltage clamp as follows: 
 
Voltage-clamps […] consist of an intracellular electrode and follower circuit to 
measure the membrane potential, a feedback amplifier to amplify any 
difference (error signal) between the recorded voltage and the desired 
value of the membrane potential, and a second intracellular electrode for 
injecting current from the output of the feedback amplifier (italicisation 
added by M. Weber). 
 
The two-electrode voltage-clamp technique is still in use in experiments with 
very large cells, e.g. certain muscle cells or Xenopus oocytes, but the patch-voltage-clamp 
technique now appears to be the standard electrophysiological technique for smaller 
cells (< ~ 50 µm in diameter). This success was made possible with the development of a 
fast amplifier to virtually simultaneously record voltage and inject current using a single 
electrode. This extension of the voltage-clamp principle to the “single-electrode situation” of 
the patch-clamp recording is achieved with the current-to-voltage (I-V) converter of a patch-
clamp amplifier. The I-V converter is part of the preamplifier or “headstage” to which the 
pipette holder of the patch-pipette is connected (see e.g. Hamill et al., 1981; Numberger 
& Draguhn, 1996; Sigworth, 1995). It is illustrated in figure 20 as part of an extended 
circuit equivalent diagram of a whole cell recording. 
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Figure 20: Circuit diagram of a whole-cell patch-clamp recording (based on Numberger & 
Draguhn, 1996; p. 69 & 88) 
 Circuit diagrams of a whole-cell recording and a simplified version of a patch-clamp amplifier.  
The circuit diagram in the upper right corner of the illustration shows the key components 
of a patch-clamp amplifier (see text for details). The main components of the current-to-
voltage converter are an operational amplifier (OPA, illustrated as a triangle, with its two 
inputs, denoted as [1] and [2], and its single output, denoted as [3]), and a feedback resistor 
(RF). The second differential amplifier (also illustrated as a triangle) is already part of the 
main amplifier. UPIP denotes the pipette potential, UCMD the command potential, and UOUT 
the output potential. The signal ground of the patch-clamp amplifier is not shown. The key 
components of the whole-cell equivalent circuit are the series resistor (RS), the membrane 
resistor (RM) and the membrane capacitor (CM).  
 
The two central characteristics of the I-V converter are: (i) The input resistance 
(ROPA) of the operational amplifier (OPA) typically is ~ 1012 Ω, which is several orders 
of magnitude higher than that of the feedback resistor (Rf; ROPA >> Rf). This means 
that basically all of the current to and from the patch pipette flows through the feedback 
resistor while hardly any of it flows through the OPA. (ii) At the output of the OPA 
(labelled [3]), a strongly amplified potential (U[3]) that is proportional to the potential 
difference between the two inputs of the OPA ([1], [2]; U[3] ~ (U[2]- U[1])) is generated. 
This means that any difference between the pipette (UPIP) and command potential 
(UCMD) causes a potential (U[3]) at the output of the OPA. This has two consequences: 
(i) Current flows through RF and into the pipette to rapidly compensate the previous 
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current flow at the pipette. (ii) The output potential of the OPA (U[3]) is relayed to the 
main amplifier where the command potential (UCMD) is subtracted and the remainder is 
recorded and transformed into current (according to a calibration factor). As these 
processes occur extremely rapidly, it is possible to record and compensate any current flow to 
and from the cell, while the cell is held at the desired holding potential (see e.g. 
Numberger & Draguhn, 1996).  
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2 MATERIALS AND METHODS 
2.1 Preparation and Cell Culture 
Parasympathetic neurons from rat intracardiac ganglia were dissociated and placed in 
tissue culture. The dissociation procedure of these neurons has been described 
previously (Xu & Adams, 1992a) and was in accordance with guidelines of Animal 
Experimentation Ethics Committees of the University of Queensland and the University 
of Heidelberg. In detail, Wistar rats (3-8 days old) were killed by decapitation, the chest 
cavity was opened and heart, lungs, oesophagus, thymus and all connecting vessels were 
taken out en bloc and transferred into dissection solution. Subsequently, lungs, 
oesophagus, trachea and bronchi, thymus, ventricles, aorta and the left atria were 
removed. The vena cava was cut open and the residual atrial tissue was stretched out 
and fixed with fine metal pins onto a sylgard coated petri dish, covered with dissection 
solution containing collagenase type II (0.8 mg ml-1) and incubated for 52-62 min at 
37°C. After the enzymatic treatment, clusters of ganglia were dissected, transferred to a 
sterile culture dish containing culture media, cut into 3 to 4 peaces and triturated 
approximately 20 times using a Pasteur pipette with a narrow, fire-polished opening. 
The isolated neurons were plated on laminin-coated glass cover slips and incubated at 
37°C for 36 - 84 h under a 95% air, 5% CO2 atmosphere before they were used for 
experiments. Figure 23 shows examples of the dissociated, cultured intracardiac neurons 
during patch-clamp experiments. 
  
2.2 Spectrophotometry 
The i.v. anaesthetics thiopental and ketamine were screened for interferences with the 
absorption characteristics of fura-2 using photospectrometry. Recording solutions were 
based on standard (Ca2+-) EGTA solutions containing 0 nM [Ca2+]s (EGTA solution) or 
> 0.1 mM [Ca2+]s (Ca2+ -EGTA solution; see: chapter 2.5 and Grynkiewicz et al., 1985). 
Absorption spectra of solutions containing either 0 (control) or the clinically relevant 
concentration of the anaesthetics (25 µM for thiopental, and 10 µM for ketamine), and 
0 or 10 µM fura-2 pentapotassium salt were recorded with a UV/vis spectrophotometer 
(Beckman DU 640, Beckman Instruments, Inc., Fullerton, CA, USA) with a wavelength 
range from 190 to 1100 nm, a spectral excitation bandwidth of ≤ 1.8 nm and a 
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photodiode for the detection of the transmitted light. Photons were collected from the 
full wavelength range of the spectrometer, since pre-experiments showed that the signal 
to noise ratio was not sufficient when a 510 nm bandpass filter was inserted between the 
solutions and the detection diode. Similarly, a 10 µM fura-2 pentapotassium salt 
concentration was chosen to provide a sufficient signal to noise ratio of the dye-related 
signal and to be within the concentration range of fura-2 to be expected inside cells 
under the experimental conditions. A scheme of the photospectrometer is presented in 
figure 21 (see chapter 1.5.1 for details on the operating principle). 
 
Figure 21: Operating principle of a Beckman DU 600 spectrophotometer  
(adopted from http://www.beckmancoulter.com) 
 Schematic of a Beckman DU series 600 photospectrometer.  
The presence of a deuterium and a tungsten source allows the illumination of the sample in 
the UV as well as in the visible range of the light, respectively. A beam combiner is 
necessary to ensure that the path of the light from both light sources is identical before 
further optical elements are passed. The key component of the spectrophotometer is the 
optical grating as it represents the basis for the generation of monochromatic light (see 
chapter 1.5.1 for details). Monochromatic light illuminates the sample and a photodiode 
detector collects the transmitted light. 
 
2.3 Fura-2 fluorescence recordings 
Intracellular [Ca2+]i transients in response to application of ACh or caffeine, were 
determined in fura-2 loaded rat intracardiac neurons using single cell ratiometric 
photometry. Neurons were incubated for ~ 1 h at room temperature in fura-2 loading 
solution. Subsequently, they were washed in (physiological salt solution) PSS and a 
recovery period of ~ 30 min before experiments was used. Mainly isolated neurons were 
selected for the experiments to minimize synaptic contacts and the activation of nearby 
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cells. Fura-2 loaded cells were illuminated with light from a 75 W xenon arc lamp, which 
was split by an optical chopper (OC-4000 Optical Chopper, Photon Technology 
International (PTI), South Brunswick, NJ, USA) and passed alternately through 340 and 
380 nm bandpass filters. A 510 nm bandpass emission filter was used and a variable 
aperture set around the cell image. The emitted light was collected by a Hamamatsu R 
928 photomultiplier tube, the output of which was digitised using a PTI interface and 
sampled at 5 Hz using Felix 1.1 software (PTI) run on a 133 MHz computer. Figure 22 
illustrates the major parts of the photometry system: 
 
Figure 22: The PTI photometry system 
(from http://www.pti-nj.com) 
 Schematic of the ratiometric PTI photometry system.  
 Light from the xenon arc lamp is split by an optical chopper and passed alternately 
through 340 and 380 nm excitation filters and via fibre optical cables to the microscope. 
Using the viewing eyepiece, the variable aperture is set around the cell image to selectively 
detect the light emitted from the cell of interest, subsequently passed through a 510 nm 
emission filter and collected by a photomultiplier tube. The photomultiplier output is 
digitised and sampled for storage on a personal computer.  
Legend:  1 arc lamp housing; 2 shutter; 3 iris; 4 IR trap; 5 broadband filter; 6 optical chopper; 7 340 
and 380 nm filters; 8 bifurcated fibre optical cable; 9 fibre optic adapter; 10 microscope; 
11 photometer; 12 adjustable iris; 13 viewing eyepiece; 14 510 nm emission filter; 
15 photomultiplier. 
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Some experiments were carried out on a ratiometric imaging system based on an 
Olympus IX 70 microscope with UV optics, a Polychrome II monochromator (Till 
Photonics, Gräfeling, Germany) alternating between 340 nm and 380 nm illumination, a 
Hamamatsu C3077 CCD camera with a C2400-80 intensifier head to collect the 
fluorescence images, a Meteor II frame grabber board (Matrox, Dorval, Quebec, 
Canada), and Simple PCI 5.0 (Compix Inc., Imaging Systems, Cranberry Township, PA, 
USA) software run on a 1600 MHz computer. 
Changes in intracellular [Ca2+] (∆[Ca2+]i) were obtained measuring the ratio of 
the intensity of the emitted 510 nm fluorescence R(F340/F380) when the cell was 
illuminated with 340 nm light (F340) to that when illuminated with 380 nm light (F380) 
and converting this ratio to approximate Ca2+ concentrations using the equation: 
 
 
 
where Rmin and Rmax are the F340/F380 ratios of the Ca2+-free and Ca2+-saturated fura-2 
sample, respectively, Sf2 is F380 of the Ca2+-free fura-2 sample and Sb2 is F380 of the Ca2+ 
bound sample. An eleven-step calibration procedure during which [Ca2+] was increased 
from approximately 0 to saturation of the dye at > 1 mM [Ca2+] was used to determine 
the numerical values for the constants in this equation using fura-2 pentapotassium salt 
and standard (Ca2+-) EGTA solutions (Grynkiewicz et al., 1985). Under the 
experimental conditions of the PTI set-up and the imaging set-up, the dissociation 
constant Kd was determined as 179 and 196 nM, respectively.  
A concentration-response curve with thiopental as antagonist for nAChR 
activation was obtained by measuring the peak increase in [Ca2+]i (∆[Ca2+]i) at each 
antagonist concentration and the experimental data points were fitted using the equation 
 
∆[Ca2+]i/∆[Ca2+]i(max) = 1/[1+([A]/EC50) n]   (4) 
 
where ∆[Ca2+]i/∆[Ca2+]i(max) represents the relative peak increase in ∆[Ca2+]i, [A] is the 
antagonist concentration, EC50 is the concentration giving half-maximal inhibition and n 
is the Hill coefficient. 
 
[Ca2+]i   = Kd   x                   x                (3)             R - RminRmax - R
Sf2
Sb2
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2.4 Patch-clamp recordings 
Membrane currents were measured with the whole-cell recording method of the patch-
clamp technique, using either the conventional, dialyzed (Hamill et al., 1981) or the 
perforated patch (Horn & Marty, 1988; Rae et al., 1991) recording configuration. The 
perforated patch configuration takes advantage of pore forming antibiotics, in the 
present study amphotericin B, to obtain electrical access to the cell interior without 
dialyzing cytoplasmic components, which are important in maintaining various 
functional responses in cells. The pipette was first tip-filled with an antibiotic-free 
solution to prevent disruption of seal formation and then backfilled with the 
amphotericin B containing solution (see chapter 1.5.3). Pipettes were pulled from 
borosilicate glass (Harvard Apparatus, Reading, UK) using a Sutter Instruments P-87 
pipette puller, were fire polished and had resistances of ~ 2.5 MΩ.   
Filled patch pipettes were mounted on a pipette holder connected with the head 
stage of a patch-clamp amplifier (EPC-7, List-Medical, Darmstadt, Germany or RK300, 
Bio-Logic, Claix, France). Voltage protocols were applied using Clampex software 
(Version 8.0, Axon Instruments Inc., Union City, CA, USA). Signals were filtered at 200 
Hz, digitised at 1 kHz (Digidata 1200 interface, Axon Instruments Inc.) and stored on 
the hard disc of a Pentium PC for further analysis. Figure 23 shows dissociated 
intracardiac neurons during one of the patch-clamp experiments. 
 
Figure 23: Agonist application and patch-clamping of cultured rat intracardiac neurons  
 Focal application of agonists on single rat intracardiac neurons during patch-clamp experiments.  
The arrow indicates the tip of the pipette of the focal pressure application system with 
which the agonists were applied to the cells. The pipette on the right hand side is the patch 
pipette. The picture shows typical neonatal rat intracardiac neurons with their spherical cell 
bodies and their lack of pronounced dendritic trees and axons. The pictures were acquired 
using the Hamamatsu imaging system described in chapter 2.3. 
20 µm
  
68
2.5 Solutions and Drugs 
Solutions for absorption measurements and for the calibration procedure of the fura-2 
signal were standard (Ca2+-) EGTA solutions containing 10 mM EGTA, 100 mM KCl, 
10 mM K-MOPS, and either 10 mM CaCl2 (Ca2+ -EGTA solution) or no added Ca2+ 
(EGTA solution), respectively (Grynkiewicz et al., 1985). The free Ca2+ ion 
concentration of the solution [Ca2+]s was > 0.1 mM in the Ca2+ -EGTA solution and 
approximately 0 in the EGTA solution. The dissection solution contained (mM): 140 
NaCl, 3 KCl, 2.5 CaCl2, 0.6 MgCl2, 7.7 glucose and 10 histidine (pH adjusted to 7.2 with 
NaOH). The culture media was high glucose Dulbecco’s Modified Eagle Media, with 
10 % (v/v) fetal calf serum, 100 U ml-1 penicillin and 0.1 mg ml-1 streptomycin. The 
fura-2-loading solution was based on physiological saline solution (PSS) containing 
(mM): 140 NaCl, 3 KCl, 2.5 CaCl2, 1.2 MgCl2, 7.7 glucose and 10 HEPES (pH adjusted 
to 7.2 with NaOH) to which pluronic-127 and fura-2 AM ester from stock solutions 
(1 mM fura-2/AM in DMSO) was added to obtain a final concentration of 0.02 % 
pluronic-127 and 5 µM fura-2 AM. During experiments, rat intracardiac neurons were 
continuously superfused with ~ 2 ml PSS/min. The relatively large Ca2+ concentration 
of 2.5 mM was chosen for the PSS due to a previous study in rat intracardiac neurons 
that has shown that nAChR induced currents reach a peak value at this Ca2+ 
concentration, with reduced currents for lower as well as higher Ca2+ concentrations 
(Fieber & Adams, 1991a). This indicates that the presence of 2.5 mM Ca2+ in the PSS 
creates are favourable condition for the observation of sufficiently large nAChR induced 
currents and possibly [Ca2+]i transients, too. Racemic mixtures of thiopental, 
pentobarbital or ketamine were added to the extracellular solution, stirred thoroughly 
and bath applied prior to agonist application. Perfusion volume during wash-in of the 
anaesthetics (≥ 5 min) was approximately ten-fold the chamber volume (1 ml) to ensure 
that the desired anaesthetic concentrations were obtained before agonist application, 
while perfusion volume during washout (≥ 10 min) was approximately twenty-fold 
chamber volume to ensure almost complete removal of the anaesthetics. Estimated 
clinically relevant anaesthetic concentrations were taken from the literature (Franks & 
Lieb, 1994; Krasowski & Harrison, 1999; Yamakura et al., 2001) and are free aqueous 
concentrations corrected for protein binding. Thiopental concentrations are nominal 
values not adjusted for the 9 % sodium carbonate content of the powder. Agonists were 
applied to the cell soma of intracardiac neurons by pressure ejection (3-8 p.s.i.; 
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Picospritzer II, General Valve Corp., Fairfield, NJ, USA) from a micropipette (3 - 5 µm 
diameter) positioned about 40 - 80 µm from the cell soma as shown in figure 23. 
Nicotinic ACh receptor activation was obtained by focal application of maximally 
effective ACh concentrations (300 - 500 µM), with maximally effective concentrations 
of the muscarinic receptor antagonist atropine (≥ 100 nM) present both in the bath 
solution and extracellular pipette solution. In unclamped cells and perforated patch-
clamp experiments, 500 µM ACh or 10 mM caffeine were applied for 1.2 s and a delay 
of at least 5 min between agonist applications was maintained. In dialyzed patch-clamp 
experiments, 300 µM ACh was applied for 0.1 s and a delay of ≥ 70 s between ACh 
applications was maintained to minimise receptor desensitization while recording 
duration for I-V curves remained acceptable. Agonists were applied several times before 
the superfusion of the anaesthetic and experiments were continued only if stable 
responses to agonist application were obtained. The pipette solution for perforated 
patch experiments contained (mM): 75 K2SO4, 55 KCl, 5 Mg SO4 and 10 HEPES, 
titrated with N-methyl-D-glucamine to pH 7.2. A stock solution of 60 mg ml-1 
amphotericin B in DMSO was prepared daily and diluted in pipette solution, providing a 
final concentration of 240 µg ml-1 amphotericin B in 0.4 % DMSO, which was kept on 
ice and protected from light. The pipette solution for dialyzed patch experiments 
contained (mM): 140 CsCl, 2 MgATP, 2 CsBAPTA, 10 HEPES titrated with CsOH to 
7.2. All experiments were carried out at room temperature (22°C). 
All chemical reagents used were of analytical grade. The following drugs were 
used: Acetylcholine chloride, amphotericin B, atropine sulphate, DMSO, ketamine 
hydrochloride, pentobarbital sodium salt, tetrodotoxin, thiopental sodium salt (Sigma 
Chemical Co., St. Louis, MO), caffeine (Fluka Chemie, Buchs, Switzerland), collagenase 
(type II; Worthington, Biochemical Corp., Lakewood, NJ, USA), CsBAPTA, fura-
2/AM, fura-2 pentapotassium salt, and pluronic-127 (Molecular Probes, Eugene, OR), 
ω-conotoxin GVIA (Alomone Labs, Ltd., Jerusalem, Israel). 
 
2.6 Data Analysis 
Peak (F340/F380) and resting (F340/F380) values of ratiometric fluorescence transients 
were determined by averaging F340/F380 values obtained from a 1.5 s period during the 
peak response and a 5 s period prior to the agonist application, respectively. Peak and 
resting F340/F380 ratios were then transformed to peak and resting [Ca2+]i, using 
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equation (3), and peak increases in [Ca2+]i (∆ [Ca2+]i) were calculated by subtracting 
resting [Ca2+]i from peak [Ca2+]i. ACh-evoked peak current amplitudes and ∆ [Ca2+]i in 
the presence of the anaesthetic (or antagonist) were averaged and compared to the mean 
control response obtained in the absence of the anaesthetic in each individual cell. With 
one exception, mean control responses were determined by averaging responses 
obtained before and after superfusion with the anaesthetic (or antagonist) to take into 
account cell rundown or incomplete recovery during washout that may occur during the 
experiment. In a control experiment involving the use of the N-type Ca2+ channel 
blocker ω-conotoxin GVIA as antagonist mean control responses were uniquely based 
on responses obtained before the wash-in of the toxin, as its effects are virtually 
irreversible (Boland et al., 1994; Feng et al., 2001). Data are expressed as the mean ± 
S.E.M. and were analysed statistically using Student’s (paired, two-tail) t-test with the 
level of significance being taken as P < 0.05 (*), 0.01 (**) or 0.001 (***). Levels of 
significance were conservatively adjusted using the Bonferroni method when multiple 
comparisons between experimental conditions in the same experiments were carried 
out. 
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3 RESULTS 
3.1 Preliminary experiments 
3.1.1 Assessment of fura-2 quenching by i.v. anaesthetics  
3.1.1.1 Spectrophotometry 
Several chemical agents ranging from heavy metal cations (Grynkiewicz et al., 1985; 
Marchi et al., 2000; Usai et al., 1999), to caffeine (Muschol et al., 1999) are known to 
interfere with fura-2 measurements. In particular, a red shift of the excitation spectra 
and quenching of the fura-2 signal was reported with increasing hydrophobicity of 
solutions (Roe et al., 1990). Since many anaesthetics, including ketamine and a number 
of barbiturates, are very lipophilic (reviewed in Franks & Lieb, 1994; Krasowski & 
Harrison, 1999), ketamine and thiopental as a representative of the barbiturates and a 
close chemical relative of its metabolite pentobarbital (Büch & Büch, 2001; Chan et al, 
1985; Charney et al, 2001; Evers & Crowder, 2001) were screened for interferences with 
the absorption characteristics of fura-2 using photospectrometry.  
Firstly, the effect of thiopental on the absorbance of the (Ca2+) –EGTA 
solutions in the absence of fura-2 was examined. As shown in figure 24A, 25 µM 
thiopental increased the absorbance of the solutions only in a minor degree in the wavelength range used 
for the fura-2 ratiometric measurements (see also legend of figure 24), but progressively 
increased for wavelengths smaller than 330 nm.  
Secondly, the effect of thiopental on the absorbance of (Ca2+) –EGTA solutions 
in the presence of 10 µM fura-2 was examined. As shown in figure 24B, the absorbance 
changes in the presence of 25 µM thiopental can still be observed in the presence of 10 µM fura-2. 
Finally, the effect on 25 µM thiopental on the absorption characteristics of fura-
2 itself was examined. To eliminate the non-specific effect of thiopental on (Ca2+) -
EGTA solutions in general (in the absence of the dye), the absorbance of the dye-free 
solutions was subtracted from that of dye-containing solutions. As shown in figure 24C, 
the resulting absorbance curves were virtually identical for solutions in the absence and 
presence of thiopental, over the complete wavelength spectra of relevance for fura-2 
excitation, showing that 25 µM thiopental did not interfere with the absorption characteristics of 
fura-2.  
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Figure 24: Effects of thiopental (thio) on the absorption spectra of Ca2+ -free or Ca2+ -containing 
solutions in the absence or presence of fura-2 pentapotassium salt  
Vertical bars indicate the full width at half maximum (FWHM) of the excitation light 
obtained by the use of typical excitation filters or monochromators in fura-2 experiments 
(for filter spectra see e.g. Omega Optical, Inc., http://www.omegafilters.com). 
A: Absorption spectra of EGTA and Ca2+ -EGTA solutions in the absence of fura-2 and the presence of 
0 (control) or 25 µM thiopental.  
Thiopental marginally increased absorbance in both Ca2+ -free and Ca2+ -containing 
solutions and was more pronounced at excitation wavelengths < 330 nm as indicated by 
the arrow.  
B: Absorption spectra of EGTA and Ca2+ -EGTA solutions containing 10 µM fura-2, and 0 (control) or 
25 µM thiopental.   
The thiopental-induced increase in absorbance at < 330 nm (as observed in A) was still 
apparent in the presence of fura-2 as indicated by arrows.  
C: Absorbtion spectra obtained by subtracting the absorption curves of solutions containing no fura-2 (see A) 
from the corresponding curves of solutions containing 10 µM fura-2 pentapotassium salt (see B).  
The subtraction eliminates unspecific absorbance effects of thiopental on solutions in 
general from possible effects on fura-2 itself. 
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Similar spectrophotometric measurements were carried out using 10 µM 
ketamine. Firstly, as can be seen in figure 25A, 10 µM ketamine marginally increased the 
absorbance of the dye-free (Ca2+) -EGTA solutions over the complete wavelength range of relevance for 
fura-2 excitation.  
Secondly, as shown in figure 25B, the absorbance increase induced by 10 µM ketamine 
was hardly detectable in the presence of 10 µM fura-2 in the (Ca2+) –EGTA solutions. 
Finally, to eliminate the non-specific effect of ketamine on (Ca2+) -EGTA 
solutions in general (in the absence of the dye), the absorbance of the dye-free solutions 
was subtracted from that of dye-containing solutions. As shown in figure 25C, the 
resulting absorbance curves were virtually identical for solutions in the absence and 
presence of ketamine, showing that ketamine did not interfere with the absorption characteristics 
of fura-2.  
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Figure 25: Effects of ketamine (ket) on the absorption spectra of Ca2+ -free or Ca2+ -containing 
solutions in the absence or presence of fura-2 pentapotassium salt  
Vertical bars indicate the full width at half maximum (FWHM) of the excitation light 
obtained by the use of typical excitation filters or monochromators in fura-2 experiments 
(for filter spectra see e.g. Omega Optical, Inc., http://www.omegafilters.com). 
A: Absorption spectra of EGTA and Ca2+ -EGTA solutions in the absence of fura-2 and the presence of 
0 (control) or 10 µM ketamine.  
Ketamine marginally increased the absorbance in both Ca2+ -free and Ca2+ -containing 
solutions over the complete wavelength range of relevance for fura-2 excitation.  
B: Absorption spectra of EGTA and Ca2+ -EGTA solutions containing 10 µM fura-2, and 0 (control) or 
10 µM ketamine.   
The increased absorbance in the presence of ketamine (as observed in A) was hardly 
detectable in the presence of fura-2.  
C: Absorbtion spectra obtained by subtracting the absorption curves of solutions containing no fura-2 (see A) 
from the corresponding curves of solutions containing 10 µM fura-2 pentapotassium salt (see B).  
The subtraction eliminates unspecific absorbance effects of ketamine on solutions in 
general from possible effects on fura-2 itself. 
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Further tests to exclude an interference of the anaesthetics with emission 
characteristics of the dye were carried out on an actual ratiometric fura-2 set-up.  
 
3.1.1.2 Calibration of the fura-2 signal on a ratiometric photometry set-up 
To exclude any thiopental or pentobarbital-induced quenching of the ratiometric fura-2 
signal, standard calibration procedures (see chapter 2.3; Grynkiewicz et al., 1985) were 
carried out on the ratiometric imaging set-up (see chapter 2.3) both in the absence 
(control: Kd = 196 ± 7 nM, Rmin = 0.738 ± 0.003, Rmax = 1.411 ± 0.026, Sf2/Sb2 = 1.487 
± 0.024; n = 8) and presence of 25 µM thiopental (Kd = 190 ± 4 nM, Rmin = 0.735 ± 
0.002, Rmax = 1.410 ± 0.017, Sf2/Sb2 = 1.487 ± 0.017; n = 8), and in the absence 
(control: Kd = 189 ± 5 nM, Rmin = 0.720 ± 0.004, Rmax = 1.470 ± 0.027, Sf2/Sb2 = 1.595 
± 0.030; n = 9) and presence of 50 µM pentobarbital (Kd = 194 ± 6 nM, Rmin = 0.715 ± 
0.005, Rmax = 1.449 ± 0.033, Sf2/Sb2 = 1.609 ± 0.039; n = 10), respectively. None of 
these values was significantly different from those obtained under the control condition 
(P > 0.3 for all values) indicating that neither 25 µM thiopental nor 50 µM pentobarbital does 
interfere with the spectral characteristics of fura-2. 
Similar control experiments were carried out for the dissociative anaesthetic 
ketamine. The following values were obtained in the absence (control: 
Kd = 210 ± 12 nM, Rmin = 0.720 ± 0.004, Rmax = 1.470 ± 0.027, Sf2/Sb2 = 1.595 ± 0.030; 
n = 9) and presence of 10 µM ketamine (Kd = 189 ± 5 nM, Rmin = 0.730 ± 0.007, 
Rmax = 1.410 ± 0.011, Sf2/Sb2 = 1.532 ± 0.025; n = 11). Neither the Kd, and Rmin nor 
Sf2/Sb2, differed significantly from control conditions (P > 0.05 for all cases). Only Rmax 
was significantly (P < 0.05), but marginally smaller in the presence of ketamine (96% of 
control) indicating that accordingly corrected Rmax values, i.e. reduced by 4 %, may have to be 
applied when fluorescence ratios are transformed into approximate [Ca2+]i (see chapter 2.3) when 
ketamine is present. 
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3.1.1.3 Resting [Ca2+]i in fura-2 loaded intracardiac neurons  
In fura-2 loaded, unclamped intracardiac neurons, the mean resting [Ca2+]i was 46 ± 
4 nM in the absence and 44 ± 4 nM1 (n = 30) in the presence of the i.v anaesthetics. The 
lack of effect of the i.v anaesthetics on resting Ca2+ levels indicates that in unstimulated neurons, 
resting [Ca2+]i and thus concentration gradients for Ca2+ ions were unchanged by the i.v. 
anaesthetics. 
 
3.1.2 Voltage-gated Ca2+ -channels contribute to nAChR-induced [Ca2+]i transients in intracardiac 
neurons 
Activation of the non-selective cationic nAChR channel in rat intracardiac neurons 
mediates not only Na+ influx, but also a considerable Ca2+ influx (Adams & Nutter, 
1992; Fieber & Adams, 1991a), which results in an increase in [Ca2+]i that can be 
detected with fura-2 (Beker et al., 2003). This cationic influx leads to a depolarization 
that could be strong enough to activate voltage-gated channels, including voltage-gated 
Ca2+ channels (Cav) that in turn may contribute to the increases in [Ca2+]i initiated by 
nAChR-activation. As these effects have not previously been assessed in rat intracardiac 
neurons, nAChR-induced Ca2+ transients were elicited in the presence or absence of the 
Ca2+ -channel blocking agents Cd2+ or ω-conotoxin GVIA. 
In one series of experiments, nAChR-induced [Ca2+]i transients were evoked by 
500 µM ACh in the presence of 1 µM Atropine and the absence (control) or presence 
of 100 µM CdCl2 bath applied. The CdCl2 concentration is typically used to non-
selectively block Cav and it has been shown to induce a total inhibition of the 
corresponding current in rat intracardiac neurons (Xu & Adams, 1992b). As illustrated 
in figure 26, CdCl2 appeared to reversibly inhibit nAChR-induced ∆[Ca2+]i in all cells examined 
(n = 4). In addition, resting [Ca2+]i appeared to continuously increase starting with the application of 
CdCl2 and was even greater during washout in all cells examined (n = 4).  
                                                 
1 Average resting [Ca2+]i was 45 ± 4 nM when approximations of [Ca2+]i using formula (3) were based on 
the corrected (i.e. reduced by 4 %) Rmax value for the ketamine condition (see chapter 3.1.1.2). 
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Figure 26: CdCl2 appears to diminish nAChR-induced [Ca2+]i transients  
 Approximate [Ca2+]i transients in response to focal application of 500 µM ACh obtained in the absence 
(control) and presence of 100 µM CdCl2 in the bath solution.  
The bath solution also contained 1 µM atropine to inhibit mAChR.  
 
Due to these apparent increases in resting [Ca2+]i we have suspected an 
interaction of Cd2+ with fura-2 and therefore carried out further control experiments 
using CdCl2 to assess the validity of the above experiment. 
We have recently shown that the application of ACh in the presence of 
mecamylamine to block nAChR channels activates muscarinic AChR (mAChR) and a 
subsequent, transient increase in [Ca2+]i due to Ca2+ release from internal stores via a 
phospholipase C (PLC) dependent second-messenger pathway. Given that increases in 
[Ca2+]i were not dependent on the presence of Ca2+ in the extracellular solution (Beker 
et al., 2003) and assuming that Cd2+ at the concentrations used merely blocks Cav, it was 
expected that increases in [Ca2+]i are unaffected by the presence of CdCl2.  
However, activation of mAChR-induced increases in [Ca2+]i by 500 µM ACh in the 
presence of 3 µM mecamylamine appeared to be similarly inhibited in the presence of 100 µM 
CdCl2 (n = 2) as can be seen in figure 27. In addition, resting [Ca2+]i again appeared to 
continuously increase starting with the application of CdCl2 and was even greater during 
washout in all cells examined (n = 2). 
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Figure 27: CdCl2 appears to diminish mAChR-induced [Ca2+]i transients  
 [Ca2+]i transients in response to focal application of 500 µM ACh obtained in the absence (control) and 
presence of 100 µM CdCl2 in the bath solution.  
The bath solution also contained 3 µM mecamylamine to inhibit nAChR.  
 
Further suspecting an interaction of Cd2+ ions with fura-2, spectrophotometric 
measurements were carried out using solutions with 0 nM [Ca2+]s (EGTA solution) or 
> 0.1 mM [Ca2+]s (Ca2+ -EGTA solution) in the presence or absence of 100 µM Cd2+.  
In analogy to the experiments described in chapter 3.1.1.1, it was firstly 
examined whether 100 µM CdCl2 alters the absorbance of solutions in the absence of 
fura-2. As shown in figure 28A, Cd2+ basically affected the absorbance all solutions to a minor, 
but constant degree over the whole wavelength range under investigation.  
Secondly, the effects of CdCl2 on the absorbance of solutions supplemented 
with 10 µM fura-2 were examined. As shown in figure 28B, the presence of CdCl2 did 
basically not affect the absorbance of the fura-2 containing Ca2+ -EGTA solution. However, it 
affected the absorbance of the fura-2 containing (Ca2+ -free) EGTA solution, with increased values for 
excitation wavelengths < 355 nm and decreased values for excitations wavelength > 355 nm. 
Finally, it was examined whether CdCl2 affects the absorption characteristics of 
fura-2 itself after any non-specific effect of CdCl2 on solutions in general (in the absence 
of the dye) had been eliminated by subtracting the absorbance of the dye-free solutions 
from those of dye-containing (10 µM fura-2) solutions. As shown in figure 28C, the 
resulting absorbance curves were only identical in the absence and presence of CdCl2 for the Ca2+ -
EGTA solutions. In contrast, CdCl2 enhanced the absorbance of the virtually Ca2+ -free EGTA 
solutions for wavelengths < 355 nm, while the absorbance for wavelengths > 355 nm was decreased, 
showing that CdCl2 interacts with fura-2 under these conditions.  
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Figure 28: Effects of CdCl2 (Cd) on the absorption spectra of Ca2+ -free or Ca2+ -containing 
solutions in the absence or presence of fura-2 pentapotassium salt  
Vertical bars indicate the full width at half maximum (FWHM) of the excitation light 
obtained by the use of typical excitation filters or monochromators in fura-2 experiments 
(for filter spectra see e.g. Omega Optical, Inc., http://www.omegafilters.com). 
A: Absorption spectra of EGTA and Ca2+ -EGTA solutions in the absence of fura-2 and the presence of 
0 (control) or 100 µM CdCl2.  
CdCl2 marginally increased the absorbance in Ca2+ -free and Ca2+ -containing solutions. 
B: Absorption spectra of EGTA and Ca2+ -EGTA solutions containing 10 µM fura-2, and 0 (control) or 
100 µM CdCl2.   
The absorbance of Ca2+ -EGTA solutions containing fura-2 was virtually unaffected by the 
presence of CdCl2. In contrast, absorbance was markedly altered when fura-2 containing 
solutions were based on (Ca2+ -free) EGTA solutions. 
C: Absorbtion spectra obtained by subtracting the absorption curves of solutions containing no fura-2 (see A) 
from the corresponding curves of solutions containing 10 µM fura-2 pentapotassium salt (see B).  
The subtraction eliminates unspecific absorbance effects of CdCl2 on solutions in general 
from possible effects on fura-2 itself. Absorbance in Ca2+ -free solutions was increased at 
excitation wavelengths < 355 nm and reduced at excitation wavelengths > 355 nm with 
CdCl2 present as indicated by the arrows.  
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Further experiments using CdCl2 were abandoned as the interaction of the 
divalent cation Cd2+ with fura-2 was also likely to confound the assessment of the 
contribution of Cav to the [Ca2+]i transients following nAChR activation. Alternatively, 
control experiments using the peptide toxin ω-conotoxin GVIA were carried out. ω-
conotoxin GVIA specifically blocks N-type Cav in a virtually irreversible manner 
(recovery > 1 hr, see Boland et al., 1994; Feng et al., 2001) and a maximally effective 
concentration (300 nM) of ω-conotoxin GVIA inhibits ~ 70 % of the voltage-gated 
Ca2+ -currents in rat intracardiac neurons (see chapter 1.4.2). Given that (i) a remainder 
of ~ 30 % of the voltage-gated Ca2+ -currents cannot be blocked by ω-conotoxin GVIA 
in intracardiac neurons and (ii) voltage-gated sodium channels may activate unblocked 
Cav by intensifying the depolarization initiated by nAChR activation, a high 
concentration (1 µM) of tetrodotoxin (TTX) to block voltage-gated sodium channels 
was used together with an almost maximally effective concentration (100 nM) of the 
expensive ω-conotoxin GVIA (Xu & Adams, 1992b). 
As shown in figure 29, 100 nM ω-conotoxin GVIA and 1 µM TTX reduced [Ca2+]i 
transients evoked by the focal application of 500 µM ACh in the presence of 1 µM 
atropine by 69 % from 26 ± 5 nM to 8 ± 2nM in fura-2 loaded intracardiac neurons (P 
< 0.01; n = 5). Note that the control condition is uniquely based on transients obtained 
prior to the wash-in of ω-conotoxin GVIA and TTX and does not include values from 
a washout condition as the effects of ω-conotoxin GVIA are virtually irreversible. The 
calculated magnitude of the inhibition may therefore be somewhat overestimated, as this 
procedure does not correct for any rundown in the cellular responses to agonist 
application. 
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Figure 29: nAChR-induced [Ca2+]i transients in rat intracardiac neurons are inhibited by ω-
conotoxin GVIA and TTX 
A: [Ca2+]i transients in response to focal application of 500 µM ACh obtained in the absence (control) and 
presence of 100 nM ω-conotoxin GVIA and 1 µM TTX in the bath solution.  
The bath solution also contained 1 µM atropine to inhibit mAChRs. 
B: Bar graphs of the changes in ACh-induced [Ca2+]i increases by ω-conotoxin GVIA and TTX together 
with 1 µM atropine bath applied.  
Bath application of 100 nM ω-conotoxin GVIA and 1 µM TTX significantly reduced ACh-
induced increases in [Ca2+]i (P < 0.01, n = 5).  
 
Taken together, the control experiments described above show that voltage-gated 
Ca2+ channels contribute to the increase in [Ca2+]i initiated by nAChR activation, but the exact 
magnitude of their contribution remains to be determined. 
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3.2 Effects of i.v. anaesthetics on [Ca2+]i transients and membrane 
currents in intracardiac neurons 
3.2.1 Thiopental 
3.2.1.1 Inhibition of nAChR-induced [Ca2+]i transients  
In fura-2-loaded rat intracardiac neurons, focal application of 500 µM ACh to the cell 
soma in the presence of the muscarinic ACh receptor antagonist, atropine (100 nM) in 
the bath solution, evoked a rapid, transient increase in [Ca2+]i (∆[Ca2+]i) of 70 ± 5 nM 
above resting [Ca2+]i (n = 21).  
In the presence of the barbiturate, thiopental (25 µM = clinical EC50; Franks & Lieb, 
1994; Krasowski & Harrison, 1999; Yamakura et al., 2001), however, the increase in 
[Ca2+]i evoked by focal application of 500 µM ACh in the presence of atropine was 
inhibited by 42 % from 66 ± 14 nM to 38 ± 10 nM (P < 0.01; n = 6) as shown in 
figure 30A. Applying ACh in the presence of atropine and varying concentrations of 
thiopental obtained a concentration-response curve. Half maximal inhibition of ∆[Ca2+]i by 
thiopental occurred at 28 µM, a value comparable to the clinical EC50 of thiopental, with a 
Hill coefficient of 1.24, as shown in figure 30 B. 
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Figure 30: Clinically relevant concentrations of thiopental inhibit nAChR-mediated [Ca2+]i 
transients in rat intracardiac neurons 
A: [Ca2+]i transients in response to focal application of 500 µM ACh obtained in the absence (control) and 
presence of 25 µM thiopental in the bath solution.  
The bath solution also contained 100 nM atropine to inhibit mAChR.  
B: Concentration-response relationship for inhibition of ACh-induced [Ca2+]i transients by thiopental in the 
presence of 100 nM atropine.  
Average [Ca2+]i responses to ACh in the presence of thiopental were normalized to average 
responses obtained with agonist applications before and after superfusion with thiopental 
in the same cells. Data points represents the mean normalized [Ca2+]i response ± S.E.M. 
from 2 to 7 cells. The curve of best fit to the data had a Kd = 28 µM and Hill coefficient of 
1.24. 
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3.2.1.2 Simultaneous inhibition of nAChR-induced currents and [Ca2+]i transients in voltage-
clamped neurons 
To exclude any contribution of a secondary influx of Ca2+ ions to the increase in [Ca2+]i 
due to the involvement of voltage-dependent Ca2+ channels activated by nAChR-
induced depolarization of the cell membrane, the influx of Ca2+ by nAChR activation 
was studied under voltage-clamp conditions. Using the perforated patch recording 
configuration, fura-2 loaded neurons were held at –60 mV and application of 500 µM 
ACh in the presence of atropine evoked peak current amplitudes and increases in peak 
[Ca2+]i of –602 ± 195 pA and 88 ± 19 nM (n = 4) from a resting [Ca2+]i of 174 ± 12 nM 
respectively2. Bath application of 25 µM thiopental reduced the peak current amplitude 
by 61 % to –237 ± 84 pA (P < 0.05; n = 4) and the [Ca2+]i response by 53 % to 
41 ± 10 nM (P < 0.05) as shown in figure 31. This result shows that a clinically relevant 
concentration of thiopental inhibits nAChR-induced peak current amplitudes and simultaneous 
increases in [Ca2+]i, without any contribution of voltage-gated Ca2+ channels.   
                                                 
2 Interestingly, resting [Ca2+]i in patched neurons was several-fold higher than in unpatched neurons. As a 
comparable increase in basal [Ca2+]i was observed in somatotropes due to Ca2+ flux via stretch-activated 
Ca2+ channels that were activated by the seal-formation during patch-clamping (Robert et al., 1999), it can 
be speculated that these channels may also be present in rat intracardiac neurons. 
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Figure 31: Inhibition of nAChR-mediated [Ca2+]i transients and membrane currents (IACh) by 
thiopental 
A: Fura-2-loaded rat intracardiac neurons were voltage-clamped at –60 mV using the perforated patch whole-
cell recording configuration.  
Traces of transient [Ca2+]i and whole-cell inward currents recorded simultaneously in 
response to 500 µM ACh in the absence and presence of 25 µM thiopental bath applied. 
The bath solution also contained 100 nm atropine.  
B, C: Bar graphs of the changes in ACh-induced [Ca2+]i increases and membrane currents by thiopental together 
with ≥ 100 nM atropine bath applied.  
Bath application of 25 µM thiopental significantly reduced ACh-induced increases in 
[Ca2+]i (P < 0.05, n = 4) and peak inward current amplitude (P < 0.05, n = 4). 
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3.2.1.3 Voltage-independent inhibition of nAChR-induced currents 
Further experiments were carried out using the dialyzed-patch recording configuration in 
which the pipette solution contained 2 mM BAPTA to surmount any intracellular Ca2+ 
buffers. The ACh-evoked currents exhibited strong inward rectification and reversed 
close to 0 mV as described previously (Adams & Nutter, 1992; Fieber & Adams, 1991a). 
As shown in figure 32A and B, bath application of 25 µM thiopental reversibly inhibited 
nAChR-induced peak current amplitudes at negative holding potentials ranging from –
120 mV to –40 mV. Thiopental significantly inhibited peak current amplitudes at –120mV by 
38 % from –1077 ± 122 pA to –671 ± 105 pA, at –80 mV by 38 % from –732 ± 81 pA 
to –454 ± 70 pA and at –40 mV by 35 % from –314 ± 32 pA to –205 ± 30 pA (n = 11, 
P < 0.00033 for each holding potential). The significance criteria (α)  of p = 0.001 were 
conservatively adjusted to p = 0.00033 for each of these three holding potentials to take 
the number of comparisons (= 3) into account. A linear regression of the relative peak 
current amplitudes and the holding potentials revealed that the slope was not 
significantly different from zero (P > 0.3), indicating that thiopental inhibition of nAChR-
induced currents was voltage-independent over the range of –120 to –40 mV  (see figure 32C).  
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Figure 32: Voltage-independent inhibition of nAChR-mediated membrane currents by thiopental in 
voltage-clamped rat intracardiac neurons 
A: Whole-cell currents evoked by 300 µM ACh in the presence of 100 nM atropine at various membrane 
potentials in the absence (control) and presence of 25 µM thiopental, as indicated by the horizontal bar. 
The dashed horizontal lines indicate control responses obtained by averaging the peak 
current amplitudes before and after superfusion with thiopental.  
B: Current-voltage relationship for peak current amplitude evoked by 300 ACh µM in the presence of 
100 nM atropine.  
Data points represent mean peak current amplitudes ± SEM of 11 cells, before, during and 
after superfusion with 25 µM thiopental. 
C: Inhibition of ACh-induced peak current amplitudes by thiopental as a function of membrane potential in 
the presence of 100 nM atropine.  
Data points represent normalized mean peak current amplitudes ± SEM of 11 cells in the 
presence of 25 µM thiopental. Responses were normalized to average responses obtained 
before and after the superfusion with 25 µM thiopental in each individual cell. A linear 
regression of the relative peak current amplitudes and the holding potentials indicated that 
the slope was not significantly different from 0 (P > 0.3). 
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3.2.1.4 No inhibition of Ca2+ release from caffeine-sensitive Ca2+ stores  
Recently, we have shown that Ca2+ influx upon nAChR activation leads to Ca2+-induced 
Ca2+ release (CICR) from intracellular, ryanodine-sensitive Ca2+ stores in rat intracardiac 
neurons (Beker et al., 2003). The secondary Ca2+ release from intracellular Ca2+ stores 
via ryanodine receptor (RyR) channels thus amplifies the nAChR-induced increase in 
[Ca2+]i. Given that thiopental has been suggested to inhibit ryanodine-induced Ca2+ 
release from the SR of papillary muscle cells (Komai & Rusy, 1994), the effect of 
thiopental on RyR channels was examined in rat intracardiac neurons. Caffeine, which is 
known to activate RyR channels, while inhibiting IP3 receptor channels (Ehrlich et al., 
1994), was used to examine the effects of thiopental on Ca2+ release from ryanodine-
sensitive intracellular stores. As shown in figure 33, application of 10 mM caffeine, which 
is likely to induce a maximal Ca2+ release from ryanodine-sensitive stores, evoked a 
transient, approximated, increase in [Ca2+]i of 92 ± 14 nM (n = 9), which was not significantly 
different from that obtained in the presence of 25 µM thiopental (90 ± 14 nM; 98 % of control, 
n = 9; P > 0.3). These data indicate that the clinical EC50 of thiopental does not inhibit RyR 
mediated-Ca2+ transients in rat intracardiac neurons.  
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Figure 33: Caffeine-induced [Ca2+]i transients are not inhibited by thiopental 
A: [Ca2+]i transients evoked upon activation of ryanodine receptors by application of 10 mM caffeine in the 
absence (control) and presence of 25 µM thiopental, as indicated by the horizontal bar.  
B: Bar graphs of caffeine-induced [Ca2+]i increases in the absence (control) and presence of 25 µM thiopental.  
Bath application of 25 µM thiopental did not significantly change caffeine-induced 
increases in [Ca2+]i (P > 0.3, n = 9).  
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3.2.2 Pentobarbital  
Bath application of the barbiturate, pentobarbital (50 µM = clinical EC50; Franks & 
Lieb, 1994; Krasowski & Harrison, 1999; Yamakura et al., 2001), reversibly inhibited 
increases in [Ca2+]i evoked by focal application of 500 µM ACh by 40 % from 
77 ± 7 nM to 46 ± 11 nM (n = 8; P < 0.01) as shown in figure 34A and C.  
 
3.2.3 Ketamine 
Similarly, the dissociative anaesthetic, ketamine (10 µM = clinical EC50; Krasowski & 
Harrison, 1999; Yamakura et al., 2001), also reversibly inhibited ACh-induced increases 
in [Ca2+]i by 43 % from 65 ± 8 nM to 37 ± 10 nM3 (n = 7; P < 0.05) as shown in figure 
34B and C.  
                                                 
3 Increases in [Ca2+]i were reduced by 40 % to 39 ± 11 nM (P < 0.05) when approximations of [Ca2+]i 
using formula (3) were based on the corrected (i.e. reduced by 4 %) Rmax value for the ketamine condition 
(see chapter 3.1.1.2). 
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Figure 34: Clinically relevant concentrations of thiopental, ketamine and pentobarbital inhibit 
nAChR-mediated [Ca2+]i transients  
A: [Ca2+]i transients in response to focal application of 500 µM ACh obtained in the absence (control) and 
presence of 50 µM pentobarbital in the bath solution.  
The bath solution also contained 100 nM atropine to inhibit mAChR. 
B: [Ca2+]i responses to 500 µM ACh focally applied in the presence of 100 nM atropine obtained in the 
absence (control) and presence of 10 µM ketamine in the bath solution.  
C: Bar graph of ∆ [Ca2+]i in response to ACh (control), ACh + 25 µM thiopental (n = 6), 50 µM 
pentobarbital (n = 8), and 10 µM ketamine (n = 7).  
Atropine (100 nM) was present in all bath solutions to inhibit mAChR. 
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4 DISCUSSION 
4.1 Assessment of fura-2 quenching by i.v. anaesthetics 
As various chemical agents, including lipophilic solutions (Muschol, 1999; Roe et al., 
1990) were shown to interfere with fura-2 measurements, we have assessed possible 
interactions of the very lipophilic anaesthetics thiopental, pentobarbital and ketamine 
with fura-2.  
Firstly, using spectrophotometry, the absorbance characteristics of clinically 
relevant concentrations of i.v. anaesthetics were examined in the presence and absence 
of fura-2. As the barbiturates thiopental and its metabolite pentobarbital are chemically 
identical with respect to all but one of their atoms (Büch & Büch, 2001; Chan et al, 
1985; Charney et al, 2001, Evers & Crowder, 2001), thiopental as the major, and 
clinically more relevant representative of the barbiturates was tested, as well as the 
chemically distinct dissociative anaesthetic ketamine.  
It was shown that (i) both 25 µM thiopental and 10 µM ketamine marginally increase 
the absorbance of (Ca2+) -EGTA solutions in an unspecific manner (also in the absence of fura-2). 
This could lead to slightly diminished excitation intensities and subsequently reduced 
emission intensities for fura-2. However, as both Ca2+ -free and Ca2+ -containing 
solutions were affected similarly, these changes should affect peak and resting values of 
[Ca2+]i transients in fura-2 loaded neurons similarly, while the calculated ∆ [Ca2+]i values, 
on which the statistical tests are based, should not be affected by the presence of the i.v. 
anaesthetics. In addition, ratiometric dyes such as fura-2 are less vulnerable to changes 
in excitation intensities than single wavelength dyes such as fluo-4, given that both 
excitation wavelengths of the dual-excitation dye are more or less affected similarly. 
(ii) The ketamine-induced increase in absorbance was uniform over the whole excitation 
spectrum examined, while the thiopental–induced increase was more pronounced at wavelengths 
< 330 nm. This can be neglected on an actual ratiometric set-up due to the narrow FWHM of 
the excitation light of the 340 nm bandpass filter or the corresponding monochromator 
setting.  
(iii) Both, the thiopental or ketamine–induced increases in absorbance are only a fraction of 
the total absorbance examined in the presence of fura-2, again indicating that the magnitude of 
this effect is likely to be negligible. 
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(iv) Most importantly, neither 25 µM thiopental nor 10 µM ketamine displayed a direct 
interaction with the dye as virtually no specific changes of the absorbance characteristics of 
fura-2 (following subtraction of the unspecific, not dye-related effects) could be 
detected in the presence of the anaesthetics.  
Taken together, these data clearly show that virtually no anaesthetic-induced 
interference with the absorbance and thus excitation characteristics of fura-2 occurs at clinically 
relevant concentrations of the anaesthetics tested, suggesting that the absorbance 
properties of fura-2 allow for the administration of moderate doses of these anaesthetics 
in fura-2 experiments. 
Furthermore, as not only the excitation, but also the emission characteristics of 
dyes can be affected by the presence of chemical agents, further control experiments were 
carried out on the actual ratiometric imaging set-up. Similar values for Kd, Rmin and Rmax and 
Sf2/Sb2 were obtained in standard calibration solutions in the absence (control) or 
presence of clinically relevant concentrations of the barbiturates thiopental or 
pentobarbital, respectively, clearly showing that fura-2 experiments can faithfully be carried out 
in the presence of these barbiturates. 
For the dissociative anaesthetic, ketamine, Rmax values were marginally, but 
significantly different from control conditions. However, statistical tests using Rmax values that had 
been corrected for the presence of ketamine yielded similar results in experiments with fura-2 loaded 
cells, indicating that the mayor conclusions remain unaffected (see chapter 3.2.3) – despite 
possible inaccuracies regarding the assessment of [Ca2+]i in the presence of ketamine.  
Finally, resting [Ca2+]i in fura-2 loaded rat intracardiac neurons were similar in the presence 
and absence of the anaesthetics indicating that driving forces for Ca2+ ions were not affected 
by the anaesthetics.  
 
4.2 Voltage-gated Ca2+ -channels contribute to nAChR-induced 
[Ca2+]i transients 
Further experiments using Ca2+ -channels blockers cadmium and ω-conotoxin GVIA have 
revealed that voltage-gated Ca2+ channels contribute to the increases in [Ca2+]i following 
nAChR activation, but the exact extend of this contribution could not be assessed.  
The voltage-gated Ca2+ -channel blocker CdCl2 appeared to strongly and reversibly 
inhibit nAChR induced increases in [Ca2+]i. Note that this observed inhibition is unlikely to 
be due to a block of nAChR channels, given that the EC50 for the CdCl2 induced block 
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of nAChR in rat intracardiac neurons is ~ 500 µM (Nutter & Adams, 1995) and thus 
about five-fold higher than the CdCl2 concentration used in the present experiment.  
The astonishing finding, however, was that mAChR induced increases in [Ca2+]i in the presence 
of mecamylamine were similarly inhibited. One explanation for the latter finding would be an 
incomplete block of nAChR by 3 µM mecamylamine and activation of voltage-gated Ca2+ 
channels following membrane depolarization initiated by cation flux through unblocked, 
activated nAChR channels. This is not unlikely, as a complete block of ACh-evoked 
currents could not even be obtained with mecamylamine concentrations several orders 
of magnitude greater than its Kd for inhibition of ACh-evoked currents in rat 
intracardiac neurons (37 nM; Fieber & Adams, 1991a). In line with that, and also in rat 
intracardiac neurons, Hogg et al. (1999) have determined the residual nAChR evoked 
current in the presence of 1 µM mecamylamine as about 12 %. In addition, several 
subunit combinations of nAChR channels, when expressed in Xenopus oocytes, 
including the very Ca2+ permeable α7 homomeric channel, have been shown to be 
relatively insensitive to mecamylamine (Chavez-Noriega et al., 1997).  
However, alternative explanations for these results do arise from multiple 
(unwanted) cadmium effects aside from a block of voltage-gate Ca2+ -channels that are likely 
to confound fluorimetric [Ca2+]i measurements. 
Cadmium’s major setback for fura-2 experiments is its direct interaction with the 
dye. Most importantly, in line with previous studies, our photospectrometer results 
demonstrate that Cd2+ ions change the absorbance of unsaturated fura-2 in a similar manner like 
Ca2+ (Hinkle et al., 1992; Marchi et al., 2000), with increased absorbance for excitation 
wavelengths below the isosbestic point (~355 nm) and reduced absorbance above it. 
Assuming that Cd2+ penetrates the cell, its interaction with intracellularly trapped fura-2 
thus would increase fluorescence ratios and erroneously suggest increases in [Ca2+]i. 
However, there is some controversy concerning the magnitude of fura-2 quenching in living cells. 
Marchi and co-workers argue that the presence of heavy metal ions does not interfere 
with fluorescent Ca2+ measurements in living cells, as cytosolic metal ligands such as 
reduced glutathione diminish dye quenching considerably, but other groups use fura-2 
quenching by Cd2+ as a method to measure Cd2+ fluxes inside cells (Hinkle et al., 1992; 
Usai et al., 1999). The crux of the matter, however, is that basically nothing is known 
about the pathways of Cd2+ entry into intracardiac neurons. In other cell types, including 
neurons, voltage-gated Ca2+ channels have been suggested to be a major entry pathway 
for Cd2+ ions (Hinkle et al., 1987; Hinkle et al., 1992), but Ca2+ -permeable receptor-
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operated channels (ROC) and other Ca2+ entry pathways have been implied, too (Usai et 
al., 1999). Taken together, as cadmium ions are known to (i) quench fura-2 and (ii) are 
thought to enter excitable cells, they are likely to disturb fura-2 measurements also in rat 
intracardiac neurons.  
A second crucial, cadmium-associated point is its perturbation of the Ca2+ homeostasis 
of cells. Most importantly, intracellular cadmium has been shown to increase [Ca2+]i 
(Benters et al., 1997). Several factors are likely to contribute to cadmium-induced rises in 
[Ca2+]i, including cadmium binding to calmodulin and other cytosolic Ca2+ -binding 
proteins (Richard et al, 1986; Vig & Nath, 1991), inhibition of Ca2+ -ATPases 
(Hechtenberg & Beyersmann, 1991; Zhang et al., 1990), and a perturbation of the IP3 
metabolism (Benters et al., 1997). In particular, Benters and co-workers (1997) observed a 
cadmium-induced transient increase in the intracellular IP3 concentration that peaked 
about 5 min following the beginning of the cadmium exposure. Increases in the 
intracellular IP3 concentrations were followed by increases in [Ca2+]i that reached a peak 
value about 15 min following the exposure to cadmium. A similar perturbation of the 
IP3 mechanism in our preparation could alternatively explain the observed inhibition of 
mAChR induced [Ca2+]i transients by cadmium ions, given that activation of mAChR in 
rat intracardiac neurons mobilizes Ca2+ from intracellular stores in a PLC – and thus 
most likely IP3 – dependent manner, as we were recently able to show (Beker et al., 
2003). In addition, the relatively slow increase in [Ca2+]i following exposure to cadmium 
as observed in the study of Benters et al. (1997) may – at least in part – explain why 
resting [Ca2+]i even appeared to increase during washout of cadmium. The increases in 
resting F340/F380 observed in our experiments using CdCl2 can therefore not only be due 
to fura-2 quenching by cadmium, but may at least in part reflect true (cadmium-related) 
increases in [Ca2+]i, indicating that driving forces for Ca2+ ions may be altered following 
cadmium application.  
Taken together, there are still major difficulties in interpreting ratiometric [Ca2+]i 
measurements in the presence of cadmium, which do not allow an unequivocal decision 
whether voltage-gated Ca2+ channels contribute to nAChR induced increases in [Ca2+]i.  
Alternative control experiments were based on the use of the N-type voltage-
gated Ca2+-channel blocker ω-conotoxin GVIA (Boland et al., 1994; Feng et al., 2001) 
together with the voltage-gated sodium channel blocker TTX. nAChR induced [Ca2+]i 
transients were inhibited in the presence of TTX and the peptide toxin ω-conotoxin 
GVIA. While these results clearly show that voltage-gated Ca2+ channels contribute to nAChR 
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induced [Ca2+]i transients, the calculated percentage of inhibition (~ 70 %) does not reflect 
the contribution of Ca2+ influx via voltage-gated Ca2+ channels to the nAChR induced 
signal in the experiments with the anaesthetics. Firstly, this calculation is likely to be an 
overestimation of the contribution of N-type voltage-gated Ca2+ channels, as the conotoxin/TTX 
condition is compared with responses before the wash-in of these drugs a control 
condition. Thus, the estimation may be confounded by rundown of the nAChR-induced 
responses during the time course of the experiment. The problem here is that the effects 
of ω-conotoxin GVIA are virtually irreversible which means that a rundown of the 
observed cellular responses cannot be detected using the reversibility criteria of the 
washout condition. Secondly, Ca2+ release from ryanodine-sensitive stores has been shown to 
contribute to nAChR induced increases in [Ca2+]i (Beker et al. 2003) and the magnitude 
of this contribution may vary with the size of the Ca2+ influx. Finally, a higher atropine 
concentration (1 µM) was used in the conotoxin experiments than in all anaesthetics 
experiments in unclamped cells (100 nM). This is crucial, as high concentrations of atropine 
can alter the size of (neuronal) nAChR induced currents (Zwart & Vijverberg, 1997), 
and thus possibly also the relative contribution of Ca2+ influx via nAChR channels to 
the nAChR induced increase in [Ca2+]i.  
 
4.3 I.v. anaesthetics inhibit nAChR-induced [Ca2+]i transients 
We have shown that the activation of nAChR channels in fura-2 loaded rat intracardiac 
neurons induces a transient increase in [Ca2+]i, which can be inhibited by clinically relevant 
concentrations of i.v. anaesthetics. Thiopental (25 µM), inhibited nAChR-induced increases in 
[Ca2+]i by 42 % and a similar inhibition was observed with pentobarbital (50 µM; 40 % 
inhibition) and with the dissociative anaesthetic, ketamine (10 µM; 43 % inhibition). 
These results are consistent with previously reported studies using oocyte expression 
systems in which i.v. anaesthetics, including barbiturates and ketamine, have been 
shown to inhibit neuronal nAChR-mediated currents (see Krasowski & Harrison, 2000; 
Yamakura et al., 2001). On a molecular and cellular level, this corresponds with the 
clinical observation indicating that no specific chemical group is required to produce the 
effects that occur during general anaesthesia (see Franks & Lieb, 1994). Given that the 
resting [Ca2+]i was similar in the absence and the presence of the i.v. anaesthetics, 
indicating that concentration gradients for Ca2+ were unaffected, then changes in the driving 
force for Ca2+ cannot account for the inhibition of ACh-induced [Ca2+]i transients 
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observed in the presence of the i.v. anaesthetics. Taken together, these results clearly 
show that clinically relevant concentrations of i.v. anaesthetics can modulate intracellular Ca2+ 
signals in response to nAChR activation and thus possibly modify various cellular, Ca2+-
dependent functions, ranging from neuronal excitability to neurotransmitter secretion in 
intracardiac ganglia. Bath application of the i.v. anaesthetics prior to ACh application is 
likely to simulate the situation that occurs during the maintenance of general anaesthesia whereby 
the receptor and anaesthetic are at equilibrium (Downie et al., 2000). Our data demonstrate 
that bath application of clinically relevant concentrations of i.v. anaesthetics in intact, 
unclamped cells inhibit nAChR-induced Ca2+ transients. These data strongly suggest 
that similar effects may occur when intracardiac neurons are exposed to cholinergic stimulation in the 
presence of i.v. anaesthetics during anaesthesia.  
The concentration-response curve for the thiopental inhibition of nAChR-induced 
increases in [Ca2+]i had a Hill coefficient of 1.24 and a half maximal inhibition, IC50 of 
28 µM, which is close to the clinical EC50 of thiopental, indicating that the nAChR may 
represent an important molecular target of clinically relevant concentrations of thiopental.  
 
4.4 Thiopental inhibits nAChR- induced currents and [Ca2+]i 
transients in voltage-clamped neurons 
4.4.1 Thiopental simultaneously inhibits nAChR-induced currents and [Ca2+]i transients 
Voltage-gated Ca2+ channels have been shown to be relatively insensitive to clinically 
relevant concentrations of general anaesthetics although a few exceptions have been 
reported (Franks & Lieb, 1994; 1998; Lynch & Pancrazio, 1994; Study, 1994). Under 
voltage-clamp conditions, ACh-induced transient increases in [Ca2+]i concomitant with 
rapid inward currents were inhibited in the presence of 25 µM thiopental. These data 
demonstrate that, (i) i.v. anaesthetic block of nAChR-induced Ca2+ transients in rat intracardiac 
neurons occurs without any contribution of voltage-gated Ca2+ channels, and (ii) a common mechanism 
underlies the simultaneous inhibition of nAChR-induced inward currents and [Ca2+]i transients by 
an i.v. anaesthetic, that is block of Ca2+ influx through nAChRs. Inhibition of ACh-evoked 
inward currents by thiopental has also been described in PC12 cells (Andoh et al. 1997) 
and for nAChRs exogenously expressed in Xenopus oocytes (Coates et al., 2001; Downie 
et al., 2000).  
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4.4.2 Voltage-independent block of nAChR-induced currents by thiopental 
Under voltage clamp conditions, thiopental inhibited nAChR-mediated currents in rat 
intracardiac neurons in a voltage-independent manner at membrane potentials ranging 
from –120 to – 40 mV, consistent with that reported previously for thiopental inhibition 
of nAChRs in PC12 cells (Andoh et al. 1997) and human α7 homomeric nAChR-
channels expressed in Xenopus oocytes (Coates et al., 2001). The voltage-independence of the 
thiopental inhibition does not exclude an action of thiopental inside the pore of the nAChR channel 
(Andoh et al., 1997), as ~ 35 % of the thiopental molecules are likely to be present in 
the non-dissociated – and thus uncharged – state under our experimental conditions. 
This can be estimated based on the pKa value for thiopental (= 7.6; see Büch & Büch, 
2001; Wellhöner, 1988), the pH value of our solutions (= 7.34; see chapter 2.5) and 
using the equation (see e.g. Wellhöner et al., 1988) 
 
nb = 1/(1+10(pKa – pH))      (5) 
 
where nb is the fraction of the (basic) drug that is present in the non-dissociated state. 
Thiopental block of nAChR-mediated currents was also observed in dialyzed patch 
experiments in which the pipette solution dictates the cytoplasmic composition, 
indicating that the mechanism underlying the observed inhibition is not dependent on diffusible 
intracellular second messenger pathways. In contrast, the involvement of diffusible intracellular 
second messengers in mediating the inhibition of receptor-channels by anaesthetics in 
Xenopus oocytes cannot be entirely eliminated (Downie et al., 2000). In particular, the 
pipette solution containing the rapid Ca2+ chelator, BAPTA, is likely to (i) surmount any 
endogenous intracellular Ca2+-buffer, (ii) to ensure a stable resting [Ca2+]i and (iii) to 
substantially suppress CICR. Therefore, it is unlikely that the inhibition of nAChR-induced 
currents observed in the presence of thiopental is due to a reduced driving force for Ca2+ caused either 
by reduced intracellular Ca2+ buffer capacities or increased CICR responses from 
internal stores. Thiopental inhibition of nAChR induced currents in rat intracardiac 
neurons is most likely due to a direct action of thiopental on nAChR channels as proposed 
previously in studies using oocyte expression systems (Coates et al., 2001; Downie et al., 
2000). 
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4.5 Thiopental does not inhibit Ca2+ release from caffeine-sensitive 
Ca2+ stores  
Given that CICR via the activation of RyR has been shown to contribute to nAChR-
induced Ca2+ transients in rat intracardiac neurons (Beker et al., 2003), the effects of 
thiopental on RyR-induced CICR were examined upon activation of RyR with caffeine. 
As millimolar concentrations of caffeine are known to interact with fura-2 and to cause 
a red shift in the excitation spectra along with a reduced dynamic range of the dye 
(Muschol, et al. 1999; Uttenweiler et al., 1995), caffeine-induced increases in [Ca2+]i 
should be treated as approximations and are likely to be underestimated. Despite that, it 
was clearly shown that clinically relevant concentrations of thiopental had no effect on caffeine-
induced increases in [Ca2+]i, indicating that thiopental is unlikely to inhibit CICR from internal 
stores by inhibiting RyR channels. It remains to be determined, whether thiopental 
potentiation of Ca2+ release from ryanodine-sensitive Ca2+ stores may occur, as reported 
previously for high concentrations of volatile anaesthetics on the Ca2+-release from the 
SR in skeletal muscle (Kunst et al., 1999, 2000). 
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5 CONCLUSION AND OUTLOOK 
We have shown that clinically relevant concentrations of i.v. anaesthetics modulate Ca2+ 
homeostasis in intracardiac neurons by inhibiting ACh-induced currents and [Ca2+]i 
transients. The inhibition of ACh-induced [Ca2+]i transients by thiopental is due to a direct 
interaction with nAChR channels to inhibit Ca2+ influx and not a consequence of block of 
voltage-dependent Ca2+ channels or inhibition of Ca2+ release following RyR activation.  
Given that ACh is the primary neurotransmitter mediating parasympathetic 
(vagal) regulation of the heart and the presence of functional nAChR channels in 
intracardiac postganglionic neurons, clinically relevant concentrations of i.v. anaesthetics may 
modulate cardiac parameters during anaesthesia by binding to postsynaptic nAChRs and depressing 
ganglionic transmission.  
A direct effect of i.v. anaesthetics on nAChR channels in mammalian intrinsic 
cardiac neurons has not previously been taken into account when interpreting changes 
in heart rate and cardiac output during anaesthesia.  
As nAChR can also be found presynaptically (MacDermott et al., 1999) as well 
as in sympathetic ganglia, it will be interesting to find out if i.v. anaesthetics similarly 
target nAChR in these regions. 
 Further studies would greatly benefit from conclusive in vivo data regarding the 
cardiovascular effects of stereoisomers of the anaesthetics studied. Once such data is available 
the effects of the stereoisomers could be studied in detail in intracardiac ganglia and 
other relevant target tissues to further pinpoint the origin of such clinical side effects. 
The present study has investigated the effects of thiopental on the RyR that were 
activated by very high concentrations of caffeine, to ensure that the inhibition of 
nAChR induced Ca2+ signals was not actually due to an inhibition of RyR channels. 
However, the use of very high concentrations of caffeine – while providing stable 
signals with a good signal to noise ratio – may not allow to detect any potentiation of 
caffeine induced Ca2+ release from ryanodine-sensitive stores.  
A better understanding of the cellular Ca2+ homeostasis during anaesthesia, 
however, will ultimately require an in-depth study of the effects of clinically relevant concentrations 
of anaesthetics on intracellular Ca2+ -release channels. In skeletal muscle, e.g. previous studies 
have shown that only anaesthetic concentrations several fold higher than those of 
clinical relevance lead to Ca2+ release from intracellular stores (Kunst et al., 1999, 2000). 
Yet, with the advancement of confocal fluorescence microscopy, it has become possible to 
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examine local Ca2+ release events from single intracellular Ca2+ release channels or clusters 
thereof. Interestingly, Uttenweiler et al. (2003) were recently able to show that clinically 
relevant concentrations of halothane induced such local Ca2+ release events from the SR 
of skeletal muscle, indicating that the RyR may have to be considered as a distinct 
molecular target of general anaesthetics. Thus, it would be highly interesting to test clinically 
relevant concentrations of anaesthetics on local Ca2+ release events caused by intracellular Ca2+ 
release channels in neurons, applying high-resolution confocal microscopy. Yet, the Ca2+ 
release events occurring in neurons are still at the very detection limit of confocal 
microscopy, even though a few reports of elementary Ca2+ release events from 
intracellular stores in neurons do exist (Koizumi et al., 1999; Melamed-Book et al., 
1999). However, in analogy with the techniques used in muscle research, it may be 
possible to chemically skin neurons and thus be able to create favourable conditions for a reliable 
occurrence and detection of local Ca2+ -release events in neurons.  
Our photospectrometer studies have indicated that fura-2 experiments are 
feasible in the presence of clinically relevant concentrations of thiopental and ketamine. 
However, one should be cautious with very high concentrations of these anaesthetics, given that 
the effects of these drugs on the absorption characteristics of solutions in general, as well as on 
fura-2 are likely to intensify with increasing concentrations of the anaesthetics. Similar concerns 
may hold true for the emission characteristics of fura-2 and other Ca2+ indicators. Taken 
together, these are possible sources of artefacts that other researchers of the field should 
clearly have in mind when using Ca2+ indicators in the presence of (high concentrations 
of) lipophilic anaesthetics.   
Another possible source of artefacts in physiological experiments in general may be related 
to the use of Cd2+: Our preliminary experiments with Cd2+ suggests that Cd2+ ions can be 
very effective voltage-gated Ca2+ channel blockers, but may enter the cytosol, where they may 
cause adverse effects such as the perturbation of the Ca2+ pumps, or the IP3 mechanism (see 
chapter 4.2). While the extend of such effects may be tolerable in brief experiments – a 
long exposure to Cd2+ could aggravate these experimental problems.  
 Based on these preliminary results, it would also be very interesting to investigate 
possible entry pathways of Cd2+ ions into neurons. The combined use of fura-2 photometry 
together with patch-clamping is a particularly promising approach to the problem: 
Voltage-clamped fura-2 loaded neurons could be exposed to extracellular recording 
solutions with varying Ca2+ and Cd2+ concentrations, while cells are exposed to certain 
voltage-protocols (in combination with specific agonists) to specifically activate 
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presumed Cd2+ permeable channels. Using the dialyzed-patch configuration with fura-2 
present in the patch-pipette and in the absence of extracellular and intracellular Ca2+ 
(together with well defined Mg2+ concentrations) may create a condition under which 
fura-2 mainly acts as a Cd2+ indicator.  
The results of the present investigation lead to the important questions of the 
involvement of stretch-activated Ca2+ permeable channels in rat intracardiac neurons, given that (i) 
an increase in resting  [Ca2+]i was found in somatotropes due to Ca2+ flux via stretch-
activated channels that were activated by the patch procedure and (ii) resting [Ca2+]i was 
also several fold increased in clamped- neurons when compared with unclamped 
neurons of the present study (see chapter 3.2.1.2). The presence of stretch-activated Ca2+ 
channels may be functionally significant, as intracardiac neurons are likely to be exposed to 
mechanical forces that could activate such mechano-sensitive channels due to the 
pumping motion of the heart.  
Finally, an intriguing possibility for pharmaceutical research that comes to mind 
when looking at nAChR subtypes would be to take advantage of the different pharmaceutical 
profiles that are related to the different subunit composition of central vs. peripheral neuronal 
nAChR. These differences could be used to develop drugs that mainly target the CNS nAChR 
but not their PNS relatives or vice versa to substantially reduce adverse side effects of such 
channel-modulating drugs and rat intracardiac neurons could provide a particularly 
interesting target tissue to test the effects of such drugs on peripheral neurons.  
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A APPENDIX 
A.1 Statistical Analysis 
A.1.1 Calibration of the fura-2 signal in the presence of i.v. anaesthetics  
Given that the properties of UV-lamps used in a fluorescence microscopes typically 
change during their life times (typically ~ 400 operating hours), calibrations on the 
ratiometric imaging set-up in the presence of the anaesthetics were carried out 
alternately with control calibrations (in the absence of the anaesthetics) to ensure that 
the experimental conditions with respect to the operating hours of the UV-lamp were 
comparable.  
At first, calibrations in the presence and absence (control #1) of thiopental were 
done. Calibrations in the presence of either pentobarbital or ketamine were carried out 
at a later stage (with more operating hours of the UV-lamp) and were compared to a 
common, second and time matched control condition (control #2).  
t-tests  (two-tail) for unpaired samples were carried out for all the constants in 
equation 3 (see chapter 2.3), namely Kd, Rmin, Rmax and Sf2/Sb2: 
 
A.1.1.1 Thiopental 
Control condition #1 (n = 8):  (Ca2+) –EGTA calibration solutions & fura-2 
Experimental condition (n = 8): + 25 µM thiopental 
 
t-test for Kd: 
T value 0.7522535606  P value 0.4643593662  Degrees of Freedom 14 
 
t-test for Rmin: 
T value 0.9182842612  P value 0.3740200449  Degrees of Freedom 14 
 
t-test for Rmax: 
T value 0.0372479221  P value 0.9708132442  Degrees of Freedom 14 
 
t-test for Sf2/Sb2: 
T value 0.0155576153  P value 0.9878068585  Degrees of Freedom 14 
 134
 
A.1.1.2 Pentobarbital 
Control condition #2 (n = 9):  (Ca2+) –EGTA calibration solutions & fura-2 
Experimental condition (n = 10): + 50 µM pentobarbital 
 
t-test for Kd: 
T value -0.5303514830  P value 0.6027277542  Degrees of Freedom 17 
 
t-test for Rmin: 
T value 0.6793582904  P value 0.5060563161  Degrees of Freedom 17 
 
t-test for Rmax: 
T value 0.4796799493  P value 0.6375681690  Degrees of Freedom 17 
 
t-test for Sf2/Sb2: 
T value -0.2673684991  P value 0.7924020947  Degrees of Freedom 17 
 
A.1.1.3 Ketamine 
Control condition #2 (n = 9):  (Ca2+) –EGTA calibration solutions & fura-2 
Experimental condition (n = 11): + 10 µM ketamine 
 
t-test for Kd: 
T value -1.4422885561  P value 0.1663958946  Degrees of Freedom 18 
 
t-test for Rmin: 
T value -1.9389820169  P value 0.0683442065  Degrees of Freedom 18 
 
t-test for Rmax: 
T value 2.1748849923  P value 0.0432139035  Degrees of Freedom 18 
 
t-test for Sf2/Sb2: 
T value 1.6113836877  P value 0.1244918372  Degrees of Freedom 18 
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A.1.2 [Ca2+]i transients in unclamped, fura-2 loaded neurons 
t-tests (two tail) for paired samples were carried out for increases in [Ca2+]i (∆[Ca2+]i) using 
nM values. Control conditions are based on responses obtained in the same cells, but in 
the absence of the antagonists (i.e. voltage-gated channel blockers or anaesthetics, 
respectively; see chapter 2.6). 
 
A.1.2.1 ACh-induced responses 
t-test for effects of ω-conotoxin GVIA (+ TTX) on ACh-induced ∆[Ca2+]i: 
Control condition:    500 µM Ach & 1 µM atropine in PSS 
Experimental condition:  + 100 nM ω-conotoxin GVIA & 1 µM TTX 
T value 5.6468834522  P value 0.0048435733  Degrees of Freedom 4 
n = 5 
 
t-test for effects of thiopental on ACh-induced ∆[Ca2+]i: 
Control condition:    500 µM ACh & 100 nM atropine in PSS 
Experimental condition:  + 25 µM thiopental 
T value 6.4995059381  P value 0.0012870977  Degrees of Freedom 5 
n = 6 
 
t-test for effects of pentobarbital on ACh-induced ∆[Ca2+]i: 
Control condition:    500 µM ACh & 100 nM atropine in PSS 
Experimental condition:  + 50 µM pentobarbital 
T value 4.5699118262  P value 0.0025744035  Degrees of Freedom 7 
n = 8 
 
t-test #1 for effects of ketamine on ACh-induced ∆[Ca2+]i (uncorrected Rmax ; see 
chapter 3.1.1.2 and 3.2.3): 
Control condition:    500 µM ACh & 100 nM atropine in PSS 
Experimental condition:  + 10 µM ketamine 
T value 2.8191590810  P value 0.0303877426  Degrees of Freedom 6 
n = 7 
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t-test #2 for effects of ketamine on ACh-induced ∆[Ca2+]i (corrected Rmax ; see chapter 
3.1.1.2 and 3.2.3): 
Control condition:    500 µM ACh & 100 nM atropine in PSS 
Experimental condition:  + 10 µM ketamine 
T value 2.4933855001  P value 0.0469465722  Degrees of Freedom 6 
n = 7 
 
A.1.2.2 Caffeine-induced responses 
t-test for effects of thiopental on caffeine-induced ∆[Ca2+]i: 
Control condition:    10 mM caffeine in PSS 
Experimental condition:  + 25 µM thiopental 
T value 0.8724328954  P value 0.4083928772  Degrees of Freedom 8 
n = 9 
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A.1.3 Combined membrane current and [Ca2+]i recordings in voltage-clamped, fura-2 loaded neurons 
(perforated-patch) 
t-tests (two tail) for paired samples were carried out for ACh-induced increases in [Ca2+]i 
(∆[Ca2+]i, using nM values), as well as for baseline-adjusted, peak current amplitudes 
(using pA values). Control conditions are based on responses obtained in the same cells, 
but in the absence of thiopental (see methods, chapter 2.6).  
 
t-test for effects of thiopental on ACh-induced ∆[Ca2+]i in cells voltage-clamped at –60 
mV: 
Control condition:  500 µM ACh & 0.1 or 1 µM atropine in PSS; 
holding potential: -60 mV 
Experimental condition:  + 25 µM thiopental 
T value 4.9234481111  P value 0.0160564992  Degrees of Freedom 3 
n = 4 
 
t-test for effects of thiopental on ACh-induced peak current amplitudes in cells voltage-
clamped at –60 mV: 
Control condition:  500 µM ACh & 0.1 or 1 µM atropine in PSS; 
holding potential: -60 mV 
Experimental condition:  + 25 µM thiopental 
T value -3.2684754177  P value 0.0468308643  Degrees of Freedom 3 
n = 4 
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A.1.4 Membrane currents in voltage-clamped neurons (dialysed -patch) 
t-tests (two tail) for paired samples were carried out for ACh-induced, baseline-adjusted 
peak current amplitudes (using pA values) for cells held at holding-potentials from –120 
mV to –40 mV. No tests were carried out for 0 or +40 mV holding potential, as hardly 
any currents can be observed at these potentials due to the reversal potential and 
rectifying characteristics of the nAChR channel (see chapter 1.4.3). Control conditions 
are based on responses obtained in the same cells, but in the absence of thiopental. The 
shown p-values are those prior to Bonferroni-adjustment (see chapter 2.6 and 3.2.1.3).  
 
Control condition:  300 µM ACh & 100 nM atropine in PSS;  
holding potentials: –120, –80, –40, (0, +40) mV 
Experimental condition:  + 25 µM thiopental 
n = 11 
 
t-test for effects of thiopental on ACh-induced peak current amplitudes at –120 mV: 
T value -10.7011027017 P value 0.0000008513  Degrees of Freedom 10 
 
t-test for effects of thiopental on ACh-induced peak current amplitudes at –80 mV: 
T value -7.1993132358  P value 0.0000292851  Degrees of Freedom 10 
 
t-test for effects of thiopental on ACh-induced peak current amplitudes at –40 mV: 
T value -8.1718566527  P value 0.0000097701  Degrees of Freedom 10 
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A.2 Pharmacological data on thiopental, pentobarbital, and ketamine 
 
drug  FW pKa % of 
molecules 
in the non-
dissociated 
state at pH 
7.4 
i.v. 
induction 
dose 
(mg/kg)
duration 
of 
induction 
dose 
(min) 
urinary 
excretion 
(%)* 
plasma 
protein 
binding 
(%) 
clearance 
(ml*min-1 
*kg-1) 
vol. 
distrib
ution 
(l/kg)
t1/2β  
(h) 
thiopental 241.33 7.62,5 ~ 398 3-57 5-87 < 11,6 ~85 ± 
41,2,5,6 
3.9 ± 1.21,6 2.3 ± 
0.51,6 
~12.17
pento-
barbital 
225.27 8.115 ~ 168   20-705 ~614 - ~0.63 ~303,5
ketamine 237.74 7.55 ~ 448 0.1-1.57 10-157 4 ± 31 ~121,2,5 15 ± 51 1.8 ± 
0.71 
~37 
 
Values are expressed as mean (± SD). 
*Excretion of unchanged drug 
1Benet et al. (1996); 2Büch & Büch (2001); 3Fichtl (2001); 4Franks & Lieb (1994), based on Ehrnebo & Odar-Cederlöf (1977); 5Wellhöner (1988); 
6Thummel & Shen (2001); 7Evers & Crowder (2001); 8Calculation of pKa values is based on equation 5 (see chapter 4.4.2). 
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